STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

LEONA M & HARRY B HELMSLEY CHARITABLE TRUST: Form 990PF, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
LEONA M & HARRY B HELMSLEY CHARITABLE TRUST (EIN 13-7184401)
Tax period
2021-04-01 to 2022-03-31
Filed
2023-02-07
IRS object ID
202300389349100520
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2023-02-07T15:59:44-06:00ReturnTs
Tax Period End2022-03-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN873231666PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1PKF O'CONNOR DAVIES ADVISORY LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1245 PARK AVENUE 12TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10167ZIPCd
FieldValueIRS element (for citing)
Return Type990PFReturnTypeCd
Tax Period Begin2021-04-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN137184401EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE LEONA M AND HARRY B HELMSLEYBusinessNameLine1Txt
Business Name Line2CHARITABLE TRUSTBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlLEONBusinessNameControlTxt
Phone2126793600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1230 PARK AVENUE 659AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10169ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonNICHOLAS J SCHIAVOPersonNm
Person TitleCFOPersonTitleTxt
Phone2126793600PhoneNum
Signature2023-02-01SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstNICHOLASPersonFirstNm
Person LastSCHIAVOPersonLastNm
FieldValueIRS element (for citing)
SSNXXX-XX-XXXXSSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonTHOMAS BLANEYPreparerPersonNm
PTINP00234022PTIN
Phone2122862600PhoneNum
Preparation2023-02-01PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer3TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2023-03-07 01:45:13ZBuildTS

Form 990-PF IRS990PF

FieldValueIRS element (for citing)
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
FMV Assets EOY$8,221,675,612FMVAssetsEOYAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd

Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses

FieldValueIRS element (for citing)
Schedule B Not RequiredYes (X)ScheduleBNotRequiredInd
Interest On Sav Rev And Expnss$17,175InterestOnSavRevAndExpnssAmt
Interest On Sav Net Invst Incm$17,175InterestOnSavNetInvstIncmAmt
Dividends Rev And Expnss$36,631,242DividendsRevAndExpnssAmt
Dividends Net Invst Incm$129,538,579DividendsNetInvstIncmAmt
Net Gain Sale Ast Rev And Expnss$761,645,902NetGainSaleAstRevAndExpnssAmt
Gross Sales Price$1,837,772,977GrossSalesPriceAmt
Cap Gain Net Incm Net Invst Incm$713,350,607CapGainNetIncmNetInvstIncmAmt
Other Income Rev And Expnss$41,198,822OtherIncomeRevAndExpnssAmt
Other Income Net Invst Incm$279,081,117OtherIncomeNetInvstIncmAmt
Total Rev And Expnss$839,493,141TotalRevAndExpnssAmt
Total Net Invst Incm$1,121,987,478TotalNetInvstIncmAmt
Comp Ofcr Dir Trst Rev And Expnss$4,376,425CompOfcrDirTrstRevAndExpnssAmt
Comp Ofcr Dir Trst Net Invst Incm$1,691,434CompOfcrDirTrstNetInvstIncmAmt
Comp Ofcr Dir Trst Dsbrs Chrtbl$2,196,238CompOfcrDirTrstDsbrsChrtblAmt
Oth Empl Slrs Wgs Rev And Expnss$15,931,176OthEmplSlrsWgsRevAndExpnssAmt
Oth Empl Slrs Wgs Net Invst Incm$5,200,197OthEmplSlrsWgsNetInvstIncmAmt
Oth Empl Slrs Wgs Dsbrs Chrtbl$10,353,131OthEmplSlrsWgsDsbrsChrtblAmt
Pension Empl Bnft Rev And Expnss$7,356,974PensionEmplBnftRevAndExpnssAmt
Pension Empl Bnft Net Invst Incm$1,775,482PensionEmplBnftNetInvstIncmAmt
Pension Empl Bnft Dsbrs Chrtbl$5,487,497PensionEmplBnftDsbrsChrtblAmt
Legal Fees Rev And Expnss$446,869LegalFeesRevAndExpnssAmt
Legal Fees Net Invst Incm$240,534LegalFeesNetInvstIncmAmt
Legal Fees Dsbrs Chrtbl$171,108LegalFeesDsbrsChrtblAmt
Accounting Fees Rev And Expnss$618,474AccountingFeesRevAndExpnssAmt
Accounting Fees Net Invst Incm$288,521AccountingFeesNetInvstIncmAmt
Accounting Fees Chrtbl Prps$280,539AccountingFeesChrtblPrpsAmt
Other Prof Fees Rev And Expnss$9,031,764OtherProfFeesRevAndExpnssAmt
Other Prof Fees Net Invst Incm$6,537,533OtherProfFeesNetInvstIncmAmt
Other Prof Fees Dsbrs Chrtbl$2,576,991OtherProfFeesDsbrsChrtblAmt
Interest Net Invst Incm$1,565,857InterestNetInvstIncmAmt
Taxes Rev And Expnss$16,033,503TaxesRevAndExpnssAmt
Taxes Net Invst Incm$3,095,765TaxesNetInvstIncmAmt
Taxes Dsbrs Chrtbl$0TaxesDsbrsChrtblAmt
Deprec And Dpltn Rev And Expnss$412,792DeprecAndDpltnRevAndExpnssAmt
Deprec And Dpltn Net Invst Incm$23,687DeprecAndDpltnNetInvstIncmAmt
Occupancy Rev And Expnss$1,118,651OccupancyRevAndExpnssAmt
Occupancy Net Invst Incm$5,163OccupancyNetInvstIncmAmt
Occupancy Dsbrs Chrtbl$1,067,322OccupancyDsbrsChrtblAmt
Trav Conf Meeting Rev And Expnss$401,351TravConfMeetingRevAndExpnssAmt
Trav Conf Meeting Net Invst Incm$33,206TravConfMeetingNetInvstIncmAmt
Trav Conf Meeting Dsbrs Chrtbl$266,155TravConfMeetingDsbrsChrtblAmt
Other Expenses Rev And Expnss$23,083,802OtherExpensesRevAndExpnssAmt
Other Expenses Net Invst Incm$52,769,729OtherExpensesNetInvstIncmAmt
Other Expenses Dsbrs Chrtbl$2,101,380OtherExpensesDsbrsChrtblAmt
Tot Opr Expenses Rev And Expnss$78,811,781TotOprExpensesRevAndExpnssAmt
Tot Opr Expenses Net Invst Incm$73,227,108TotOprExpensesNetInvstIncmAmt
Tot Opr Expenses Dsbrs Chrtbl$24,500,361TotOprExpensesDsbrsChrtblAmt
Contri Paid Rev And Expnss$461,305,969ContriPaidRevAndExpnssAmt
Contri Paid Dsbrs Chrtbl$385,014,429ContriPaidDsbrsChrtblAmt
Total Expenses Rev And Expnss$540,117,750TotalExpensesRevAndExpnssAmt
Total Expenses Net Invst Incm$73,227,108TotalExpensesNetInvstIncmAmt
Total Expenses Dsbrs Chrtbl$409,514,790TotalExpensesDsbrsChrtblAmt
Excess Revenue Over Expenses$299,375,391ExcessRevenueOverExpensesAmt
Net Investment Income$1,048,760,370NetInvestmentIncomeAmt

Form990 PF Balance Sheets Form990PFBalanceSheetsGrp

FieldValueIRS element (for citing)
Cash BOY$32,275,203CashBOYAmt
Cash EOY$27,238,568CashEOYAmt
Cash EOYFMV$27,238,568CashEOYFMVAmt
Sav And Temp Cash Invst BOY$62,457,618SavAndTempCashInvstBOYAmt
Sav And Temp Cash Invst EOY$53,717,402SavAndTempCashInvstEOYAmt
Sav And Temp Cash Invst EOYFMV$53,717,402SavAndTempCashInvstEOYFMVAmt
Acct Rcvbl$449,759AcctRcvblAmt
Acct Rcvbl EOY$449,759AcctRcvblEOYAmt
Acct Rcvbl EOYFMV$449,759AcctRcvblEOYFMVAmt
Prepaid Expenses BOY$1,132,903PrepaidExpensesBOYAmt
Prepaid Expenses EOY$993,143PrepaidExpensesEOYAmt
Prepaid Expenses EOYFMV$993,143PrepaidExpensesEOYFMVAmt
Corporate Stock BOY$736,377,294CorporateStockBOYAmt
Corporate Stock EOY$591,948,988CorporateStockEOYAmt
Corporate Stock EOYFMV$591,948,988CorporateStockEOYFMVAmt
Other Investments BOY$7,438,326,657OtherInvestmentsBOYAmt
Other Investments EOY$7,406,511,362OtherInvestmentsEOYAmt
Other Investments EOYFMV$7,406,511,362OtherInvestmentsEOYFMVAmt
Land Bldg Equip Cost Or Other Bss$9,637,533LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$2,338,162LandBldgEquipAccumDeprecAmt
Land BOY$2,756,942LandBOYAmt
Land EOY$7,299,371LandEOYAmt
Land EOYFMV$7,299,371LandEOYFMVAmt
Other Assets BOY$40,261,279OtherAssetsBOYAmt
Other Assets EOY$133,517,019OtherAssetsEOYAmt
Other Assets EOYFMV$133,517,019OtherAssetsEOYFMVAmt
Total Assets BOY$8,313,587,896TotalAssetsBOYAmt
Total Assets EOY$8,221,675,612TotalAssetsEOYAmt
Total Assets EOYFMV$8,221,675,612TotalAssetsEOYFMVAmt
Accounts Payable BOY$11,454,781AccountsPayableBOYAmt
Accounts Payable EOY$12,198,129AccountsPayableEOYAmt
Grants Payable BOY$385,738,876GrantsPayableBOYAmt
Grants Payable EOY$462,030,416GrantsPayableEOYAmt
Other Liabilities BOY$48,968,356OtherLiabilitiesBOYAmt
Other Liabilities EOY$42,966,460OtherLiabilitiesEOYAmt
Total Liabilities BOY$446,162,013TotalLiabilitiesBOYAmt
Total Liabilities EOY$517,195,005TotalLiabilitiesEOYAmt
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind
No Donor Rstr Net Assests BOY$7,867,425,883NoDonorRstrNetAssestsBOYAmt
No Donor Rstr Net Assests EOY$7,704,480,607NoDonorRstrNetAssestsEOYAmt
Tot Net Ast Or Fund Balances BOY$7,867,425,883TotNetAstOrFundBalancesBOYAmt
Tot Net Ast Or Fund Balances EOY$7,704,480,607TotNetAstOrFundBalancesEOYAmt
Total Liabilities Net Ast BOY$8,313,587,896TotalLiabilitiesNetAstBOYAmt
Total Liabilities Net Ast EOY$8,221,675,612TotalLiabilitiesNetAstEOYAmt

Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp

FieldValueIRS element (for citing)
Tot Net Ast Or Fund Balances BOY$7,867,425,883TotNetAstOrFundBalancesBOYAmt
Excess Revenue Over Expenses$299,375,391ExcessRevenueOverExpensesAmt
Other Increases$6,516,842OtherIncreasesAmt
Subtotal$8,173,318,116SubtotalAmt
Other Decreases$468,837,509OtherDecreasesAmt
Tot Net Ast Or Fund Balances EOY$7,704,480,607TotNetAstOrFundBalancesEOYAmt

Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail

Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp (485 entries)

PropertyPropertyDescHow AcquiredHowAcquiredCdGross Sales PriceGrossSalesPriceAmtCost Or Other BasisCostOrOtherBasisAmtGain Or LossGainOrLossAmtGains Minus Excess Or LossesGainsMinusExcessOrLossesAmtSoldSoldDt
SALE OF PUBLICLY TRADED SECURITIESP$783,260,325$502,142,463$281,117,862$281,117,862
ACADIAN FRONTIER MARKETSP$6,043,498$6,043,498$6,043,4982021-04-12
ACADIAN FRONTIER MARKETSP$5,256,152$5,256,152$5,256,1522021-04-23
ACADIAN FRONTIER MARKETSP$704,849$704,849$704,8492021-05-07
ACADIAN FRONTIER MARKETSP$116,909$116,909$116,9092021-06-07
ACADIAN FRONTIER MARKETSP$100,187$100,187$100,1872021-07-02
ACADIAN FRONTIER MARKETSP$15,765,801$15,765,801$15,765,8012021-04-16
ACADIAN FRONTIER MARKETSP$7,271,558$7,271,558$7,271,5582021-11-29
ACADIAN FRONTIER MARKETSP$627,403$627,403$627,4032021-12-23
ACADIAN FRONTIER MARKETSP$14,718,858$14,718,858$14,718,8582021-11-12
ACCEL GROWTH FD IV LPP$762,599$762,599$762,5992021-05-03
ACCEL GROWTH FD IV LPP$1,371,954$1,371,954$1,371,9542021-12-30
ACCEL GROWTH FD IV LPP$1,927,891$1,927,891$1,927,8912021-09-01
ACCEL GROWTH FD IV LPP$844,748$844,748$844,7482021-09-27
ACCEL GROWTH FD IV LPP$794,475$794,475$794,4752021-10-05
ACCEL GROWTH FD IV LPP$795,456$795,456$795,4562021-10-08
ACCEL GROWTH FD IV LPP$827,150$827,150$827,1502021-09-21
ACCEL GROWTH FD IV LPP$898,054$898,054$898,0542021-07-09
ACCEL GROWTH FD IV LPP$935,520$935,520$935,5202021-06-28
ACCEL GROWTH FD IV LPP$916,349$916,349$916,3492021-06-22
ACCEL GROWTH FD IV LPP$922,445$922,445$922,4452021-06-09
ACCEL GROWTH FD IV LPP$1,678,310$1,678,310$1,678,3102021-04-13
ACCEL GROWTH FD IV LPP$918,329$918,329$918,3292021-06-15
ACCEL GROWTH FUND II LPP$3,023,197$3,023,197$3,023,1972021-09-07
ACCEL GROWTH FUND II LPP$1,049,551$1,049,551$1,049,5512021-06-07
ACCEL GROWTH FUND II LPP$651,714$651,714$651,7142021-10-12
ACCEL GROWTH FUND II LPP$1,519,324$1,519,324$1,519,3242021-09-09
ACCEL GROWTH FUND II LPP$892,266$892,266$892,2662021-06-22
ACCEL GROWTH FUND II LPP$805,302$805,302$805,3022021-06-11
ACCEL GROWTH FUND III LPP$1,506,581$1,506,581$1,506,5812021-09-15
ACCEL GROWTH FUND V LPP$193,482$193,482$193,4822022-01-14
ACCEL INDIA V LPP$629,258$629,258$629,2582021-10-19
ACCEL LEADERS FUND II LPP$643,613$643,613$643,6132022-02-04
ACCEL LEADERS FUND LPP$1,294,558$1,294,558$1,294,5582021-09-03
ACCEL LEADERS FUND LPP$861,407$861,407$861,4072022-03-10
ACCEL LEADERS FUND LPP$490,375$490,375$490,3752022-03-22
ACCEL LEADERS FUND LPP$1,836,781$1,836,781$1,836,7812021-04-08
ACCEL LEADERS FUND LPP$584,066$584,066$584,0662021-06-07
ACCEL XIP$549,774$549,774$549,7742021-09-08
ACCEL XIP$557,760$557,760$557,7602022-02-01
ACCEL XIP$207,655$207,655$207,6552021-09-14
ACCEL XIP$250,682$250,682$250,6822021-09-07
ACCEL XIP$552,167$552,167$552,1672022-02-09
ACCEL XIP$126,456$126,456$126,4562021-12-08
ACCEL XIP$199,073$199,073$199,0732021-09-17
ACCEL XIP$978,678$978,678$978,6782021-09-07
ACCEL XII LPP$1,225,001$1,225,001$1,225,0012021-07-20
ACCEL XII LPP$2,092,646$2,092,646$2,092,6462021-10-14
AH PARALLEL FUND III LPP$755,268$755,268$755,2682021-05-05
AH PARALLEL FUND III LPP$1,913,779$1,913,779$1,913,7792021-04-14
AH PARALLEL FUND III LPP$96,328$96,328$96,3282021-05-14
AH PARALLEL FUND III LPP$1,292,278$1,292,278$1,292,2782021-05-21
AH PARALLEL FUND III LPP$905,039$905,039$905,0392021-06-23
AH PARALLEL FUND III LPP$838,046$838,046$838,0462021-08-06
AH PARALLEL FUND III LPP$2,040,811$2,040,811$2,040,8112021-11-19
AH PARALLEL FUND III LPP$931,238$931,238$931,2382022-02-25
AH PARALLEL FUND IV LPP$858,855$858,855$858,8552021-11-09
AH PARALLEL FUND IV LPP$855,947$855,947$855,9472021-10-07
AH PARALLEL FUND IV LPP$1,472,731$1,472,731$1,472,7312021-08-30
AH PARALLEL FUND V LPP$141,753$141,753$141,7532021-08-12
ANDREESSEN HOROWITZ FD III LPP$1,364,143$1,364,143$1,364,1432022-02-25
ANDREESSEN HOROWITZ FD III LPP$16,413,572$16,413,572$16,413,5722021-04-14
ANDREESSEN HOROWITZ FD III LPP$2,984,077$2,984,077$2,984,0772021-11-19
ANDREESSEN HOROWITZ FD III LPP$1,304,066$1,304,066$1,304,0662021-08-06
ANDREESSEN HOROWITZ FD III LPP$407,573$407,573$407,5732021-06-23
ANDREESSEN HOROWITZ FD III LPP$10,861,471$10,861,471$10,861,4712021-05-21
ANDREESSEN HOROWITZ FD III LPP$337,833$337,833$337,8332021-05-05
ANDREESSEN HOROWITZ FD IV LPP$4,222,417$4,222,417$4,222,4172021-08-30
ANDREESSEN HOROWITZ FD IV LPP$2,867,922$2,867,922$2,867,9222021-10-07
ANDREESSEN HOROWITZ FD IV LPP$3,302,350$3,302,350$3,302,3502021-11-09
ANDREESSEN HOROWITZ FUND V LPP$364,128$364,128$364,1282021-08-12
ANDREESSEN HOROWITZ LSV FD IP$3,122,023$3,122,023$3,122,0232021-05-12
ANDREESSEN HOROWITZ LSV FD IP$3,122,023$3,122,023$3,122,0232021-05-11
ANDREESSEN HOROWITZ LSV FD IP$3,314,660$3,314,660$3,314,6602021-04-13
ANDREESSEN HOROWITZ LSV FD IP$2,493,527$2,493,527$2,493,5272021-04-14
ANDREESSEN HOROWITZ LSV FD IP$1,644,627$1,644,627$1,644,6272021-05-21
ANDREESSEN HOROWITZ LSV FD IP$7,951,120$7,951,120$7,951,1202021-11-09
ANDREESSEN HOROWITZ LSV FD IP$3,122,023-$3,122,023-$3,122,0232021-05-12
ARBORETUM IVP$2,970,948$2,970,948$2,970,9482021-06-22
ARBORETUM IVP$3,604,563$3,604,563$3,604,5632021-10-26
ARBORETUM IVP$676,144$676,144$676,1442021-12-07
ARBORETUM VENTURES IV LPP$2,309,164$2,309,164$2,309,1642021-10-26
ARBORETUM VENTURES IV LPP$153,564$153,564$153,5642021-06-22
BAYVIEW OPPORTUNITY OFFSHORE IVA LPP$685,417$685,417$685,4172022-01-14
BLACKROCK US DEBT INDEX FUND BP$20,000,000$21,408,607-$1,408,607-$1,408,6072022-03-30
BLACKROCK US DEBT INDEX FUND BP$26,435$27,262-$827-$8272022-01-26
BLACKROCK US DEBT INDEX FUND BP$30,000,000$32,423,251-$2,423,251-$2,423,2512022-03-25
BLACKROCK US DEBT INDEX FUND BP$24,999$24,901$98$982021-07-28
BLACKROCK US DEBT INDEX FUND BP$26,571$26,726-$155-$1552021-10-27
BLACKROCK US DEBT INDEX FUND BP$21,278$21,637-$359-$3592021-05-10
CHATHAM ASSET HIGH YIELD OFFSHORE FUND LTDP$5,000,000$2,926,577$2,073,423$2,073,4232022-03-31
CHATHAM ASSET PARTNERS HIGH YIELD FUND LPP$5,000,000$2,902,961$2,097,039$2,097,0392022-03-31
CHATHAM ASSET PARTNERS HIGH YIELD FUND LPP$2,931$1,778$1,153$1,1532021-09-30
CHATHAM CO INVESTP$5,000,000$3,256,345$1,743,655$1,743,6552021-07-31
CHATHAM CO INVESTP$5,000,000$3,190,600$1,809,400$1,809,4002021-08-31
CHATHAM CO INVESTP$5,000,000$3,048,481$1,951,519$1,951,5192021-09-30
CHATHAM CO INVESTP$5,000,000$3,012,583$1,987,417$1,987,4172021-10-31
CHATHAM CO INVESTP$5,000,000$2,943,605$2,056,395$2,056,3952021-11-30
CHATHAM CO INVESTP$5,000,000$2,908,518$2,091,482$2,091,4822021-12-31
CHATHAM CO INVESTP$5,000,000$3,409,031$1,590,969$1,590,9692021-04-30
CHATHAM CO INVESTP$5,000,000$2,887,386$2,112,614$2,112,6142022-02-28
CHATHAM CO INVESTP$5,000,000$2,865,182$2,134,818$2,134,8182022-03-31
CHATHAM CO INVESTP$5,000,000$3,323,904$1,676,096$1,676,0962021-06-30
CHATHAM CO INVESTP$5,000,000$3,394,787$1,605,213$1,605,2132021-05-31
CHATHAM CO INVESTP$5,000,000$2,872,622$2,127,378$2,127,3782022-01-31
COLLER INTERNATIONAL PARTNERS VIP$391,304$391,304$391,3042021-09-08
COLLER INTERNATIONAL PARTNERS VIP$1,190,000$1,190,000$1,190,0002021-11-12
COLLER INTERNATIONAL PARTNERS VIP$1,400,000$1,400,000$1,400,0002021-10-27
COLLER INTERNATIONAL PARTNERS VIP$730,034$730,034$730,0342022-01-10
COLLER INTERNATIONAL PARTNERS VIP$430,500$430,500$430,5002022-03-04
COLLER INTERNATIONAL PARTNERS VIP$930,723$930,723$930,7232021-08-13
COLLER INTERNATIONAL PARTNERS VIP$753,100$753,100$753,1002021-06-16
COLLER INTERNATIONAL PARTNERS VIP$449,037$449,037$449,0372021-04-19
EIG ENERGY FD XVII LPP$8,143$8,143$8,1432021-04-23
EIG ENERGY FD XVII LPP$78,764$78,764$78,7642021-06-04
EIG ENERGY FUND XVI LPP$209,157$209,157$209,1572021-04-28
EIG ENERGY FUND XVI LPP$2,576$2,576$2,5762022-01-25
EIG ENERGY XVIIP$2,908$2,908$2,9082021-04-23
EMERGENCE CAPITAL PARTNERS IIIP$21,425,317$21,425,317$21,425,3172022-01-06
EMERGENCE CAPITAL PARTNERS IIIP$3,595,293$3,595,293$3,595,2932021-11-12
EMERGENCE CAPITAL PARTNERS IIIP$1,745,588$1,745,588$1,745,5882021-09-28
EMERGENCE CAPITAL PARTNERS IV LPP$3,790,048$3,790,048$3,790,0482021-09-02
ENERGY FUND XV-A LPP$72,796$72,796$72,7962021-12-01
EPIRIS FUND II B LPP$644,037$644,037$644,0372021-10-28
EPIRIS IIP$6,893$6,893$6,8932021-10-18
FORTISSIMO IVP$2,833,128$2,833,128$2,833,1282021-04-08
FORTISSIMO IVP$1,579,410$1,579,410$1,579,4102021-08-26
FORTISSIMO IVP$87,200$87,200$87,2002021-12-29
FORTISSIMO IVP$87,200$87,200$87,2002021-12-29
FRAZIER LIFE SCI PUBLIC FD LPP$40,838$40,838$40,8382021-11-01
FRAZIER LIFE SCI PUBLIC FD LPP$159,240$159,240$159,2402021-12-17
FRAZIER LIFE SCIENCES IX LPP$225,634-$225,634-$225,6342021-05-25
FRAZIER LIFE SCIENCES IX LPP$254,331$254,331$254,3312021-06-15
FRAZIER LIFE SCIENCES IX LPP$326,233$326,233$326,2332021-07-08
FRAZIER LIFE SCIENCES IX LPP$2,528,006$2,528,006$2,528,0062021-12-31
FRAZIER LIFE SCIENCES IX LPP$4,462,880$4,462,880$4,462,8802022-02-09
FRAZIER LIFE SCIENCES IX LPP$43,664$43,664$43,6642021-08-06
FRAZIER LIFE SCIENCES IX LPP$1,149,177$1,149,177$1,149,1772021-08-09
FRAZIER LIFE SCIENCES X LPP$201,963$201,963$201,9632021-09-29
FRAZIER LIFE SCIENCES X LPP$341,938$341,938$341,9382021-11-24
FRAZIER LIFE SCIENCES X LPP$312,788$312,788$312,7882021-11-15
FRAZIER LIFE SCIENCES X LPP$71,396$71,396$71,3962021-06-24
FRAZIER LIFE SCIENCES X LPP$269,979$269,979$269,9792021-10-22
GA MANAGED ACCOUNT PROGRAMP$111,027$111,027$111,0272021-09-02
GA MANAGED ACCOUNT PROGRAMP$25,580$25,580$25,5802021-09-29
GA MANAGED ACCOUNT PROGRAMP$228,439$228,439$228,4392021-07-27
GA MANAGED ACCOUNT PROGRAMP$575,546$575,546$575,5462021-07-23
GA MANAGED ACCOUNT PROGRAMP$279,264$279,264$279,2642021-07-20
GA MANAGED ACCOUNT PROGRAMP$227,636$227,636$227,6362021-07-16
GA MANAGED ACCOUNT PROGRAMP$372,092$372,092$372,0922021-06-17
GA MANAGED ACCOUNT PROGRAMP$877,858$877,858$877,8582021-06-02
GA MANAGED ACCOUNT PROGRAMP$92,332$92,332$92,3322021-05-25
GA MANAGED ACCOUNT PROGRAMP$4,551,767$4,551,767$4,551,7672021-04-29
GA MANAGED ACCOUNT PROGRAMP$1,305,759$1,305,759$1,305,7592022-03-30
GA MANAGED ACCOUNT PROGRAMP$465$465$4652021-12-23
GA MANAGED ACCOUNT PROGRAMP$160,272$160,272$160,2722021-12-17
GA MANAGED ACCOUNT PROGRAMP$319,657$319,657$319,6572021-11-23
GA MANAGED ACCOUNT PROGRAMP$49,370$49,370$49,3702021-06-30
GA MANAGED ACCOUNT PROGRAMP$764,379$764,379$764,3792021-11-12
GAVEA INVESTMENT FUND V B LPP$334,593$334,593$334,5932021-05-21
GAVEA INVESTMENT FUND V B LPP$740,446$740,446$740,4462021-05-06
GENERAL ATLANTIC SERVICE COMPANY LLCP$10,640,404$10,640,404$10,640,4042021-12-23
GENERAL ATLANTIC SERVICE COMPANY LLCP$1,587,956$1,587,956$1,587,9562021-09-13
GENERAL ATLANTIC SERVICE COMPANY LLCP$1,855,989$1,855,989$1,855,9892021-07-21
GENERAL ATLANTIC SERVICE COMPANY LLCP$464,870$464,870$464,8702021-07-16
GENERAL ATLANTIC SERVICE COMPANY LLCP$7,549,283$7,549,283$7,549,2832021-06-30
GENERAL ATLANTIC SERVICE COMPANY LLCP$2,751,418$2,751,418$2,751,4182021-06-10
GENERAL ATLANTIC SERVICE COMPANY LLCP$3,903,065$3,903,065$3,903,0652021-06-09
GENERAL ATLANTIC SERVICE COMPANY LLCP$617,418$617,418$617,4182021-05-10
GENERAL ATLANTIC SERVICE COMPANY LLCP$922,213$922,213$922,2132021-08-11
GENERAL ATLANTIC SERVICE COMPANY LLCP$287,537-$287,537-$287,5372021-10-08
GENERAL ATLANTIC SERVICE COMPANY LLCP$605,568$605,568$605,5682021-12-02
GENERAL ATLANTIC SERVICE COMPANY LLCP$1,832,219$1,832,219$1,832,2192021-08-06
GENERAL ATLANTIC SERVICE COMPANY LLCP$236,159$236,159$236,1592021-12-29
GENERAL ATLANTIC SERVICE COMPANY LLCP$16,981$16,981$16,9812022-03-30
GENERAL ATLANTIC SERVICE COMPANY LLCP$480,225$480,225$480,2252021-04-09
GENERL ATLANTIC 2013P$454,688$454,688$454,6882021-05-10
GENERL ATLANTIC 2013P$328,868$328,868$328,8682022-03-30
GENERL ATLANTIC 2018P$670$670$6702021-05-25
GENERL ATLANTIC 2018P$28,185$28,185$28,1852021-06-17
GENERL ATLANTIC 2018P$85,220$85,220$85,2202021-12-17
GOLDEN GATE CAP OPP FUND MGTP$4,036,883$4,036,883$4,036,8832021-09-28
GOLDEN GATE CAP OPP FUND MGTP$9,349,937$9,349,937$9,349,9372021-05-14
GOLDEN GATE CAP OPP FUND MGTP$6,593,147$6,593,147$6,593,1472021-05-14
GOLDEN GATE CAP OPP FUND MGTP$5,023,730$5,023,730$5,023,7302021-09-28
GOLDEN GATE CAP OPP FUND MGTP$51,484,482$80,344,042-$28,859,560-$28,859,5602021-12-31
GOLDEN GATE CAP OPP FUND MGTP$51,484,482$80,344,042-$28,859,560-$28,859,5602021-12-31
GOLDENTREE OFFSHORE FUND SIDE POCKET 8P$53,652$53,652$53,6522021-04-30
GOLDENTREE OFFSHORE FUND SIDE POCKET 8P$130,055$130,055$130,0552022-02-28
GOLDENTREE OFFSHORE FUND SIDE POCKET 8P$1,171,054$1,171,054$1,171,0542022-02-28
GOLDENTREE OFFSHORE FUND SIDE POCKET 8P$6,253,988$6,253,988$6,253,9882021-10-31
GSO CAPITAL SOLUTIONP$150,802$150,802$150,8022021-07-22
GSO CAPITAL SOLUTIONS FD III LPP$54,118$54,118$54,1182021-06-29
GSO CAPITAL SOLUTIONS FD III LPP$12,995$12,995$12,9952022-02-24
GSO CAPITAL SOLUTIONS FD III LPP$72,238$72,238$72,2382021-10-27
GSO CAPITAL SOLUTIONS FD III LPP$12,235$12,235$12,2352021-09-30
GSO CAPITAL SOLUTIONS FD III LPP$31,275$31,275$31,2752021-12-20
GSO CAPITAL SOLUTIONS FD III LPP$17$17$172021-11-18
GSO CAPITAL SOLUTIONS FD III LPP$2,884$2,884$2,8842021-09-02
GSO CAPITAL SOLUTIONS FUND II LPP$568,666$568,666$568,6662022-03-31
GSO CAPITAL SOLUTIONS FUND II LPP$300,933$300,933$300,9332021-12-22
GSO CAPITAL SOLUTIONS FUND II LPP$862,970$862,970$862,9702021-11-23
H.I.G. GROWTH BUYOUTS & EQUITY FUND II L.P..P$4,547,554$4,547,554$4,547,5542022-03-09
HARBOUR ENERGY FUND LPP$15,541,938$15,541,938$15,541,9382021-03-31
HARBOUR ENERGY FUND LPP$17,409,877-$17,409,877-$17,409,8772021-03-31
HIG BAYSIDE LOAN OPPORTUNITY FEEDER FUND III (EUROPE-US$) LP$85,392$85,392$85,3922021-10-15
HIG BAYSIDE LOAN OPPORTUNITY FEEDER FUND III (EUROPE-US$) LP$537,186$537,186$537,1862021-08-20
HIG BAYSIDE LOAN OPPORTUNITY FEEDER FUND III (EUROPE-US$) LP$123,915$123,915$123,9152021-04-29
HIG BIOVENTURES IIP$1,469,593$1,469,593$1,469,5932022-03-03
HIG BRAZIL & LATIN AME PTNRS MASTER B LPP$192,237$192,237$192,2372022-03-01
HIG BRAZIL & LATIN AME PTNRS MASTER B LPP$552,452$552,452$552,4522021-09-13
HIG BRAZIL & LATIN AME PTNRS MASTER B LPP$407,271$407,271$407,2712021-07-02
HIG BRAZIL & LATIN AME PTNRS MASTER C LPP$407,271$407,271$407,2712021-07-02
HIG BRAZIL & LATIN AME PTNRS MASTER C LPP$552,452$552,452$552,4522021-09-13
HIG BRAZIL & LATIN AME PTNRS MASTER C LPP$192,237$192,237$192,2372022-03-01
HIG BRAZIL LATAM BP$187,669$187,669$187,6692022-03-01
HIG BRAZIL LATAM CP$187,669$187,669$187,6692022-03-01
HIG CAPITAL PARTNERS V L PP$2,457,479$2,457,479$2,457,4792021-07-28
HIG CAPITAL PARTNERS V L PP$1,414,386$1,414,386$1,414,3862021-06-25
HIG CAPITAL PARTNERS V L PP$8,549,112$8,549,112$8,549,1122021-10-26
HIG CAPITAL PARTNERS V L PP$1,393,508$1,393,508$1,393,5082021-12-29
HIG MIDDLE MKT LBO FD II LPP$1,621,239$1,621,239$1,621,2392021-06-24
HIG MIDDLE MKT LBO FD II LPP$3,718,411$3,718,411$3,718,4112021-10-22
HIG MIDDLE MKT LBO FD II LPP$1,068,400$1,068,400$1,068,4002022-03-25
HIG MIDDLE MKT LBO FD II LPP$4,989,393$4,989,393$4,989,3932022-01-14
HIG MIDDLE MKT LBO FD II LPP$5,998,290$5,998,290$5,998,2902021-12-03
HIGHCLERE INTL SMALL CAP FUNDP$10,000,000$10,000,212-$212-$2122021-05-07
HIGHCLERE INTL SMALL CAP FUNDP$203,549$203,558-$9-$92021-04-30
HIGHCLERE INTL SMALL CAP FUNDP$124,456$124,456$124,4562022-03-31
HIGHCLERE INTL SMALL CAP FUNDP$128,012$128,012$128,0122022-02-28
HIGHCLERE INTL SMALL CAP FUNDP$129,759$129,759$129,7592022-01-31
HIGHCLERE INTL SMALL CAP FUNDP$140,321$140,321$140,3212021-12-31
HIGHCLERE INTL SMALL CAP FUNDP$12,500,000$12,500,000$12,500,0002021-12-07
HIGHCLERE INTL SMALL CAP FUNDP$144,929$144,929$144,9292021-11-30
HIGHCLERE INTL SMALL CAP FUNDP$12,500,000$1,877,387$10,622,613$10,622,6132021-11-05
HIGHCLERE INTL SMALL CAP FUNDP$163,006$882,733-$719,727-$719,7272021-10-31
HIGHCLERE INTL SMID CAP FUNDP$109,447$109,447$109,4472021-04-30
HIGHCLERE INTL SMID CAP FUNDP$99,300$99,300$99,3002021-05-31
HIGHCLERE INTL SMID CAP FUNDP$18,000,000$18,000,000$18,000,0002021-05-07
HIGHCLERE INTL SMID CAP FUNDP$20,000,000$20,000,000$20,000,0002021-06-07
HIGHCLERE INTL SMID CAP FUNDP$84,495$84,495$84,4952021-06-30
HIGHCLERE INTL SMID CAP FUNDP$85,060$85,060$85,0602021-07-31
HIGHCLERE INTL SMID CAP FUNDP$87,509$87,509$87,5092021-08-31
HIGHCLERE INTL SMID CAP FUNDP$85,692$85,692$85,6922021-09-30
HIGHCLERE INTL SMID CAP FUNDP$78,622$78,622$78,6222021-10-31
HIGHCLERE INTL SMID CAP FUNDP$12,500,000$12,500,000$12,500,0002021-11-05
HIGHCLERE INTL SMID CAP FUNDP$68,698$68,698$68,6982021-11-30
HIGHCLERE INTL SMID CAP FUNDP$12,500,000$12,500,000$12,500,0002021-12-07
HIGHCLERE INTL SMID CAP FUNDP$63,477$63,477$63,4772021-12-31
HIGHCLERE INTL SMID CAP FUNDP$59,851$59,851$59,8512022-01-31
HIGHCLERE INTL SMID CAP FUNDP$58,784$58,784$58,7842022-02-28
HIGHCLERE INTL SMID CAP FUNDP$57,314$57,314$57,3142022-03-31
IDG BREYER CAPITAL FUND LPP$125,348$125,348$125,3482021-05-21
IDG CHINA CAPITAL FUND III LPP$263,591$263,591$263,5912021-12-28
IDG CHINA VENTURE CAP FD IV LPP$2,117,895$2,117,895$2,117,8952021-08-31
IDG-ACCEL CHINA CAPITAL FUND II L.P.P$1,674,729$1,674,729$1,674,7292021-10-29
IDG-ACCEL CHINA CAPITAL FUND II L.P.P$833,149$833,149$833,1492021-06-18
IDG-ACCEL CHINA CAPITAL FUND II L.P.P$1,641,417$1,641,417$1,641,4172021-12-30
IDG-ACCEL CHINA GROWTH FUND III L.P.P$849,833$849,833$849,8332021-12-17
IDG-ACCEL CHINA GROWTH FUND III L.P.P$436,414$436,414$436,4142021-06-04
IRON POINT IVP$321,188$321,188$321,1882021-12-31
IRON POINT RE PARTNERS IV LPP$487,378$487,378$487,3782022-03-30
IRON POINT RE PARTNERS IV LPP$483,261$483,261$483,2612021-12-31
LA CAPITAL GLOBAL EQUITY FUNDP$25,589$25,589$25,5892021-04-30
LA CAPITAL GLOBAL EQUITY FUNDP$25,988$25,988$25,9882021-05-31
LA CAPITAL GLOBAL EQUITY FUNDP$14,000,000$14,000,000$14,000,0002021-06-04
LA CAPITAL GLOBAL EQUITY FUNDP$23,857$23,857$23,8572021-06-30
LA CAPITAL GLOBAL EQUITY FUNDP$22,212$22,212$22,2122021-08-31
LA CAPITAL GLOBAL EQUITY FUNDP$21,315$21,315$21,3152021-09-30
LA CAPITAL GLOBAL EQUITY FUNDP$22,091$22,091$22,0912021-10-31
LA CAPITAL GLOBAL EQUITY FUNDP$18,000,000$18,000,000$18,000,0002021-11-04
LA CAPITAL GLOBAL EQUITY FUNDP$18,763$18,763$18,7632021-11-30
LA CAPITAL GLOBAL EQUITY FUNDP$19,529$19,529$19,5292021-12-31
LA CAPITAL GLOBAL EQUITY FUNDP$18,757$18,757$18,7572022-01-31
LA CAPITAL GLOBAL EQUITY FUNDP$18,298$18,298$18,2982022-02-28
LA CAPITAL GLOBAL EQUITY FUNDP$18,593$18,593$18,5932022-03-31
LA CAPITAL GLOBAL EQUITY FUNDP$15,000,000$15,000,000$15,000,0002021-07-08
LA CAPITAL GLOBAL EQUITY FUNDP$21,719$21,719$21,7192021-07-31
LACM WORLD SMALL CAP EQUITY FUND LPP$15,000,000$15,930,051-$930,051-$930,0512021-07-08
LACM WORLD SMALL CAP EQUITY FUND LPP$21,586$85,504-$63,918-$63,9182021-10-29
LACM WORLD SMALL CAP EQUITY FUND LPP$12,000,000$15,442,890-$3,442,890-$3,442,8902021-11-04
LACM WORLD SMALL CAP EQUITY FUND LPP$8,000,000$24,702,789-$16,702,789-$16,702,7892021-05-06
LACM WORLD SMALL CAP EQUITY FUND LPP$26,953$696,465-$669,512-$669,5122021-04-30
LACM WORLD SMALL CAP EQUITY FUND LPP$18,403$686,793-$668,390-$668,3902022-03-31
LACM WORLD SMALL CAP EQUITY FUND LPP$18,241$680,748-$662,507-$662,5072022-02-28
LACM WORLD SMALL CAP EQUITY FUND LPP$18,030$1,226,912-$1,208,882-$1,208,8822022-01-31
LACM WORLD SMALL CAP EQUITY FUND LPP$19,413$1,321,045-$1,301,632-$1,301,6322021-12-31
MHR INST PARTNERS IVP$214,413$214,413$214,4132021-04-21
MHR INST PARTNERS IVP$313,005$313,005$313,0052021-05-25
MHR INST PARTNERS IVP$88,098$88,098$88,0982021-07-06
MHR INST PARTNERS IVP$41,943$41,943$41,9432021-08-24
MHR INST PARTNERS IVP$217,960$217,960$217,9602021-09-08
MHR INST PARTNERS IVP$61,302$61,302$61,3022021-09-29
MHR INST PARTNERS IVP$179,609$179,609$179,6092021-10-06
MHR INST PARTNERS IVP$941,196$941,196$941,1962021-12-30
MHR LONGEVITY FUND LPP$2,599,659$2,272,606$327,053$327,0532021-03-05
MHR LONGEVITY FUND LPP$2,024,796$1,688,549$336,247$336,2472021-06-30
MHR LONGEVITY FUND LPP$624,108$523,402$100,706$100,7062021-11-30
ORBIMED ASIA PARTNERS III LPP$1,008,201$1,008,201$1,008,2012021-12-29
ORBIMED ISRAEL GPP$2,494,266-$2,494,266-$2,494,2662021-09-17
ORBIMED PRIVATE INVEST VI LPP$212,319$212,319$212,3192021-12-16
ORBIMED ROYALTY PTNRS II LPP$218,281-$218,281-$218,2812022-03-16
ORBIMED ROYALTY PTNRS II LPP$43,808$43,808$43,8082021-06-21
ORBIMED ROYALTY PTNRS II LPP$32,499$32,499$32,4992021-12-13
ORBIMED ROYALTY PTNRS II LPP$76,078$76,078$76,0782021-08-20
PEG SECONDARY PE II LP AND AIVP$5,046,213$3,928,356$1,117,857$1,117,8572021-12-31
PEG SECONDARY PE INVESTORS II LPP$200,459$200,459$200,4592021-04-16
PEG SECONDARY PE INVESTORS II LPP$1,026,685$1,026,685$1,026,6852021-11-17
PEG SECONDARY PE INVESTORS II LPP$336,062$336,062$336,0622021-07-22
PEG SECONDARY PE INVESTORS II LPP$1,943,541-$1,943,541-$1,943,5412022-01-18
PEG SECONDARY PE INVESTORS III LPP$280,309$280,309$280,3092021-07-15
PEG SECONDARY PE INVESTORS III LPP$826,089$826,089$826,0892021-11-23
PEG SECONDARY PE INVESTORS LLCP$154,917$154,917$154,9172021-08-26
PEG SECONDARY PE INVESTORS LLCP$1,638,552-$1,638,552-$1,638,5522022-01-18
PEG SECONDARY PE INVESTORS LLC AND AIVP$2,913,911$1,570,771$1,343,140$1,343,1402021-12-31
PITANGO GROWTHP$1,142,909$1,142,909$1,142,9092021-09-30
PITANGO VTR VIP$1,539,801$1,539,801$1,539,8012021-07-28
SEQUOIA CAP CHINA GR FD V LPP$196,564$196,564$196,5642021-09-01
SEQUOIA CAP CHINA GR FD V LPP$86,521$86,521$86,5212021-09-27
SEQUOIA CAP CHINA GR FD V LPP$78,915$78,915$78,9152022-01-13
SEQUOIA CAP CHINA GR FD V LPP$48,653$48,653$48,6532021-06-25
SEQUOIA CAP CHINA GR FD V LPP$51,318$51,318$51,3182021-06-29
SEQUOIA CAP CHINA GROWTH FD III LPP$1,141,750$1,141,750$1,141,7502021-11-30
SEQUOIA CAP CHINA GROWTH FD III LPP$1,198,782$1,198,782$1,198,7822022-02-17
SEQUOIA CAP CHINA GROWTH FD III LPP$443,625$443,625$443,6252021-06-28
SEQUOIA CAP CHINA GROWTH FD III LPP$1,266,981$1,266,981$1,266,9812022-01-18
SEQUOIA CAP CHINA GROWTH FD III LPP$43,933$43,933$43,9332022-01-13
SEQUOIA CAP CHINA GROWTH FD III LPP$34,901$34,901$34,9012021-11-19
SEQUOIA CAP CHINA GROWTH FD III LPP$108,588$108,588$108,5882021-05-07
SEQUOIA CAP CHINA GROWTH FD III LPP$134,841$134,841$134,8412021-06-23
SEQUOIA CAP CHINA GROWTH FD III LPP$1,768,012$1,768,012$1,768,0122021-09-23
SEQUOIA CAP CHINA GROWTH FD III LPP$1,031,481$1,031,481$1,031,4812021-08-31
SEQUOIA CAP CHINA GROWTH FD III LPP$1,422,952$1,422,952$1,422,9522021-11-08
SEQUOIA CAP CHINA GROWTH IV LPP$186,195$186,195$186,1952021-09-02
SEQUOIA CAP CHINA GROWTH IV LPP$44,991$44,991$44,9912021-07-26
SEQUOIA CAP CHINA GROWTH IV LPP$1,850,771$1,850,771$1,850,7712021-09-27
SEQUOIA CAP CHINA GROWTH IV LPP$115,447$115,447$115,4472021-10-20
SEQUOIA CAP CHINA GROWTH IV LPP$109,518$109,518$109,5182022-01-20
SEQUOIA CAP CHINA GROWTH IV LPP$4,112,210$4,112,210$4,112,2102021-09-01
SEQUOIA CAP CHINA GROWTH IV LPP$1,031,131$1,031,131$1,031,1312021-06-29
SEQUOIA CAP CHINA GROWTH IV LPP$984,655$984,655$984,6552021-06-25
SEQUOIA CAP CHINA GRWTH VI LPP$5,552$5,552$5,5522021-06-22
SEQUOIA CAP CHINA VENTURE FD IV LPP$1,070,083$1,070,083$1,070,0832021-10-29
SEQUOIA CAP CHINA VENTURE FD IV LPP$382,817$382,817$382,8172021-10-22
SEQUOIA CAP CHINA VENTURE V LPP$181,394$181,394$181,3942021-12-30
SEQUOIA CAP CHINA VENTURE V LPP$1,594,670$1,594,670$1,594,6702021-09-10
SEQUOIA CAP CHINA VENTURE VI LPP$40,645$40,645$40,6452021-06-23
SEQUOIA CAP CHINA VENTURE VI LPP$111,223$111,223$111,2232022-01-13
SEQUOIA CAP CHINA VENTURE VI LPP$58,656$58,656$58,6562022-01-20
SEQUOIA CAP CHINA VENTURE VI LPP$51,394$51,394$51,3942021-09-02
SEQUOIA CAP CHINA VENTURE VI LPP$37,621$37,621$37,6212021-10-22
SEQUOIA CAP CHINA VENTURE VI LPP$36,913$36,913$36,9132021-05-27
SEQUOIA CAP GBL GR III CHINA ANNEX LPP$119,477-$119,477-$119,4772022-01-13
SEQUOIA CAP GBL GROWTH FD IIP$98,211$98,211$98,2112021-12-10
SEQUOIA CAP GBL GROWTH FD IIP$1,782,585$1,782,585$1,782,5852021-11-22
SEQUOIA CAP GBL GROWTH FD IIP$168,321$168,321$168,3212022-02-24
SEQUOIA CAP GBL GROWTH FD IIP$314,656$314,656$314,6562022-02-25
SEQUOIA CAP GBL GROWTH FD IIP$904,634$904,634$904,6342022-02-28
SEQUOIA CAP GBL GROWTH FD IIP$426,463$426,463$426,4632022-01-20
SEQUOIA CAP GBL GROWTH FD IIP$357,784$357,784$357,7842021-04-26
SEQUOIA CAP GBL GROWTH FD IIP$683,882$683,882$683,8822021-06-25
SEQUOIA CAP GBL GROWTH FD IIP$718,463$718,463$718,4632021-06-29
SEQUOIA CAP GBL GROWTH FD IIP$175,196$175,196$175,1962021-07-26
SEQUOIA CAP GBL GROWTH FD IIP$105,357$105,357$105,3572021-08-31
SEQUOIA CAP GBL GROWTH FD IIP$2,815,736$2,815,736$2,815,7362021-09-01
SEQUOIA CAP GBL GROWTH FD IIP$725,024$725,024$725,0242021-09-02
SEQUOIA CAP GBL GROWTH FD IIP$198,318$198,318$198,3182021-09-23
SEQUOIA CAP GBL GROWTH FD IIP$1,255,206$1,255,206$1,255,2062021-09-27
SEQUOIA CAP GBL GROWTH FD IIP$449,556$449,556$449,5562021-10-20
SEQUOIA CAP GBL GROWTH FD IIP$157,090$157,090$157,0902021-11-08
SEQUOIA CAP GBL GROWTH FD IIP$224,874$224,874$224,8742021-11-19
SEQUOIA CAP GBL GROWTH FD IIP$134,380$134,380$134,3802022-01-18
SEQUOIA CAP GLOBAL EQ FUNDP$18,793,401$3,403,850$15,389,551$15,389,5512021-07-26
SEQUOIA CAP GLOBAL EQ FUNDP$11,137,547$2,017,226$9,120,321$9,120,3212021-07-26
SEQUOIA CAP GLOBAL EQ FUNDP$1,341,170$242,912$1,098,258$1,098,2582021-07-26
SEQUOIA CAP GLOBAL EQ FUNDP$4,727,882$856,311$3,871,571$3,871,5712021-07-26
SEQUOIA CAP US GROWTH FD VI LPP$130,388$130,388$130,3882021-04-26
SEQUOIA CAP US GROWTH FD VI LPP$526,670$526,670$526,6702021-11-12
SEQUOIA CAP US GROWTH FD VI LPP$541,871$541,871$541,8712022-02-18
SEQUOIA CAP US GROWTH FD VI LPP$44,678-$44,678-$44,6782021-08-24
SEQUOIA CAP US GROWTH FD VI LPP$44,678$44,678$44,6782021-08-24
SEQUOIA CAP US GROWTH FD VI LPP$420,919$420,919$420,9192021-11-18
SEQUOIA CAP US GROWTH FD VI LPP$561,892$561,892$561,8922021-11-22
SEQUOIA CAP US GROWTH FD VI LPP$61,574$61,574$61,5742021-11-23
SEQUOIA CAP US GROWTH FD VI LPP$227,016$227,016$227,0162022-02-11
SEQUOIA CAP US GROWTH FD VI LPP$44,678$44,678$44,6782021-08-24
SEQUOIA CAP US GROWTH FD VI LPP$19,607$19,607$19,6072021-06-16
SEQUOIA CAP US GROWTH FD VI LPP$136,168$136,168$136,1682021-08-13
SEQUOIA CAP US GROWTH FD VI LPP$20,032$20,032$20,0322021-06-02
SEQUOIA CAP US GROWTH FD VII LPP$435,040$435,040$435,0402021-10-28
SEQUOIA CAP US GROWTH FD VII LPP$27,236$27,236$27,2362022-02-25
SEQUOIA CAP US GROWTH FD VII LPP$317,214$317,214$317,2142022-02-28
SEQUOIA CAP US GROWTH FD VII LPP$51,599$51,599$51,5992021-07-08
SEQUOIA CAP US GROWTH FD VII LPP$314,920$314,920$314,9202021-06-02
SEQUOIA CAP US GROWTH FD VII LPP$309,121$309,121$309,1212021-06-16
SEQUOIA CAP US GROWTH FD VII LPP$46,403$46,403$46,4032021-06-29
SEQUOIA CAP US GROWTH FD VII LPP$104,776$104,776$104,7762021-08-11
SEQUOIA CAP US GROWTH FD VII LPP$98,015$98,015$98,0152021-08-30
SEQUOIA CAP US GROWTH FD VII LPP$18,967$18,967$18,9672021-11-19
SEQUOIA CAP US GROWTH FD VII LPP$622,861$622,861$622,8612021-11-22
SEQUOIA CAP US GROWTH FD VII LPP$14,197$14,197$14,1972022-02-24
SEQUOIA CAP US VENTURE FD XV LPP$91,993$91,993$91,9932021-09-21
SEQUOIA CAP US VENTURE FD XV LPP$126,366$126,366$126,3662021-04-06
SEQUOIA CAP US VENTURE FD XV LPP$60,792$60,792$60,7922021-08-13
SEQUOIA CAP US VENTURE FD XV LPP$27,490$27,490$27,4902021-11-23
SEQUOIA CAPITAL GLOBAL GROWTH FDP$1,480,355$1,480,355$1,480,3552021-11-12
SEQUOIA CAPITAL GLOBAL GROWTH FDP$1,589,407$1,589,407$1,589,4072022-02-18
SEQUOIA CAPITAL GLOBAL GROWTH FDP$583,983$583,983$583,9832021-04-26
SEQUOIA CAPITAL GLOBAL GROWTH FDP$292,977$292,977$292,9772021-07-26
SEQUOIA CAPITAL GLOBAL GROWTH FDP$1,203,240$1,203,240$1,203,2402021-09-02
SEQUOIA CAPITAL GLOBAL GROWTH FDP$736,170$736,170$736,1702021-10-20
SEQUOIA CAPITAL GLOBAL GROWTH FDP$3,285,313$3,285,313$3,285,3132021-11-18
SEQUOIA CAPITAL GLOBAL GROWTH FDP$209,704$209,704$209,7042022-02-25
SEQUOIA CAPITAL GLOBAL GROWTH FDP$1,323,352$1,323,352$1,323,3522022-02-25
SEQUOIA CAPITAL GLOBAL GROWTH FDP$677,244$677,244$677,2442022-02-24
SEQUOIA CAPITAL GLOBAL GROWTH FDP$107,914$107,914$107,9142022-02-24
SEQUOIA CAPITAL GLOBAL GROWTH FDP$1,770,304$1,770,304$1,770,3042022-02-11
SEQUOIA CAPITAL GLOBAL GROWTH FDP$712,545$712,545$712,5452022-01-20
SEQUOIA CAPITAL GLOBAL GROWTH FDP$1,009,425$1,009,425$1,009,4252021-11-19
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$150,404$150,404$150,4042021-06-29
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$950,365$950,365$950,3652021-06-16
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$576,780$576,780$576,7802021-09-01
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$178,167$178,167$178,1672021-09-23
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$253,919$253,919$253,9192021-09-27
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$84,314$84,314$84,3142021-11-08
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$2,198,913$2,198,913$2,198,9132021-11-18
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$71,074$71,074$71,0742022-01-18
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$1,154,709$1,154,709$1,154,7092022-02-11
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$968,788$968,788$968,7882021-06-02
SEQUOIA CAPITAL GLOBAL GROWTH FD III - ENDURANCE PARTNERS LPP$142,592$142,592$142,5922021-06-25
SEQUOIA CAPITAL U.S. GROWTH FUND V L.P.P$1,462,337$1,462,337$1,462,3372021-11-12
SEQUOIA CAPITAL U.S. GROWTH FUND V L.P.P$1,468,146$1,468,146$1,468,1462022-02-18
SEQUOIA CAPITAL U.S. GROWTH FUND V L.P.P$20,227$20,227$20,2272021-09-09
SEQUOIA CAPITAL U.S. GROWTH FUND V L.P.P$413,904$413,904$413,9042021-11-19
SEQUOIA CAPITAL U.S. GROWTH FUND V L.P.P$331,097$331,097$331,0972022-02-24
SEQUOIA CAPITAL U.S. GROWTH FUND V L.P.P$648,586$648,586$648,5862022-02-25
SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P..P$127,609$127,609$127,6092021-12-17
SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P..P$786,061$786,061$786,0612022-02-28
SEQUOIA CAPITAL U.S. VENTURE FUND XIV L.P..P$1,513,940$1,513,940$1,513,9402021-11-22
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$107,591$87,168$20,423$20,4232021-04-30
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$110,280$86,389$23,891$23,8912021-07-30
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$109,497$86,617$22,880$22,8802021-06-30
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$110,494$86,433$24,061$24,0612021-05-28
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$69,135$55,056$14,079$14,0792022-03-31
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$68,370$55,444$12,926$12,9262022-02-28
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$111,438$86,080$25,358$25,3582021-08-31
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$69,964$54,831$15,133$15,1332021-11-30
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$72,574$53,721$18,853$18,8532021-12-31
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$113,440$85,551$27,889$27,8892021-10-29
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$100,000,000$75,415,391$24,584,609$24,584,6092021-10-29
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$109,896$86,385$23,511$23,5112021-09-30
THE MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUSTP$70,061$54,718$15,343$15,3432022-01-31
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$87,366$79,953$7,413$7,4132021-04-30
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$73,681$66,120$7,561$7,5612022-03-31
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$89,074$79,567$9,507$9,5072021-06-30
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$88,564$79,617$8,947$8,9472021-07-30
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$89,392$79,433$9,959$9,9592021-08-31
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$10,000,000$8,885,907$1,114,093$1,114,0932021-09-07
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$84,177$75,885$8,292$8,2922021-09-30
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$85,408$75,618$9,790$9,7902021-10-29
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$12,500,000$11,067,200$1,432,800$1,432,8002021-11-04
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$76,074$71,835$4,239$4,2392021-11-30
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$12,500,000$11,803,332$696,668$696,6682021-12-06
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$73,629$66,235$7,394$7,3942021-12-31
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$74,089$66,099$7,990$7,9902022-01-31
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$74,309$66,017$8,292$8,2922022-02-28
THE SILCHESTER INTERNATIONAL INVESTORS INTERNATIONAL VALUEP$89,747$79,490$10,257$10,2572021-05-28
VENTURE LENDING & LEASING VII LLCP$260,000$260,000$260,0002021-12-08
VENTURE LENDING & LEASING VII LLCP$300,000$300,000$300,0002021-08-09
VENTURE LENDING & LEASING VII LLCP$300,000$300,000$300,0002021-04-05
VENTURE LENDING & LEASING VII LLCP$140,000$140,000$140,0002022-03-10
VENTURE LENDING & LEASING VII LLCP$763,849$763,849$763,8492021-09-10
VENTURE LENDING & LEASING VII LLCP$1,151,524$1,151,524$1,151,5242021-07-02
VENTURE LENDING & LEASING VIII LLCP$1,059,489$1,059,489$1,059,4892021-07-02
WTI VLL IXP$116,357$116,357$116,3572021-11-24
WTI VLL VIIIP$98,000$98,000$98,0002021-06-25
WTI VLL VIIIP$346,430$346,430$346,4302021-08-10
WTI VLL VIIIP$49,000$49,000$49,0002021-09-27
WTI VLL VIIIP$318,500$318,500$318,5002021-12-10
YORK CO INVEST 1P$452,173$452,173$452,1732021-12-14
YORK DISTRESSED ASSET FD III LPP$2,763,089$2,763,089$2,763,0892022-02-11
YORK DISTRESSED ASSET FD III LPP$4,019,690$4,019,690$4,019,6902021-08-12
YORK EUROPEAN DISTRESSED CREDIT FUND II LPP$635,222$635,222$635,2222022-01-26
YORK EUROPEAN DISTRESSED CREDIT FUND LPP$822,574$822,574$822,5742021-04-01
K-1 ADJUSTMENTS, NET OF UBI AND RELATED AMOUNTS ABOVEP-$138,034,051-$138,034,051
FieldValueIRS element (for citing)
Capital Gain Net Income$713,350,607CapitalGainNetIncomeAmt

Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp

FieldValueIRS element (for citing)
Investment Income Excise Tax$14,577,769InvestmentIncomeExciseTaxAmt
Tax Under Section511$0TaxUnderSection511Amt
Subtotal$14,577,769SubtotalAmt
Subtitle A Tax$0SubtitleATaxAmt
Tax Based On Investment Income$14,577,769TaxBasedOnInvestmentIncomeAmt
Estimated Plus Ovpmt Incm Tx$15,460,988EstimatedPlusOvpmtIncmTxAmt
Exempt Frgn Org Tax Wthld At Srce$0ExemptFrgnOrgTaxWthldAtSrceAmt
Extsn Request Income Tax Paid$4,100,000ExtsnRequestIncomeTaxPaidAmt
Backup Withholding Withheld$0BackupWithholdingWithheldAmt
Total Payments And Credits$19,560,988TotalPaymentsAndCreditsAmt
Form2220 AttachedYes (X)Form2220AttachedInd
Es Penalty$0EsPenaltyAmt
Overpayment$4,983,219OverpaymentAmt
Applied To ES Tax$4,983,219AppliedToESTaxAmt
Refund$0RefundAmt

Statements Regarding Acty StatementsRegardingActyGrp

FieldValueIRS element (for citing)
Legislative Political Acty0LegislativePoliticalActyInd
More Than100 Spent0MoreThan100SpentInd
Form1120 POL Filed0Form1120POLFiledInd
Section4955 Organization Tax$0Section4955OrganizationTaxAmt
Section4955 Managers Tax$0Section4955ManagersTaxAmt
Tax Reimbursed$0TaxReimbursedAmt
Activities Not Previously Rpt0ActivitiesNotPreviouslyRptInd
Changes To Articles Or Bylaws0ChangesToArticlesOrBylawsInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Organization Dissolved Etc0OrganizationDissolvedEtcInd
Section508e Rqr SatisfiedYes (1)Section508eRqrSatisfiedInd
At Least5000 In AssetsYes (1)AtLeast5000InAssetsInd
Org Report Or Register StateNYOrgReportOrRegisterStateCd
Form990 PF Filed With Atty GenYes (1)Form990PFFiledWithAttyGenInd
Private Operating Foundation0PrivateOperatingFoundationInd
New Substantial Contributors0NewSubstantialContributorsInd
Own Controlled EntityYes (1)OwnControlledEntityInd
Donor Advised Fund0DonorAdvisedFundInd
Comply With Public Insp RqrYes (1)ComplyWithPublicInspRqrInd
Website AddressHELMSLEYTRUST.ORGWebsiteAddressTxt

Persons With Books Name PersonsWithBooksName

FieldValueIRS element (for citing)
Business Name Line1NICHOLAS J SCHIAVO CFOBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2126793600PhoneNum

Location Of Books US Address LocationOfBooksUSAddress

FieldValueIRS element (for citing)
Address Line1230 PARK AVENUE SUITE 659AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10169ZIPCd
FieldValueIRS element (for citing)
Foreign Accounts QuestionYes (1)ForeignAccountsQuestionInd
Foreign CountryASForeignCountryCd
Foreign CountryAUForeignCountryCd
Foreign CountryBAForeignCountryCd
Foreign CountryBGForeignCountryCd
Foreign CountryBEForeignCountryCd
Foreign CountryBCForeignCountryCd
Foreign CountryBRForeignCountryCd
Foreign CountryCAForeignCountryCd
Foreign CountryCIForeignCountryCd
Foreign CountryCOForeignCountryCd
Foreign CountryHRForeignCountryCd
Foreign CountryCYForeignCountryCd
Foreign CountryEZForeignCountryCd
Foreign CountryDAForeignCountryCd
Foreign CountryEGForeignCountryCd
Foreign CountryFIForeignCountryCd
Foreign CountryFRForeignCountryCd
Foreign CountryGMForeignCountryCd
Foreign CountryGRForeignCountryCd
Foreign CountryHKForeignCountryCd
Foreign CountryHUForeignCountryCd
Foreign CountryICForeignCountryCd
Foreign CountryINForeignCountryCd
Foreign CountryIDForeignCountryCd
Foreign CountryISForeignCountryCd
Foreign CountryITForeignCountryCd
Foreign CountryJAForeignCountryCd
Foreign CountryJOForeignCountryCd
Foreign CountryKZForeignCountryCd
Foreign CountryKEForeignCountryCd
Foreign CountryKUForeignCountryCd
Foreign CountryLHForeignCountryCd
Foreign CountryMYForeignCountryCd
Foreign CountryMXForeignCountryCd
Foreign CountryMOForeignCountryCd
Foreign CountryNLForeignCountryCd
Foreign CountryNZForeignCountryCd
Foreign CountryNIForeignCountryCd
Foreign CountryNOForeignCountryCd
Foreign CountryMUForeignCountryCd
Foreign CountryPKForeignCountryCd
Foreign CountryPMForeignCountryCd
Foreign CountryRPForeignCountryCd
Foreign CountryPLForeignCountryCd
Foreign CountryPOForeignCountryCd
Foreign CountryQAForeignCountryCd
Foreign CountryROForeignCountryCd
Foreign CountryRSForeignCountryCd
Foreign CountrySNForeignCountryCd
Foreign CountrySIForeignCountryCd
Foreign CountrySFForeignCountryCd
Foreign CountryKSForeignCountryCd
Foreign CountrySPForeignCountryCd
Foreign CountryCEForeignCountryCd
Foreign CountrySWForeignCountryCd
Foreign CountrySZForeignCountryCd
Foreign CountryTWForeignCountryCd
Foreign CountryTZForeignCountryCd
Foreign CountryTHForeignCountryCd
Foreign CountryTSForeignCountryCd
Foreign CountryAEForeignCountryCd
Foreign CountryUKForeignCountryCd
Foreign CountryVMForeignCountryCd
Foreign CountryZAForeignCountryCd
Foreign CountryZIForeignCountryCd

Statements Regarding Acty4720 StatementsRegardingActy4720Grp

FieldValueIRS element (for citing)
Sale Or Exch Disqualified PrsnYes (1)SaleOrExchDisqualifiedPrsnInd
Brrw Or Lend Disqualified Prsn0BrrwOrLendDisqualifiedPrsnInd
Furn Goods Disqualified PrsnYes (1)FurnGoodsDisqualifiedPrsnInd
Pay Comp Disqualified PrsnYes (1)PayCompDisqualifiedPrsnInd
Transfer Ast Disqualified Prsn0TransferAstDisqualifiedPrsnInd
Payment To Government Official0PaymentToGovernmentOfficialInd
Acts Fail To Qlfy As Exceptions0ActsFailToQlfyAsExceptionsInd
Uncorrected Prior Acts0UncorrectedPriorActsInd
Undistributed Income PY0UndistributedIncomePYInd
Business HoldingsYes (1)BusinessHoldingsInd
Excess Business Holdings0ExcessBusinessHoldingsInd
Jeopardy Investments0JeopardyInvestmentsInd
Uncorrected PY Jeopardy Invst0UncorrectedPYJeopardyInvstInd
Influence Legislation0InfluenceLegislationInd
Influence Election0InfluenceElectionInd
Grants To Individuals0GrantsToIndividualsInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Noncharitable Purpose0NoncharitablePurposeInd
Transactions Fail To Qlfy As Exc0TransactionsFailToQlfyAsExcInd
Maintained Expenditure RspnsYes (1)MaintainedExpenditureRspnsInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (1)SubjToTaxRmnrtnExPrchtPymtInd

Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp

Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdTitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmtEmployee Benefit ProgramEmployeeBenefitProgramAmtExpense Account Other AllwncExpenseAccountOtherAllwncAmt
SANDOR FRANKEL
C/O TRUST 230 PARK AVENUENEW YORKNY10169TRUSTEE25.00$125,000$0$0
DAVID PANZIRER
C/O TRUST 230 PARK AVENUENEW YORKNY10169TRUSTEE35.00$125,000$0$0
WALTER PANZIRER
C/O TRUST 230 PARK AVENUENEW YORKNY10169TRUSTEE32.00$125,000$0$0
SARAH E PAUL
C/O TRUST 230 PARK AVENUENEW YORKNY10169CEO & GENERAL COUNSEL (STMT 22)40.00$703,476$164,438$0
STEPHANIE A CUSKLEY
C/O TRUST 230 PARK AVENUENEW YORKNY10169CHIEF EXECUTIVE OFFICER THRU 10/31/2140.00$1,578,355$128,388$0
ROSALIND M HEWSENIAN
C/O TRUST 230 PARK AVENUENEW YORKNY10169CHIEF INVESTMENT OFFICER40.00$1,671,096$204,786$0
NICHOLAS J SCHIAVO
C/O TRUST 230 PARK AVENUENEW YORKNY10169CHIEF FINANCIAL OFFICER40.00$393,338$117,317$0

Compensation Highest Paid Empl CompensationHighestPaidEmplGrp (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdTitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmtEmployee BenefitsEmployeeBenefitsAmtExpense AccountExpenseAccountAmt
MEENAKSHI C LAKSHMAN
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIR. OF STRATEGY & R40.00$938,579$173,897$0
AL Y KIM
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIRECTOR OF INVESTME40.00$915,458$171,409$0
JOSHUA W FENTON
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIRECTOR OF INVESTME40.00$914,728$171,522$0
CHRISTOPHER J RAPCEWICZ
C/O TRUST 230 PARK AVENUENEW YORKNY10169DIR. OF RISK MNGMT.40.00$910,449$157,200$0
BRIAN B CHUN
C/O TRUST 230 PARK AVENUENEW YORKNY10169INVESTMENT OFFICER40.00$461,296$88,692$0
FieldValueIRS element (for citing)
Other Employee Paid Over50k84OtherEmployeePaidOver50kCnt

Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (5 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdService TypeServiceTypeTxtCompensationCompensationAmtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCd
HIG MIDDLE MARKET LBO FUND II LP
600 5TH AVE 24TH FLNEW YORKNY10020INVESTMENT MANAGEMENT$4,581,511
HIG CAPITAL PARTNERS V LP
600 5TH AVE 24TH FLNEW YORKNY10020INVESTMENT MANAGEMENT$3,220,352
HIGHCLERE INTERNATIONAL INVESTORS
INVESTMENT MANAGEMENT$2,901,4432 MANCHESTER SQUARELONDONUK
IFP GLOBAL EQUITY LP
INVESTMENT MANAGEMENT$1,516,005LEVEL 1 10 PORTMAN SQUARELONDONUKW1H 6AZ
ACADIAN ASSET MANAGEMENT LLC
PO BOX 412216BOSTONMA02241INVESTMENT MANAGEMENT$1,206,736
FieldValueIRS element (for citing)
Contractor Paid Over50k47ContractorPaidOver50kCnt

Summary Of Direct Chrtbl Acty SummaryOfDirectChrtblActyGrp

FieldValueIRS element (for citing)
Description1FOR THE PRODUCTION OF VIDEO AND OTHER DESIGN SUPPORT TO COMMUNICATE IMPACT IN FURTHERANCE OF THE FOUNDATION'S MISSION.Description1Txt
Expenses1$1,003,948Expenses1Amt
Description2FOR TECHNICAL SUPPORT TO GRANTEES TO MEET THEIR STRATEGIC AND COMMUNICATIONS NEEDS TO DRIVE FURTHER IMPACT OF THEIR CHARITABLE WORK.Description2Txt
Expenses2$334,053Expenses2Amt
Description3FOR CONVENING EXPERTS TO EXPLORE PROGRAM PRIORITIES, SHARE RESEARCH AND IDEAS, AND BRAINSTORM NEW AREAS OF IMPACT IN SUPPORT OF THE FOUNDATION'S MISSION.Description3Txt
Expenses3$60,868Expenses3Amt

Sum Of Program Related Invst SumOfProgramRelatedInvstGrp

FieldValueIRS element (for citing)
Description1THETIS PHARMACEUTICALS, LLC - DEVELOPMENT OF NOVEL RESOLVIN E1 THERAPY FOR CROHN'S TREATMENTDescription1Txt
Expenses1$3,285,274Expenses1Amt
Description2PERCUSENSE, INC. - DEVELOPMENT OF CONTINUOUS GLUCOSE AND KETONE METER FOR TREATMENT IN T1DDescription2Txt
Expenses2$600,000Expenses2Amt
All Other Program Rltd Invst Tot$410,000AllOtherProgramRltdInvstTotAmt
Total$4,295,274TotalAmt

Minimum Investment Return MinimumInvestmentReturnGrp

FieldValueIRS element (for citing)
Average Monthly FMV Of Sec$8,179,026,450AverageMonthlyFMVOfSecAmt
Average Monthly Cash Balances$194,222,475AverageMonthlyCashBalancesAmt
FMV All Other Noncharitable Ast$497,417FMVAllOtherNoncharitableAstAmt
Total FMV Of Unused Assets$8,373,746,342TotalFMVOfUnusedAssetsAmt
Reduction Claimed$0ReductionClaimedAmt
Acquisition Indebtedness$0AcquisitionIndebtednessAmt
Adjusted Total FMV Of Unused Ast$8,373,746,342AdjustedTotalFMVOfUnusedAstAmt
Cash Deemed Charitable$125,606,195CashDeemedCharitableAmt
Net Vl Noncharitable Assets$8,248,140,147NetVlNoncharitableAssetsAmt
Minimum Investment Return$412,407,007MinimumInvestmentReturnAmt

Distributable Amount DistributableAmountGrp

FieldValueIRS element (for citing)
Minimum Investment Return$412,407,007MinimumInvestmentReturnAmt
Tax Based On Investment Income$14,577,769TaxBasedOnInvestmentIncomeAmt
Total Tax$14,577,769TotalTaxAmt
Distributable Before Adj$397,829,238DistributableBeforeAdjAmt
Recoveries Qualfied Distri$451,754RecoveriesQualfiedDistriAmt
Distributable Before Ded$398,280,992DistributableBeforeDedAmt
Deduction From Distributable$0DeductionFromDistributableAmt
Distributable As Adjusted$398,280,992DistributableAsAdjustedAmt

PF Qualifying Distributions PFQualifyingDistributionsGrp

FieldValueIRS element (for citing)
Expenses And Contributions$409,514,790ExpensesAndContributionsAmt
Program Related Invst Total$4,295,274ProgramRelatedInvstTotalAmt
Charitable Assets Acquis Paid$4,560,789CharitableAssetsAcquisPaidAmt
Qualifying Distributions$418,370,853QualifyingDistributionsAmt

Undistributed Income UndistributedIncomeGrp

FieldValueIRS element (for citing)
Distributable As Adjusted$398,280,992DistributableAsAdjustedAmt
Undistributed Income PY$120,476,741UndistributedIncomePYAmt
Total For Prior Years$0TotalForPriorYearsAmt
Total Excess Distribution Cyov$0TotalExcessDistributionCyovAmt
Qualifying Distributions$418,370,853QualifyingDistributionsAmt
Applied To Year1$120,476,741AppliedToYear1Amt
Applied To Prior Years$0AppliedToPriorYearsAmt
Treated As Distri From Corpus$0TreatedAsDistriFromCorpusAmt
Applied To Current Year$297,894,112AppliedToCurrentYearAmt
Remaining Distri From Corpus$0RemainingDistriFromCorpusAmt
Excess Distri Cyov App CY Corpus$0ExcessDistriCyovAppCYCorpusAmt
Excess Distribution Cyov App CY$0ExcessDistributionCyovAppCYAmt
Total Corpus$0TotalCorpusAmt
Prior Year Undistributed Incm$0PriorYearUndistributedIncmAmt
Prior Year Deficiency Or Tax$0PriorYearDeficiencyOrTaxAmt
Taxable1$0Taxable1Amt
Taxable2$0Taxable2Amt
Undistributed Income CY$100,386,880UndistributedIncomeCYAmt
Corpus Distri170b1 E Or4942g3$0CorpusDistri170b1EOr4942g3Amt
Excess Distri Cyov From Yr5$0ExcessDistriCyovFromYr5Amt
Excess Distri Cyov To Next Yr$0ExcessDistriCyovToNextYrAmt

Supplementary Information SupplementaryInformationGrp

FieldValueIRS element (for citing)
Only Contri To PreselectedYes (X)OnlyContriToPreselectedInd

Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (544 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient RelationshipRecipientRelationshipTxtRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line1RecipientForeignAddress/AddressLine1TxtAddress Line2RecipientForeignAddress/AddressLine2TxtCityRecipientForeignAddress/CityNmCountryRecipientForeignAddress/CountryCdAddress Line2RecipientUSAddress/AddressLine2Txt
4YOUANDME
2901 THIRD AVENUESEATTLEWA98121N/APCWEARABLES TO MEASURE STRESS AND FORECAST CROHNS SYMPTOMS$84,107
A GLIMMER OF HOPE FOUNDATION
3103 BEE CAVES ROADAUSTINTX78746N/APFINTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA$1,449,415
AGRICULTURAL RESEARCH ORGANIZATION
N/AGOVTHE HELMSLEY CENTER FOR AI IN AGRICULTURE AT THE VOLCANI CENTER$1,591,900DERECH HAMACCABIM 68 RISHONLETSIYONRISHON LETSIYONIS
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
4000 AMBASSADOR DRIVEANCHORAGEAK99508N/APCTULUKSAK WATER AND WASTEWATER SYSTEM$792,660
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVEBRONXNY104611975N/APCPRECLINICAL WORK TO ADVANCE D-PEPTIDES AS ANTIGEN-SPECIFIC IMMUNOTHERAPY$2,381,358
ALIMENTIV INC
N/ANCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$366,257100 DUNDAS STREETLONDONCA
ALIMENTIV INC
N/ANCSTENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM$116,515100 DUNDAS STREETLONDONCA
ALVIN AILEY DANCE FOUNDATION INC
THE JOAN WEILL CENTER FOR DANCENEW YORKNY10019N/APCGENERAL OPERATING SUPPORT$10,000
ALYN HOSPITAL - REHABILITATION CENTER FOR CHILDREN AND YOUTH
N/APCALYN CENTER FOR INNOVATION IN PEDIATRIC REHABILITATION RESEARCH$777,74984 SHMARYAHU LEVIN STJERUSALEMIS
AMC MEDICAL RESEARCH BV
N/APCIDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE$942,690MEIBERGDREEF 9AMSTERDAMNL
AMC MEDICAL RESEARCH BV
N/APCIDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE$50,570MEIBERGDREEF 9AMSTERDAMNL
AMERICAN CAMPING ASSOCIATION INC
5000 STATE ROAD 67 NORTHMARTINSVILLEIN46151N/APCACA PROFESSIONAL DEVELOPMENT 2022 - 2024$46,860
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCADA MENTAL HEALTH EDUCATION PROGRAM 2022 - 2024$382,893
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APC2022-2024 TYPE 1 DIABETES CAMP INITIATIVE$331,219
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCCGM SUPPORT FOR ADAS HEALTH EQUITY NOW 4TH NETWORK - COLUMBUS STUDY$150,000
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCFOCUS ON FELLOWS, DIABETES IS PRIMARY, PROFESSIONAL MEMBERSHIP PROJECTS$300,000
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCPATRON SUPPORT OF THE ASSOCIATION'S 79TH, 80TH, AND 81ST SESSIONS$75,000
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCAMERICAN BOARD OF TELEHEALTH PROGRAM EXPANSION$1,346,286
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCMISSION: LIFELINE STROKE MT AND POST-ACUTE STROKE CARE QUALITY STANDARDS$1,144,990
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCMISSION: LIFELINE STROKE SYSTEM OF CARE IN NEBRASKA$1,034,941
AMERICAN PHARMACISTS ASSOCIATION FOUNDATION
2215 CONSTITUTION AVE NWWASHINGTONDC20037N/APCEXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACY$249,913
AMERICAN TELEMEDICINE ASSOCIATION
901 NGLEBE RDARLINGTONVA22203N/APCGENERAL OPERATING SUPPORT$24,000
AMERICARES FOUNDATION INC
88 HAMILTON AVESTAMFORDCT06840N/APCMATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS$930,374
AMERICARES FOUNDATION INC
88 HAMILTON AVESTAMFORDCT06840N/APCOXYGEN FOR SUNTRESO HOSPITAL$183,200
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606N/ANCEXPANSION OF DANATECH PLATFORM$400,000
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606N/ANCAADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS$216,544
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD
N/APCFECAL MICROBIOTA TRANSPLANTATION IN CROHNS DISEASE: THE MIRO STUDY$758,947LEVEL 2FITZROYAS
AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER
1325 S CLIFF AVENUESIOUX FALLSSD57105N/APCAVERA BEHAVIORAL HEALTH CENTER EXPANSION$3,000,000
AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER
1325 S CLIFF AVENUESIOUX FALLSSD57105N/APCAVERA BEHAVIORAL HEALTH CENTER EXPANSION$500,000
AVERA MERRILL PIONEER HOSPITAL
1100 S 10TH AVEROCK RAPIDSIA51246N/APCEEMERGENCY AND EPHARMACY AT AVERA MERRILL PIONEER HOSPITAL$19,959
BALLAD RESEARCH INSTITUTE
10865 ROAD TO THE CURESAN DIEGOCA92121N/APCCD127-HIGH T-CELL POPULATIONS AS BIOMARKERS$516,369
BAPTIST MEDICAL CENTRE
N/APCEMERGENCY CENTRE AND DOCTOR HOUSING DEVELOPMENT$1,513,500BAPTIST MEDICAL CENTRE ROADNALERIGUGH
BAYLOR COLLEGE OF MEDICINE
OFFICE OF RESEARCHHOUSTONTX77030N/APCEMR-BASED PREDICTIVE ANALYTICS FOR TARGETED & PROACTIVE T1D CARE$500,994
BAYLOR COLLEGE OF MEDICINE
OFFICE OF RESEARCHHOUSTONTX77030N/APCPILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE$501,482
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
1201 NINTH AVENUESEATTLEWA981012795N/APCGUIDELINES FOR CLINICAL FOLLOW-UP OF MULTIPLE ISLET AUTOANTIBODIES$70,000
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
1201 NINTH AVENUESEATTLEWA981012795N/APCLINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN IN T1D$581,045
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
1201 NINTH AVENUESEATTLEWA981012795N/APCGUIDELINES FOR CLINICAL PRACTICE OF AUTOANTIBODY POSITIVE INDIVIDUALS$70,000
BETH ISRAEL DEACONESS MEDICAL CENTER INC
330 BROOKLINE AVENUEBOSTONMA022155491N/APCPROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD$526,637
BEYOND TYPE 1
1001 LAUREL ST STE BSAN CARLOSCA94070N/APCDIABETIC KETOACIDOSIS (DKA) CAMPAIGN PHASE 3$451,667
BIG HORN HOSPITAL ASSOCIATION
17 N MILES AVEHARDINMT59034N/APCEEMERGENCY AND EPHARMACY AT BIG HORN HOSPITAL ASSOCIATION IN HARDIN, MT$24,948
BILLINGS CLINIC FOUNDATION
2917 TENTH AVENUE NORTHBILLINGSMT59102N/APCMONTANA PSYCHIATRY RESIDENCY PROGRAM SUSTAINING SUPPORT$1,000,000
BIPARTISAN POLICY CENTER INC
1225 I ST NW 1000WASHINGTONDC20005N/APCSTRENGTHENING HEALTH CARE DELIVERY AND SERVICES IN RURAL AMERICA$622,488
BIPARTISAN POLICY CENTER INC
1225 I ST NW 1000WASHINGTONDC20005N/APCRURAL HEALTH CARE TASK FORCE$149,200
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209WILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$15,576,000ORANGE STREET
BOSTON MEDICAL CENTER CORPORATION
ONE BOSTON MEDICAL PLACEBOSTONMA02118N/APCSTAGING CROHNS DISEASE USING MUCOSAL EXOSOMES$94,406
BOSTON MEDICAL CENTER CORPORATION
ONE BOSTON MEDICAL PLACEBOSTONMA02118N/APCSTAGING CROHNS DISEASE USING MUCOSAL EXOSOMES$55,704
BOSTON SYMPHONY ORCHESTRA INC
301 MASSACHUSETTS AVENUEBOSTONMA02115N/APCGENERAL OPERATING SUPPORT$10,000
BOULDER CITY HOSPITAL INC
901 ADAMS BLVDBOULDER CITYNV89005N/APCBOULDER CITY HOSPITAL ULTRASOUND INITIATIVE$100,838
BOULDER CITY HOSPITAL INC
901 ADAMS BLVDBOULDER CITYNV89005N/APCBOULDER CITY HOSPITAL EQUIPMENT REVITALIZATION PROJECT$663,285
BRIDGES TO PROSPERITY INC
1031 33RD STREETDENVERCO80205N/APCTRANSFORMATIVE CONNECTIVITY IN RURAL ETHIOPIA$5,262,850
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCGLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS$548,201
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCPEN-PLUS EXPANSION$1,325,594
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCINVESTIGATION OF ANTI-GM-CSF AUAB AS A DISEASE DETERMINANT IN CD$872,027
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCGENERAL OPERATING SUPPORT$20,000
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCGLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS$3,031,033
BURGESS HEALTH CENTER
1600 DIAMOND STREETONAWAIA51040N/APCEEMERGENCY AND EPHARMACY AT BURGESS HEALTH CENTER$33,587
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
N/AGOVUK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO CD TREATMENTS$312,018HILLS ROADCAMBRIDGEUK
CANDID
32 OLD SLIP 24TH FLOORNEW YORKNY10005N/APCGENERAL OPERATING SUPPORT$17,551
CARE FOR THE HOMELESS
30 EAST 33RD STREET 5TH FLOORNEW YORKNY10016N/APCNEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE$200,000
CARE-FOR-RARE FOUNDATION
N/APCVEOIBD FROM PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES - MUNICH$643,036DR VON HAUNERSCHES KINDERSPITALMUNICHGM
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCBOUSSOUMA AND ZIGA, BURKINA FASO IMPROVED WASH INFRASTRUCTURE & SERVICES$2,045,026
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCINTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT IN GHANA$2,589,304
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCMAYI MWANA PROJECT: HELPING ZAMBIAN MOTHERS & NEWBORNS SURVIVE & THRIVE$1,066,649
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCRURAL EMERGENCY HEALTH SERVICE AND TRANSPORT FOR SYSTEM DEVELOPMENT$1,597,757
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCCOMMUNITY RECOVERY AND RESILIENCE IN EASTERN ETHIOPIA$2,752,636
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCLONG-TERM RESPONSE TO SARS-COV-2 VACCINATION IN A DIVERSE IBD POPULATION$976,541
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCVEOIBD PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES CEDARS-SINAI$115,500
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCTARGETING MICROORGANISMS IN CREEPING FAT$375,747
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCTARGETING MICROORGANISMS IN CREEPING FAT$393,039
CENTER FOR EXCELLENCE IN HEALTH CARE JOURNALISM
10 NEFF HALLCOLUMBIAMO65211N/ASOIITRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND HEALTH REPORTING$180,005
CENTER FOR URBAN COMMUNITY SERVICES INC
198 EAST 121ST STREETNEW YORKNY10035N/APCNEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE$200,000
CENTRAL MONTANA MEDICAL FACILITIES INC
408 WENDELL AVELEWISTOWNMT59457N/APCCANCER CENTER AT CENTRAL MONTANA MEDICAL CENTER$1,840,000
CENTRE HOSPITALIER REGIONAL DE NANCY
N/AGOVPREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS/ COMORBIDITIES IN CD CARE$173,55529 AVENUE MAL DE LATTRE DE TASSIGNYNANCYFR
CHILDREN OF THE LIGHT INTERNATIONAL MINISTRIES INC
1171 E 95TH STREETBROOKLYNNY11236N/APCGENERAL OPERATING SUPPORT$25,000
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCVEOIBD PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES- BOSTON$1,155,528
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCNOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULINS$662,214
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCDEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM$1,162,617
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCGLUCOSE-RESPONSIVE APPROACHES TO INSULIN AND GLUCAGON DELIVERY$567,507
CHILDREN'S HOSPITAL LOS ANGELES
SABAN RESEARCH INSTITUTELOS ANGELESCA90027N/APCTEAM CLINIC: EXPANSION OF A CARE MODEL FOR ADOLESCENTS WITH T1D$360,832
CHILDREN'S HOSPITAL LOS ANGELES
SABAN RESEARCH INSTITUTELOS ANGELESCA90027N/APCBEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE$527,168
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCDEVELOP A PROGNOSTIC AI MODEL FOR FORECASTING CD PATIENT OUTCOMES$1,242,522
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCDELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D$833,493
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCPRECISION CROHNS DISEASE MANAGEMENT UTILIZING PREDICTIVE PROTEIN PANELS$613,632
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCBIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHNS DISEASE$692,740
CHILDREN'S HOSPITAL OF PHILADELPHIA
2716 SOUTH STREETPHILADELPHIAPA191462305N/APCCROHNS DISEASE EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM$281,734
CHILDREN'S HOSPITAL OF PHILADELPHIA
2716 SOUTH STREETPHILADELPHIAPA191462305N/APCCROHNS DISEASE EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM$424,937
CHILDREN'S HUNGER FUND
13931 BALBOA BLVDSYLMARCA91342N/APCMEDICAL AND ORPHAN CARE INITIATIVE IN ETHIOPIA$250,409
CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROADKANSAS CITYMO64108N/APCTYPE 1 DIABETES RAPID LEARNING LAB$445,112
CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROADKANSAS CITYMO64108N/APCTYPE 1 DIABETES RAPID LEARNING LAB$2,012,361
CITIZENS HOUSING AND PLANNING COUNCIL OF NEW YORK INC
42 BROADWAY STE 2010NEW YORKNY10004N/APCEDUCATION FOR NYC POLICYMAKERS ON HOUSING INITIATIVES TO IMPROVE HEALTH$200,000
CITY PARKS FOUNDATION
830 FIFTH AVENUENEW YORKNY10065N/APCCATALYST: GROWING INTENSIVE PARK ENGAGEMENT IN VULNERABLE COMMUNITIES$479,444
CITY PARKS FOUNDATION
830 FIFTH AVENUENEW YORKNY10065N/APCNYC GREEN RELIEF & RECOVERY FUND$537,825
CIVICA FOUNDATION
2912 WEST EXECUTIVE PARKWAYLEHIUT84043N/APCAFFORDABLE INSULIN BIOSIMILARS$5,000,000
CLALIT HEALTH SERVICES
N/APCKIRYAT SHMONA MEDICAL CLINIC$1,118,393101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCBIO-MDT APPROACH TO PERSONALIZED TREATMENT OF POUCHITIS$748,810101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCCLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM$589,062101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCTHE IBDMED NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL & PREVENTION$451,795101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCPET/CT SCANNER FOR EMEK MEDICAL CENTER IN AFULA, ISRAEL$2,075,000101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCMEDICAL EQUIPMENT FOR CARMEL MEDICAL CENTER IN HAIFA, ISRAEL$3,896,000101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCCOVID-19 VACCINE RESPONSES IN PATIENTS WITH IBD$165,855101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCCLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM$589,062101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCEARLY CROHNS DISEASE: UNDERSTANDING PATHOGENESIS, BEHAVIOR, RESPONSE$112,000101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCISRAELI IBD RESEARCH NUCLEUS (IIRN): CONSORTIUM MANAGEMENT$32,000101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCBIO-MDT APPROACH TO PERSONALIZED TREATMENT OF POUCHITIS$582,660101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCKIRYAT SHMONA MEDICAL CLINIC$1,405,714101 ARLOZOROV STREETTEL AVIVIS
CLARINDA REGIONAL HEALTH CENTER
220 ESSIE DAVISON DRIVECLARINDAIA51632N/AGOVEEMERGENCY AT CLARINDA REGIONAL HEALTH CENTER$16,247
CLINICAL DATA INTERCHANGE STANDARDS CONSORTIUM INC
401 WEST 15TH STREET SUITE 800AUSTINTX78701N/APCCDISC STANDARDS DEVELOPMENT PROJECT FOR TYPE 1 DIABETES$14,355
CLINTON HEALTH ACCESS INITIATIVE INC
383 DORCHESTER AVENUE SUITE 400BOSTONMA02127N/APCMARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE$845,202
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCPOVERTY TRACKER SURVEY: HEALTHCARE NEEDS & USE OF LOW-INCOME NEW YORKERS$81,367
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCNOVEL SPATIALLY RESOLVED GENOMIC PROFILING OF CROHNS DISEASE TISSUE$210,228
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCPOVERTY TRACKER SURVEY: HEALTHCARE NEEDS & USE OF LOW-INCOME NEW YORKERS$110,040
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCNOVEL SPATIALLY RESOLVED GENOMIC PROFILING OF CROHNS DISEASE TISSUE$146,811
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCCOMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE$232,672
COMMUNITY CENTERS INC
2 ST ROCH AVENUEGREENWICHCT06830N/APCGENERAL OPERATING SUPPORT$35,000
COMMUNITY MEMORIAL HOSPITAL DISTRICT
2731 HEALTHCARE DRIVESYRACUSENE68446N/AGOVECARE EMERGENCY AT SYRACUSE AREA HEALTH$33,296
CONSORCI INSTITUT D'INVESTIGACIONES BIOMEDICAS AUGUST
N/AGOVEARLY DETECTION OF PERIANAL FISTULIZING DISEASE$270,828ROSSELL 149BARCELONASP
CONSORCI INSTITUT D'INVESTIGACIONES BIOMEDICAS AUGUST
N/AGOVEARLY DETECTION OF PERIANAL FISTULIZING DISEASE$262,204ROSSELL 149BARCELONASP
COUNCIL ON FOUNDATIONS INC
1255 23RD ST NWWASHINGTONDC20037N/APCGENERAL OPERATING SUPPORT$34,000
COUNCIL ON THE ENVIRONMENT INC
100 GOLD ST SUITE 3300NEW YORKNY10038N/APCINTER-GENERATIONAL, VIABLE GREENSPACE IN NYCHA COMMUNITIES$116,600
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSUPPORT FOR CCF'S CROHNS AND COLITIS CONGRESS- JANUARY, 2022$205,000
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD$544,115
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSUPPORT JUNIOR SCIENTISTS TO ESTABLISH CAREERS IN IBD RESEARCH.$1,067,400
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD$494,615
CROHN'S AND COLITIS CANADA
N/APCIMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS$323,98360 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCRCT TO IMPROVE TRANSITION OF PATIENTS W CD FROM PEDIATRIC TO ADULT CARE$261,03060 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCSUPPORT FOR CROHNS & COLITIS CANADA 2020- 21 PATIENT PROGRAMS$65,99060 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCRCT TO IMPROVE TRANSITION OF PATIENTS W CD FROM PEDIATRIC TO ADULT CARE$315,00960 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCIMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS$165,64860 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS UK
N/APC2021 2022 OPERATING SUPPORT FOR CROHNS AND COLITIS UK$75,9001 BISHOPS SQUAREHATFIELDUK
CROHN'S COLITIS CURE
N/APCDEVELOPMENT OF CCCARE-P, A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE$175,2331 OCONNELL STREETSYDNEYAS
DARTMOUTH- HITCHCOCK CLINIC
ONE MEDICAL CENTER DRIVELEBANONNH03756N/APCCAPACITY BUILDING FOR VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM$195,140
DE LA SALLE SOLIDARIETAINTERNAZIONALE ONLUS
N/APCESTABLISHING A ROBUST MEDICAL EDUCATION CENTER - ETHIOPIA$294,372VIA AUREALIA 476ROMEIT
DE LA SALLE SOLIDARIETAINTERNAZIONALE ONLUS
N/APCETHIOPIAN CATHOLIC UNIVERSITY DIAGNOSTIC LABORATORY$1,043,204VIA AUREALIA 476ROMEIT
DELAWARE COUNTY MEMORIAL HOSPITAL
709 W MAIN STMANCHESTERIA52057N/APCEEMERGENCY AND EPHARMACY AT REGIONAL MEDICAL CENTER IN MANCHESTER, IA$29,195
DUKE UNIVERSITY
C/O OFFICE OF RESEARCH SUPPORTDURHAMNC277054677N/APCUTILIZATION OF INTERACTION BETWEEN AMINO ACIDS & GIP IN PANCREATIC CELLS$275,000
ELLSWORTH MUNICIPAL HOSPITAL
920 SOUTH OAK STREETIOWA FALLSIA50126N/AGOVEPHARMACY AT HANSEN FAMILY HOSPITAL$8,493
ENGINEERING MINISTRIES INTERNATIONAL USA
7025 CAMPUS DRIVECOLORADO SPRINGSCO80920N/APCALASKA WASH PROJECT$6,680,429
FALL RIVER HEALTH SERVICES
1201 HIGHWAY 71 SHOT SPRINGSSD57747N/APCEEMERGENCY AT FALL RIVER HEALTH SERVICES$17,325
FEEDING SOUTH DAKOTA
4701 N WESTPORT AVESIOUX FALLSSD571070123N/APCGENERAL OPERATING SUPPORT$25,000
FIRST AFFILIATED HOSPITAL OF SUN YAT-SEN UNIVERSITY
N/AGOVINDUSTRIALIZATION RELATED ENVIRONMENTAL CHANGES & MICROBIOME ALTERATIONS$120,00058 ZHONGSHAN II ROADGUANGZHOUCH
FLORESTA USA INCORPORATED
4747 MORENA BLVD STE 100SAN DIEGOCA92117N/APCSCALING AT THE WATERSHED LEVEL TO EQUIP RURAL FAMILIES$1,048,129
FLOYD VALLEY HOSPITAL
714 LINCOLN STREET NELE MARSIA51031N/AGOVEEMERGENCY AT FLOYD VALLEY HEALTHCARE$14,837
FOR INSPIRATION AND RECOGNITION OF SCIENCE TECHNOLOGY
200 BEDFORD STREETMANCHESTERNH03101N/APCINSPIRE YOUNG PEOPLE TO BE SCIENCE AND TECHNOLOGY LEADERS$200,000
FORSCHERGRUPPE DIABETES EV
N/APCFR1DA-PLUS COHORT STUDY$467,844HELMHOLTZ ZENTRUM MUNCHENNEUHERBERGGM
FRANCISCAN CARE SERVICES INC
430 N MONITOR STWEST POINTNE68788N/APCTELE-EMERGENCY SERVICES AT FRANCISCAN HEALTHCARE$114,632
FRIENDS OF THE ISRAEL DEFENSE FORCES
60 EAST 42 STREETNEW YORKNY10165N/APCTHE UNIFORM TO UNIVERSITY SCHOLARSHIP PROGRAM$334,400
FUND FOR PUBLIC HEALTH IN NEW YORK INC
22 CORTLANDT STREET SUITE 802NEW YORKNY10007N/APCNYC VACCINE EQUITY PARTNER ENGAGEMENT PROJECT$2,249,533
FUND FOR PUBLIC HOUSING INC
90 CHURCH STREETNEW YORKNY10007N/APCSTRATEGIC PLANNING AND DEMONSTRATION PROJECT$200,000
GALILEE MEDICAL CENTER
N/AGOVPURCHASE OF TWO ECMO MACHINES FOR GALILEE MEDICAL CENTER$157,000GALILEE MEDICAL CENTERNAHARIYAIS
GEORGIA TECH RESEARCH CORPORATION
505 10TH STREET NWATLANTAGA303320420N/ASOIII FITRACKING & INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN CD PATIENTS$951,960
GIRLS WITH GUTS
6024 RIDGE AVENUEPHILADELPHIAPA19128N/APC2021 & 2022 OPERATING SUPPORT TO GIRLS WITH GUTS.$9,862
GIRLS WITH GUTS
6024 RIDGE AVENUEPHILADELPHIAPA19128N/APC2021 2022 OPERATING SUPPORT TO GIRLS WITH GUTS.$9,862
GLOBAL SOLIDARITY FUND
425 LEXINGTON AVENEW YORKNY10017N/APCJOB CREATION IN ETHIOPIA$1,508,200
GORDON MEMORIAL HOSPITAL DISTRICT
300 E 8TH STGORDONNE69343N/AGOVEEMERGENCY AT GORDON MEMORIAL HOSPITAL$14,384
GRAND CANYON UNIVERSITY
3300 WEST CAMELBACK ROADPHOENIXAZ85017N/APCDEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR$766,986
GRANTMAKERS FOR EFFECTIVE ORGANIZATIONS
1310 L STREET NWWASHINGTONDC20005N/APCGENERAL OPERATING SUPPORT$18,920
GRANTMAKERS IN HEALTH
1100 CT AVENUE NWWASHINGTONDC20036N/APCGENERAL OPERATING SUPPORT$23,760
GRANTMAKERS IN HEALTH
1100 CT AVENUE NWWASHINGTONDC20036N/APCGRANTMAKERS IN HEALTH EFFECTIVE PHILANTHROPY FUND$30,197
GUARDIAN ORG FOUNDATION
900 17TH STREET NW SUITE 250WASHINGTONDC20006N/APCAN INDEPENDENT JOURNALISM SERIES ON NON-COMMUNICABLE DISEASES$875,000
GUTTENBERG MUNICIPAL HOSPITAL
200 MAIN STGUTTENBERGIA52052N/AGOVEEMERGENCY AND EPHARMACY AT GUTTENBERG MUNICIPAL HOSPITAL$26,922
HANNOVERSCHE KINDERHEILANSTALT
N/APCFR1DA IN NORTH GERMANY: PRE-SYMPTOMATIC TYPE 1 DIABETES TESTING IN KIDS$286,700JANUSZ-KORCZAK-ALLEE 12HANNOVERGM
HARLAN COUNTY HEALTH SYSTEM
717 NORTH BROWNALMANE689200836N/AGOVEPHARMACY AT HARLAN COUNTY HEALTH SYSTEM$9,737
HEALTH ADVOCACY SUMMIT INC
1962 DOCKSIDE DRIVEGREENWOODID46143N/APC2021 OPERATING SUPPORT FOR HEALTH ADVOCACY SUMMIT AND THE CCYAN$25,000
HEALTH ADVOCACY SUMMIT INC
1962 DOCKSIDE DRIVEGREENWOODIN46143N/APC2021 OPERATING SUPPORT FOR HEALTH ADVOCACY SUMMIT AND THE CCYAN$25,000
HEALTH FINANCE INSTITUTE
1690 NORTH QUINN STREETARLINGTONVA22209N/APCCATALYZE FINANCE & PARTNERS TO ADDRESS GLOBAL BURDEN OF CHRONIC DISEASE$1,633,848
HEALTHPARTNERS INSTITUTE
PO BOX 1309MINNEAPOLISMN55440N/APCDIRECT INTEGRATION OF CGM DATA INTO THE EMR$284,446
HEALTHPARTNERS INSTITUTE
PO BOX 1309MINNEAPOLISMN55440N/APCDIRECT INTEGRATION OF CGM DATA INTO THE EMR$258,500
HEBREW UNIVERSITY OF JERUSALEM
N/APCMETHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS$775,164OFFICE OF THE PRESIDENTJERUSALEMIS
HEBREW UNIVERSITY OF JERUSALEM
N/APCMETHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS$18,350OFFICE OF THE PRESIDENTJERUSALEMIS
HEBREW UNIVERSITY OF JERUSALEM
N/APCMETHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS$249,301OFFICE OF THE PRESIDENTJERUSALEMIS
HELEN KELLER INTERNATIONAL
ONE DAG HAMMARSKJOLD PLAZANEW YORKNY10017N/APCA CONTINUED PATH TO RESILIENCE AND EMPOWERMENT$1,902,757
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD DRIED BLOOD SPOT OMICS TO PREDICT HEALTH OUTCOMES IN CHILDREN$604,654HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL$1,800,000HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCCONTINUATION OF THE GPPAD-02-STUDY$2,428,367HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$668,907HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCFR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT$263,397HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCIDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION$3,653,834HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL$2,705,330HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HENRY J KAISER FAMILY FOUNDATION
185 BERRY STREET NO 2000SAN FRANCISCOCA94107N/APCKHN RURAL HEALTH DESK$1,451,938
HERLEV OG GENTOFTE HOSPITAL
N/AGOVUTILIZATION OF INTERACTION BETWEEN AMINO ACIDS & GIP IN PANCREATIC CELLS$275,000HERLEV AND GENTOFTE HOSPITALHERLEVDA
HERLEV OG GENTOFTE HOSPITAL
N/AGOVTARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D$249,897HERLEV AND GENTOFTE HOSPITALHERLEVDA
HILLEL YAFFE MEDICAL CENTER
N/AGOVPURCHASE TWO ECMO MACHINES FOR HILLEL YAFFE MEDICAL CENTER$155,418HA-SHALOM STHADERAIS
HUMBOLDT COUNTY HOSPITAL DISTRICT
118 E HASKELL STREETWINNEMUCCANV89445N/AGOVULTRASOUND EQUIPMENT$209,393
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCVEOIBD: PRECISION DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES$220,000
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCMODULATING EARLY LIFE MICROBIOME THROUGH DIETARY INTERVENTION IN CROHNS$479,190
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCSAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC CROHNS DISEASE$267,814
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCEVALUATING AID TECHNOLOGY IN PREGNANT WOMEN WITH T1D$482,282
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCNEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE$664,751
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCMODULATING EARLY LIFE MICROBIOME THROUGH DIETARY INTERVENTION IN CROHNS$492,812
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCSAFETY AND TOLERABILITY OF ORAL BFAHF-2 IN PEDIATRIC CROHNS DISEASE$375,235
ICHUD HATZALAH ISRAEL 1221 (RA)
N/APCUNITED HATZALAH HUMANITARIAN MISSION FOR UKRAINE$385,00078 YIRMIYAHU STJERUSALEMIS
ICHUD HATZALAH ISRAEL 1221 (RA)
N/APCURGENT NEED FOR PROTECTIVE VESTS AND HELMETS$500,00078 YIRMIYAHU STJERUSALEMIS
IDA COUNTY IOWA COMMUNITY HOSPITAL
701 EAST SECOND STREETIDA GROVEIA51445N/APCECARE PHARMACY AT HORN MEMORIAL HOSPITAL$24,192
IDEOORG
444 SPEAR STREETSAN FRANCISCOCA94105N/APCHUMAN-CENTERED DESIGN STUDY OF T1D IN MEDICALLY UNDERSERVED COMMUNITIES.$200,000
IDEOORG
444 SPEAR STREETSAN FRANCISCOCA94105N/APCHUMAN-CENTERED DESIGN STUDY OF T1D IN MEDICALLY UNDERSERVED COMMUNITIES.$150,000
INCLINE VILLAGE COMMUNITY HOSPITAL FOUNDATION
880 ALDER AVEINCLINE VILLAGENV89451N/APCDIAGNOSTIC IMAGING EQUIPMENT RELATED FUNDING SUPPORT$1,796,260
INDIANA UNIVERSITY (AMPATH PROJECT)
702 ROTARY CIRCLEINDIANAPOLISIN46202N/APCAMPATH MODEL REPLICATION IN GHANA$2,131,500
INDIANA UNIVERSITY
702 ROTARY CIRCLEINDIANAPOLISIN46202N/APCAMPATH MODEL REPLICATION IN GHANA$3,474,440
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$41,4011 RUE LOUIS RECHDUDELANGELU
INSTITUT NATIONALE DE LA SANTE DE LA RECHERCHE MEDICALE
N/AGOVBENIGN ISLET AUTOIMMUNITY TO T1D: CD8+ T-CELL BIOMARKERS OF PROGRESSION$373,43186 RUE REGNAULTPARISFR
INSTITUT NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE
N/AGOVBENIGN ISLET AUTOIMMUNITY TO T1D: CD8+ T-CELL BIOMARKERS OF PROGRESSION$178,28686 RUE REGNAULTPARISFR
INSULIN FOR LIFE USA INC
2555 SW 76TH STREETGAINESVILLEFL32608N/APCINSULIN FOR LIFE USA STRENGTHENING ORGANIZATIONAL CAPACITY$296,175
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCTHE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND$693,935HARKORTSTR 1MUNSTERGM
INTERNATIONAL WATER MANAGEMENT INSTITUTE
N/APCWATER SECURE AFRICA INITIATIVE: OPEN DATA CUBE EXTENSION$942,226127 SUNIL MAWATHABATTARAMULLACE
IOWA DEPARTMENT OF PUBLIC HEALTH
321 EAST 12THDES MOINESIA50319N/AGOVIOWA FIRST RESPONDER AED INITIATIVE$5,283,804
ISRAEL ANTIQUITIES AUTHORITY
N/AGOVJAY & JEANIE SCHOTTENSTEIN NATIONAL CAMPUS FOR THE ARCHAEOLOGY OF ISRAEL$2,600,00027 SULTAN SULEIMAN STREETJERUSALEMIS
ISRAEL CROHN'S DISEASE AND ULCERATIVE COLITIS FOUNDATION
N/APC2020 OPERATING SUPPORT FOR CCFI'S EMERGENCY TRANSPORTATION PROGRAM$57,428YOKNEAM 5TEL AVIVIS
ISRAEL CROHN'S DISEASE AND ULCERATIVE COLITIS FOUNDATION
N/APC2020 OPERATING SUPPORT FOR CCFI'S EMERGENCY TRANSPORTATION PROGRAM$59,407YOKNEAM 5TEL AVIVIS
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W DIABETES RETINOPATHY$56,265
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY$600,000
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCCGM MONITORING OF MATERNAL DYSGLYCEMIA$453,159
JDRF AUSTRALIA
N/APCENDIA FOLLOW UP 2020-2022$1,133,60180-84 CHANDOS STREETSYDNEYAS
JDRF AUSTRALIA
N/APCENDIA EARLY TO MID-CAREER SCIENCE ACCELERATOR AWARDS 2021$239,78480-84 CHANDOS STREETSYDNEYAS
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCDEVELOPMENT OF NOVEL INSULIN INFUSION SET$432,631
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCJDRF GLOBAL DIABETES ACCESS INITIATIVE$999,800
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCJDRF TRAINING PROGRAMS$1,250,000
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCHCP T1D EDUCATION PROGRAM (STATE OF AFFAIRS AND PEAK)$99,699
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCAUTOIMMUNITY SCREENING IN KIDS (ASK) RENEWAL$400,000
JDRF T1D FUND LLC
99 HIGH STREETBOSTONMA02110N/APCJDRF T1D FUND PHASE III$3,000,000
JENNIE M MELHAM MEMORIAL MEDICAL CENTER INC
145 MEMORIAL DRIVEBROKEN BOWNE68822N/APCEPHARMACY AT JENNIE M MELHAM MEMORIAL MEDICAL CENTER, INC.$11,360
JERUSALEM COLLEGE OF TECHNOLOGY
N/APCHELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING$2,859,00021 HAVAAD HALEUMI STJERUSALEMIS
JOHNS HOPKINS UNIVERSITY
733 NORTH BROADWAY MRB 117BALTIMOREMD21205N/APCA MULTIDISCIPLINARY BIOENGINEERING APPROACH TO FISTULA-IN-ANO IN CROHNS$360,255
JOHNS HOPKINS UNIVERSITY
733 NORTH BROADWAY MRB 117BALTIMOREMD21205N/APCA MULTIDISCIPLINARY BIOENGINEERING APPROACH TO FISTULA-IN-ANO IN CROHNS$239,373
JOSLIN DIABETES CENTER INC
ONE JOSLIN PLACEBOSTONMA02215N/APCAN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES$1,177,265
JUVENILE DIABETES RESEARCH FOUNDATION CANADA
N/APCJDRF CANADA PSYCHOSOCIAL HEALTH INITIATIVE$54,000235 YORKLAND BLVD SUITE 600TORONTOCA
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCINNODIA HARVEST$481,994WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCAN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT$530,355WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCSUPPORT FOR INNODIA HARVEST ACTIVITIES AT ACADEMIC CONSORTIUM MEMBERS.$792,845WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCAN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT$497,699WAAISTRAAT 6 BOX 5105LEUVENBE
KING'S COLLEGE LONDON
N/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III$1,509,981150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCIDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHNS DISEASE$740,062150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCEVALUATE THE BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA$46,929150 STAMFORD STREETLONDONUK
KITTSON MEMORIAL HOSPITAL ASSOCIATION
1010 SOUTH BIRCH AVENUEHALLOCKMN56728N/APCEEMERGENCY AT KITTSON HEALTHCARE$29,321
KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITT MUNCHEN
N/AGOVFMT FOR MAINTENANCE OF REMISSION AFTER EEN TREATMENT IN CROHNS DISEASE$639,055FEODOR-LYNEN-STRAE 17MUNCHENGM
KMR ADVANCEMENT OF MEDICAL CENTERS LTD
N/APCESTABLISHMENT OF THE HEALTH DISCOVERY TOWER$2,950,7508 HAALIYAH STHAIFAIS
LAKES REGIONAL HEALTHCARE
HIGHWAY 71 SOUTHSPIRIT LAKEIA51360N/AGOVECARE PHARMACY AT LAKES REGIONAL HEALTHCARE$27,140
LANDER COUNTY HOSPITAL DISTRICT
535 SOUTH HUMBOLDT STREETBATTLE MOUNTAINNV898201988N/AGOVRADIOLOGY EQUIPMENT FOR BATTLE MOUNTAIN GENERAL HOSPITAL$142,265
LINCOLN COUNTY HOSPITAL DISTRICT
700 NORTH SPRING STREETCALIENTENV89008N/AGOVGROVER C. DILS MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT$666,782
LIVING WATER INTERNATIONAL
4001 GREENBRIAR DRIVESTAFFORDTX77477N/APCINTEGRATED WASH PROGRAM IN CHIPATA DISTRICT, ZAMBIA$1,251,684
LUCAS COUNTY HEALTH CENTER
1200 NORTH 7TH STREETCHARITONIA50049N/APCAVERA ECARE EMERGENCY VIRTUAL HEALTH AT LUCAS COUNTY HEALTH CENTER$118,418
MACCABI HEALTHCARE SERVICES
N/APCMOBILE MAMMOGRAPHY UNIT$877,00027 HAMERED STTEL AVIVIS
MACCABI HEALTHCARE SERVICES
N/APCDA VINCI 4XI SYSTEM DUAL CONSOLE SURGICAL ROBOT AND STERILIZATION EQUIP.$3,505,00027 HAMERED STTEL AVIVIS
MADISON COUNTY MEMORIAL HOSPITAL
300 W HUTCHINGS STREETWINTERSETIA50273N/AGOVIMPLEMENTATION OF EEMERGENCY AT MADISON COUNTY HEALTH CARE SYSTEM$111,961
MAINEHEALTH
22 BRAMHALL STREETPORTLANDME04102N/APCTRANSFORMING RURAL DIABETES CARE IN MAINE$729,688
MARY C WHEELER SCHOOL INC
216 HOPE STREETPROVIDENCERI02906N/APCGENERAL OPERATING SUPPORT$10,000
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCTETHERED CAPSULE ENDOMICROSCOPY VISUALIZATION OF THE CROHNS BOWEL WALL$100,000
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCCROHNS DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION$350,279
MAT-SU TRAILS & PARKS FOUNDATION
PO BOX 652PALMERAK99645N/APCINDEPENDENCE MINE REHABILITATION$1,339,417
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$495,833
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APC2019-2021 MILITARY SCIENCES MEDICAL TRAINING/SUPPORT PROJECT (ARIZONA)$124,891
MEDICAL COLLEGE OF CORNELL UNIVERSITY
1300 YORK AVENUENEW YORKNY100654805N/APCTARGETING THE MYCOBIOME IN CROHNS DISEASE$283,903
MEEKER MEMORIAL HOSPITAL
612 S SIBLEY AVELITCHFIELDMN55355N/AGOVEEMERGENCY AT MEEKER MEMORIAL HOSPITAL$18,524
MEEKER MEMORIAL HOSPITAL
612 S SIBLEY AVELITCHFIELDMN55355N/AGOVEPHARMACY AT MEEKER MEMORIAL HOSPITAL$30,671
MERCY HEALTH SERVICES IOWA CORP
308 NORTH MAPLE AVENUENEW HAMPTONIA50659N/APCEEMERGENCY AT MERCYONE NEW HAMPTON MEDICAL CENTER$15,178
MI STATE UNIVERSITY
HANNAH ADMINISTRATION BUILDINGEAST LANSINGMI488242601N/APCA C-PEPTIDE COMPLEX FOR IMPROVED GLUCOSE METABOLISM IN PEOPLE WITH T1D$430,158
MIDDLE EAST MEDIA AND RESEARCH INSTITUTE INC
PO BOX 27837WASHINGTONDC20038N/APCIRAN STUDIES PROJECT$100,000
MONROE COUNTY HOSPITAL
6580 165TH STREETALBIAIA52531N/AGOVEPHARMACY AT MONROE COUNTY HOSPITAL & CLINICS$156,759
MONTANA DEPARTMENT OF HEALTH AND HUMAN SERVICES
PO BOX 202951HELENAMT59620N/AGOVMONTANA FIRST RESPONDER AED PROJECT$191,663
MONTANA DEPARTMENT PUBLIC HEALTH AND HUMAN SERVICES
PO BOX 202951HELENAMT59620N/AGOVMONTANA FIRST RESPONDER AED PROJECT$219,190
MONUMENT HEALTH NETWORK INC
2140 JUNCTION AVESTURGISSD57785N/APCEEMERGENCY AT MONUMENT HEALTH STURGIS HOSPITAL$129,650
NATIONAL COMMITTEE FOR QUALITY ASSURANCE
1100 13TH ST NWWASHINGTONDC20005N/APCTRANSFORM HEALTHCARE THROUGH MEASUREMENT, TRANSPARENCY, & ACCOUNTABILITY$1,336,294
NATIONAL PARK FOUNDATION
1500 K ST NWWASHINGTONDC20005N/APCBERING LAND BRIDGE VISITOR CENTER$848,202
NATURAL AREAS CONSERVANCY INC
1234 FIFTH AVENUENEW YORKNY10029N/APCFORMALIZING A NEW YORK CITY TRAIL SYSTEM$500,000
NATURE CONSERVANCY
4245 NORTH FAIRFAX DRIVE SUITE 100ARLINGTONVA22203N/APCFUTURE FOREST NEW YORK CITY PHASE II$500,000
NCD ALLIANCE
N/APCPUTTING PEOPLE WITH NCDS FIRST: DRIVING ADVOCACY, CHANGE, IMPROVING CARE$1,015,45031-33 AVENUE GIUSEPPE MOTTAGENEVASZ
NCD ALLIANCE
N/APCGENERAL OPERATING SUPPORT$42,50031-33 AVENUE GIUSEPPE MOTTAGENEVASZ
NCD ALLIANCE
N/APCPUTTING PEOPLE WITH NCDS FIRST: DRIVING ADVOCACY, CHANGE, IMPROVING CARE$1,055,70031-33 AVENUE GIUSEPPE MOTTAGENEVASZ
NEBRASKA DEPARTMENT OF HEALTH & HUMAN SERVICES
301 CENTENNIAL MALL SOUTHLINCOLNNE68508N/AGOVNEBRASKA FIRST RESPONDER AED PROJECT$5,608,814
NEVADA COMMUNITY FOUNDATION INC
1980 FESTIVAL PLAZA DRIVELAS VEGASNV89135N/APCDESERT VIEW AND MESA VIEW HOSPITAL EQUIPMENT REVITALIZATION PROJECT$2,216,426
NEW DESTINY HOUSING CORPORATION
12 W 37TH STREET 7TH FLOORNEW YORKNY10018N/APCAFTERCARE INTERVENTION TO IMPROVE HOUSING & HEALTH STABILITY$376,970
NEW VENTURE FUND
1201 CT AVE NW SUITE 300WASHINGTONDC20036N/APCTYPE 1 DIABETES CAMPS PROJECT (2022 - 2024)$3,302,000
NEW VENTURE FUND
1201 CT AVE NW SUITE 300WASHINGTONDC20036N/APCGENERAL OPERATING SUPPORT FOR THE OPEN RESEARCH FUNDERS GROUP$45,000
NEW VENTURE FUND
1201 CT AVE NW SUITE 300WASHINGTONDC20036N/APCTYPE 1 DIABETES CAMPS PROJECT (2022 - 2024)$102,000
NEW YORK CITY BALLET INC
DAVID H KOCH THEATERNEW YORKNY10023N/APCGENERAL OPERATING SUPPORT FOR NEW COMBINATIONS FUND$15,000
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
125 WORTH STREETNEW YORKNY10013N/APCEXPRESSCARE TELE-BEHAVIORAL SERV. & STRATEGIES (NYC HIGH NEEDS PATIENTS)$1,657,500
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
125 WORTH STREETNEW YORKNY10013N/APCEXPRESSCARE PLATFORM UPDATE AND SERVICE DELIVERY TO HOMELESS PATIENTS$250,000
NEW YORK UNIVERSITY
665 BROADWAYNEW YORKNY10012N/APCANALYSIS OF MEDICAID DATA TO IMPROVE CARE FOR HOMELESS PATIENTS$98,834
NEW YORK UNIVERSITY
665 BROADWAYNEW YORKNY10012N/APCEVALUATION OF INTERVENTIONS FOR COLLABORATIVE FOR HOMELESS HEALTHCARE$194,404
NEW YORK UNIVERSITY
665 BROADWAYNEW YORKNY10012N/APCIDENTIFYING ENVIRONMENTAL CONTRIBUTORS TO CROHNS DISEASE$695,626
NEW YORK-PRESBYTERIAN FUND INC
850 THIRD AVENUENEW YORKNY10022N/APCIMPROVING CARE FOR UNDERSERVED CHILDREN WITH T1D$200,000
NEWCASTLE UNIVERSITY
N/APCGPPAD UK EXPANSION: NEWCASTLE$15,776NEWCASTLE UPON TYNENEWCASTLEUK
NORTH DAKOTA DEPARTMENT OF HEALTH
600 E BOULEVARD AVENUEBISMARCKND585050200N/AGOVNORTH DAKOTA LAW ENFORCEMENT AED PROJECT$153,789
NORTHERN WESTCHESTER HOSPITAL ASSOCIATION
400 EAST MAIN STREETMOUNT KISCONY10549N/APCMATERNAL CHILD HEALTH UNIT FACILITIES RENOVATION$200,000
NURU INTERNATIONAL
2020 PENNSYLVANIA AVE NWWASHINGTONDC20006N/APCNURU ETHIOPIA: SUSTAINING IMPACT THROUGH 2021 AND BEYOND$550,893
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK RDPORTLANDOR972393098N/AGOVDESIGN AND EVALUATION OF A MDI DECISION SUPPORT SYSTEM$515,974
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK RDPORTLANDOR972393098N/AGOVTO EXPAND THE NICH PROGRAM IN THE CALIFORNIA BAY AREA$1,316,877
PALO ALTO VETERANS INSTITUTE FOR RESEARCH
3801 MIRANDA AVENUEPALO ALTOCA943040038N/APCCELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHNS DISEASE$499,175
PALO ALTO VETERANS INSTITUTE FOR RESEARCH
3801 MIRANDA AVENUEPALO ALTOCA943040038N/APCCELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHNS DISEASE$500,825
PANORAMA GLOBAL
2101 FOURTH AVENUE SUITE 2100SEATTLEWA98121N/APCTYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND$833,440
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
1 LETTERMAN DRIVESAN FRANCISCOCA94129N/APCSTUDYING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES.$750,000
PATH
2201 WESTLAKE AVENUESEATTLEWA98121N/APCGENERAL OPERATING SUPPORT$17,750
PATH
2201 WESTLAKE AVENUESEATTLEWA98121N/APCTHE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE$1,404,393
PAWNEE COUNTY MEMORIAL HOSPITAL
600 I STREETPAWNEE CITYNE68420N/AGOVEEMERGENCY AT PAWNEE COUNTY MEMORIAL HOSPITAL$11,936
PAWNEE COUNTY MEMORIAL HOSPITAL
600 I STREETPAWNEE CITYNE68420N/AGOVECARE PHARMACY AT PAWNEE COUNTY MEMORIAL HOSPITAL$150,545
PERSHING COUNTY HOSPITAL DISTRICT
855 SIXTH STREETLOVELOCKNV89419N/AGOVPERSHING GENERAL HOSPITAL EQUIPMENT REVITALIZATION PROJECT.$401,978
PHILANTHROPY NEW YORK INC
320 EAST 43RD STREETNEW YORKNY10017N/APCGENERAL OPERATING SUPPORT$39,250
PHILIP HEALTH SERVICES INC
503 W PINE STREETPHILIPSD57567N/APCIMPLEMENTATION OF AVERA EEMERGENCY AT PHILIP HEALTH SERVICES$29,491
PLATTE VALLEY HEALTHCARE PROJECT
203 S 1ST STSARATOGAWY82331N/APCCT SCANNER AT NORTH PLATTE VALLEY MEDICAL CENTER$500,000
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
25 SHATTUCK STREETBOSTONMA02115N/APCCREATING MICRONEEDLE-BASED SENSOR TO ENHANCE AUTOMATED INSULIN DELIVERY$924,309
PROJECT HOSPITALITY INC
100 PARK AVENUESTATEN ISLANDNY10302N/APCGENERAL OPERATING SUPPORT$25,000
PROJECT NYAME NSA LTD
33 WILLETS LANEMANHASSETNY11030N/APCPROJECT NYAME NSA ZAMBIA EXPANSION$277,650
PROJECT RENEWAL INC
200 VARICK STREET SUITE 900NEW YORKNY10014N/APCNEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE$200,000
PROVIDENCE MEDICAL CENTER
1200 PROVIDENCE ROADWAYNENE68787N/APCEEMERGENCY AT PROVIDENCE MEDICAL CENTER$16,407
PROVIDENCE MEDICAL CENTER
1200 PROVIDENCE ROADWAYNENE68787N/APCEPHARMACY AT PROVIDENCE MEDICAL CENTER$21,140
PUBLIC HEALTH SOLUTIONS
40 WORTH STREET 5TH FLOORNEW YORKNY10013N/APCNEW YORK CITY COLLABORATIVE FOR HOMELESS HEALTHCARE$500,000
PUBLIC HEALTH SOLUTIONS
40 WORTH STREET 5TH FLOORNEW YORKNY10013N/APCNEW YORK CITY FUND FOR YOUTH AND FAMILY HOMELESSNESS$550,000
PULITZER CENTER ON CRISIS REPORTING
1779 MASSACHUSETTS AVE NWWASHINGTONDC20036N/APCBUILDING RESILIENCE THROUGH JOURNALISM AND EDUCATION$223,410
RAMBAM HEALTH CORPORATION
N/APCPOINT OF CARE ASSAY FOR SERUM NEUTRALIZING ANTI-IFX ANTIBODIES$142,800HAALIA HASNIA 8HAIFAIS
RAMBAM HEALTH CORPORATION
N/APCPOINT OF CARE ASSAY FOR SERUM NEUTRALIZING ANTI-IFX ANTIBODIES$120,355HAALIA HASNIA 8HAIFAIS
RAMBAM HEALTH CORPORATION
N/APCPREDICTING AND OPTIMIZING DRUG THERAPY IN CROHNS DISEASE$350,000HAALIA HASNIA 8HAIFAIS
REGENTS OF THE UNIVERSITY OF MI
3003 SOUTH STATE STREETANN ARBORMI48109N/APCHEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS$412,982
REGENTS OF THE UNIVERSITY OF MI
3003 SOUTH STATE STREETANN ARBORMI48109N/APCUNDERSTANDING PERSISTENT SYMPTOMS IN QUIESCENT CROHNS DISEASE$270,158
REGENTS OF THE UNIVERSITY OF MI
3003 SOUTH STATE STREETANN ARBORMI48109N/APCUSE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS.$381,754
REGENTS OF THE UNIVERSITY OF MI
3003 SOUTH STATE STREETANN ARBORMI48109N/APCUNDERSTANDING PERSISTENT SYMPTOMS IN QUIESCENT CROHNS DISEASE$30,894
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVMINNESOTA FIRST RESPONDER AED PROJECT$12,644,876
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVPHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR T1D$350,000
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVREDEFINING THE FUTURE OF EMERGENCY MEDICINE$1,752,819
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVPRECLINICAL DEVELOPMENT OF A MONOCLONAL ANTIBODY TO SERPINB13$875,045
REGION HOVEDSTADEN
N/AGOVIDENTIFICATION/SCREENING OF NOVEL GLUCAGONOTROPIC ALPHA-CELL RECEPTORS$200,000KONGENS VAENGE 2HILLERDDA
ROCKEFELLER PHILANTHROPY ADVISORS INC
6 WEST 48TH STREET 10TH FLOORNEW YORKNY10036N/APCFUNDING TO SUPPORT COVID COLLABORATIVE - BEREAVED CHILDREN PROJECT$175,000
ROCKEFELLER PHILANTHROPY ADVISORS INC
6 WEST 48TH STREET 10TH FLOORNEW YORKNY10036N/APCCOVID COLLABORATIVE - INCREASING VACCINE UPTAKE IN RURAL AMERICA$250,000
ROSEBUD COMMUNITY HOSPITAL INC
383 NORTH 17TH AVENUEFORSYTHMT59327N/APCEPHARMACY AND ADM AT ROSEBUD HEALTH CARE CENTER IN FORSYTH, MONTANA$11,262
ROUNDABOUT THEATRE COMPANY INC
231 W 39TH STREET 1200NEW YORKNY10018N/APCGENERAL OPERATING SUPPORT$10,000
SAFE WATER NETWORK
122 EAST 42ND STREETNEW YORKNY10168N/APCSCALING AFFORDABLE SAFELY MANAGED WATER SUPPLY$2,367,100
SAGE BIONETWORKS
2901 THIRD AVESEATTLEWA981213014N/APCEXTENSION OF VEOIBD DATA COORDINATION$71,204
SAINT LOUIS UNIVERSITY
221 NORTH GRAND BOULEVARDSAINT LOUISMO631032006N/APCNOVEL TARGET TO FIGHT ALPHA CELL DYSFUNCTION & STOP HYPOGLYCEMIA IN T1D$260,774
SALVATION ARMY WORLD SERVICE OFFICE
615 SLATERS LANEALEXANDRIAVA22314N/ASOIWATER SYSTEM IMPROVEMENTS AT CHIKANKATA MISSION$1,200,000
SANFORD RESEARCH
2301 E 60TH STREET NSIOUX FALLSD571040569N/APCSANFORD PLEDGE: PHASES 1 AND 2$603,695
SCHWARTZREISMAN SCIENCE EDUCATION CENTER REHOVOT
N/APCTHE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT$2,540,089HERZL ST 234REHOVOTIS
SHAARE ZEDEK MEDICAL CENTER
N/APCPOPULATION-BASED ANALYSES OF IBD USING ADMINISTRATIVE DATABASE$143,00012 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APC"TASTY & HEALTHY" DIET: A RANDOMIZED CONTROLLED TRIAL FOR INDUCING AND MAINTAINING REMISSION IN CROHN'S DISEASE.$666,49212 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APCPREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK$379,43912 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APCPOPULATION-BASED ANALYSES OF IBD USING ADMINISTRATIVE DATABASE$137,00012 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APC"TASTY & HEALTHY" DIET: A RANDOMIZED CONTROLLED TRIAL FOR INDUCING AND MAINTAINING REMISSION IN CROHN'S DISEASE.$415,66912 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APCPREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK$413,46812 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APCTHE HELMSLEY CANCER CENTER AT SHAARE ZEDEK MEDICAL CENTER JERUSALEM$9,908,26412 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APCEQUIPMENT PURCHASES FOR THE NEW RADIOTHERAPY CENTER$791,10512 SHMUEL BAIT STREETJERUSALEMIS
SHATTERPROOF A NONPROFIT CORP
101 MERRITT 7 CORPORATE PARKNORWALKCT06851N/APCGENERAL OPERATING SUPPORT$200,000
SHATTERPROOF A NONPROFIT CORP
101 MERRITT 7 CORPORATE PARKNORWALKCT06851N/APCGENERAL OPERATING SUPPORT$200,000
SHENANDOAH MEDICAL CENTER
300 PERSHING AVESHENANDOAHIA51601N/APCSHENANDOAH MEDICAL CENTER / AVERA EEMERGENCY IMPLEMENTATION PROJECT$38,299
SIMULATION IN MOTION MONTANA INC
C/O MONTANA MEDICAL ASSOCIATIONHELENAMT59601N/APCCAPACITY BUILDING FOR A SUSTAINABLE SIMULATION IN MOTION MONTANA PROGRAM$500,000
SIMULATION IN MOTION MONTANA INC
C/O MONTANA MEDICAL ASSOCIATIONHELENAMT59601N/APCCAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA$96,066
SIOUX COUNCIL BOY SCOUTS OF AMERICA
800 N WEST AVENUESIOUX FALLSSD57104N/APCWETLAND\NATURE STUDY AREA DEVELOPMENT: LEWIS AND CLARK SCOUT CAMP$75,000
SIOUX VALLEY MEMORIAL HOSPITAL ASSOCIATION
300 SIOUX VALLEY DRIVECHEROKEEIA51012N/APCECARE EMERGENCY AT CHEROKEE REGIONAL MEDICAL CENTER$34,691
SNV NETHERLANDS DEVELOPMENT ORGANISATION
N/APCHEALTHY FUTURE FOR ALL IMPROVING WATER, SANITATION, HYGIENE & NUTRITION$1,191,913PARKSTRAAT 83DEN HAAGNL
SOCIETY FOR THE PRESERVATION OF NEW ENGLAND ANTIQUITIES
141 CAMBRIDGE STREETBOSTONMA02114N/APCGENERAL OPERATING SUPPORT$35,000
SOS CHILDREN'S VILLAGES-USA INC
1620 I STREET NW SUITE 220WASHINGTONDC20006N/APCEDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA$2,401,776
SOUTH DAKOTA HALL OF FAME
1480 S MAIN STCHAMBERLAINSD57325N/APCGENERAL OPERATING SUPPORT$20,000
SOUTH DAKOTA PARKS & WILDLIFE FOUNDATION
523 E CAPITOLPIERRESD57501N/ASOIII FICUSTER STATE PARK BISON CENTER$3,000,000
SOUTH LYON HEALTH CENTER INC
213 S WHITACRE STYERINGTONNV894472561N/APCSOUTH LYON MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT$518,553
SOUTHCENTRAL FOUNDATION
4501 DIPLOMACY DRANCHORAGEAK99508N/APCFWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM$1,425,805
ST LUKE HEALTH CARE FOUNDATION
28W609 HICKORY LNWEST CHICAGOIL60185N/APCTEACHING HOSPITAL INFRASTRUCTURE IMPROVEMENTS$210,306
ST ROSE DOMINICAN HEALTH FOUNDATION
102 E LAKE MEAD PARKWAYHENDERSONNV89015N/ASOIII FIMEDICAL SIMULATION EQUIPMENT$462,090
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCEFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHNS DISEASE$331,803
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDEVELOPMENT OF A CONTINUOUS MULTIANALYTE SENSOR FOR T1D$1,366,476
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCINVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHNS DISEASE$758,929
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCMICROBIOME-BASED THERAPEUTICS FOR CROHNS DISEASE$990,845
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCEXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT$1,296,812
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCLONGITUDINAL STUDY OF MYOELECTRIC GUTPRINT OF CROHNS PATIENTS$243,550
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCEFFECTS OF AN INTERMITTENT REDUCED CALORIE DIET ON CROHNS DISEASE$334,722
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCEXERCISE EDUCATION AT NEW ONSET OF T1D$249,169
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCEXERCISE EDUCATION AT NEW ONSET OF T1D$183,151
STATE OF SOUTH DAKOTA
600 E CAPITOL AVENUEPIERRESD57501N/AGOVSOUTH DAKOTA FIRST RESPONDER AUTOMATED EXTERNAL DEFIBRILLATOR PROJECT$178,000
STICHTING ACCESS TO MEDICINE FOUNDATION
N/APCEXPANDING ACCESS TO T1D CARE$625,000NARITAWEG 227AMSTERDAMNL
STICHTING HEALTH ACTION INTERNATIONAL
N/APCADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLLY$1,246,224OVERTOOM 60/IIAMSTERDAMNL
STICHTING PHARMACCESS INTERNATIONAL
N/APCINVESTING IN QUALITY HEALTHCARE THROUGH SAFECARE$254,457AHTC TOWER C4 PAASHEUVELWEG 25AMSTERDAMNL
SYNERGOS INSTITUTE INC
3 EAST 54TH STREETNEW YORKNY10022N/APCIMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS$998,553
SYNERGOS INSTITUTE INC
3 EAST 54TH STREETNEW YORKNY10022N/APCIMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS$1,485,316
T1D EXCHANGE INC
11 AVENUE DE LAFAYETTEBOSTONMA02111N/APCDATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D$513,697
T1D EXCHANGE INC
11 AVENUE DE LAFAYETTEBOSTONMA02111N/APCDATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D$354,000
T1D EXCHANGE INC
11 AVENUE DE LAFAYETTEBOSTONMA02111N/APCDATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D$354,000
T1D EXCHANGE INC
11 AVENUE DE LAFAYETTEBOSTONMA02111N/APCDATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D$3,686,424
T1D EXCHANGE INC
11 AVENUE DE LAFAYETTEBOSTONMA02111N/APCDATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D$513,696
T1D EXCHANGE INC
11 AVENUE DE LAFAYETTEBOSTONMA02111N/APCDATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D$354,000
TAMPERE UNIVERSITY FOUNDATION SR
N/APCVIRUSES AND ANTIVIRAL IMMUNE MARKERS IN TWO ENDOTYPES OF TYPE 1 DIABETES$305,030KALEVANTIE 4 33100TAMPEREFI
TAMPERE UNIVERSITY FOUNDATION SR
N/APCDEVELOPMENT OF MULTIPLEX MICROBIAL ANTIBODY SCREENING ARRAY FOR STUDIES$481,830KALEVANTIE 4 33100TAMPEREFI
TECHNISCHE UNIVERSITT DRESDEN
N/AGOVGENOMIC INFLUENCE OF MATERNAL T1D - UNDERSTANDING PROTECTION AGAINST T1D$271,691HELMHOLTZSTR 10DRESDENGM
TECHNISCHE UNIVERSITT DRESDEN
N/AGOVSUPPORT SCREENING FOR ISLET AUTOANTIBODIES IN CHILDREN.$212,157HELMHOLTZSTR 10DRESDENGM
THE ACADEMIC COLLEGE AT TEL-HAI
N/APCHELMSLEY SCIENCE BUILDING FOR HEALTH, ENVIRONMENT, AND BIOTECH STUDIES$634,900TEL-HAI COLLEGEUPPER GALILEEIS
THE ASPEN INSTITUTE INC
2300 N STREETWASHINGTONDC20037N/APCTHE ASPEN INSTITUTE IS AN EDUCATIONAL AND POLICY STUDIES ORGANIZATION$995,988
THE BARUCH PADEH MEDICAL CENTER PORIYA
N/AGOVTHE HELMSLEY REHABILITATION CENTER OF THE NORTH$5,115,157THE BARUCH PADEH MEDICAL CENTERPORIATIBERIASIS
THE BARUCH PADEH MEDICAL CENTER PORIYA
N/AGOVCONSTRUCTION OF THE 12-BED INTENSIVE CARE AND RESPIRATION UNIT$2,321,666THE BARUCH PADEH MEDICAL CENTERPORIATIBERIASIS
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCHUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHNS DISEASE$476,319
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCHUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHNS DISEASE$719,309
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCNOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE$3,000,000
THE CENTER FOR EFFECTIVE PHILANTHROPY INC
675 MASSACHUSETTS AVENUECAMBRIDGEMA02139N/APCGENERAL OPERATING SUPPORT$41,500
THE CHINESE UNIVERSITY OF HONG KONG
N/APCMATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE$506,838PI CHIU BUILDINGSHATINHK
THE CHINESE UNIVERSITY OF HONG KONG
N/APCIBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN$423,667PI CHIU BUILDINGSHATINHK
THE CHINESE UNIVERSITY OF HONG KONG
N/APCMATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE$481,225PI CHIU BUILDINGSHATINHK
THE CHINESE UNIVERSITY OF HONG KONG
N/APCIBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN$239,672PI CHIU BUILDINGSHATINHK
THE CITY OF HOPE
1500 E DUARTE RDDUARTECA91010N/APCUNDERSTANDING GENETIC PROTECTION FROM T1D.$275,000
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$808,555
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCDEVELOP IUS AND HISTOPATHOLOGY INDICES FOR MONITORING STRICTURING CD$403,400
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCCROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS$573,271
THE DIATRIBE FOUNDATION
804 HAIGHT STSAN FRANCISCOCA94117N/APCDIATRIBE LEARN$200,000
THE END FUND INC
2 PARK AVENUE 18TH FLOORNEW YORKNY10016N/APCELIMINATION OF PARASITIC WORMS IN ETHIOPIA$1,300,001
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCVISUALIZATION OF COVID-19 VACCINE SEROLOGY IN CD$84,7622500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCDEVELOP PROTEIN PANEL TO IDENTIFY FIBROSTENOTIC CD PATIENTS$631,7392500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCTHE CHANGING EPIDEMIOLOGY OF CROHNS IN THE WESTERN WORLD$188,7362500 UNIVERSITY DRIVE NWCALGARYCA
THE HARDING FORD VISION INC
157-22 TUSKEGEE AIRMEN WAYJAMAICANY11433N/APCGENERAL OPERATING SUPPORT$25,000
THE HEALTH & HOUSING CONSORTIUM INC
STADIUM STATIONBRONXNY10452N/APCSTRATEGY BUILDING FOR HEALTH AND HOUSING CONSORTIUM EXPANSION$290,000
THE HOLE IN THE WALL GANG FUND INC
555 LONG WHARF DRIVENEW HAVENCT06511N/APCGENERAL OPERATING SUPPORT$15,000
THE JEWISH AGENCY FOR ISRAEL
N/APCJEWISH REFUGEES/ALIYAH CANDIDATES FROM UKRAINE$500,00048 KING GEORGE STREETJERUSALEMIS
THE LEGATUM INSTITUTE FOUNDATION
N/ANCPHASE TWO OF THE UNITED STATES PROSPERITY INDEX$50,00011 CHARLES STREETLONDONUK
THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL
N/APCOPP. FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS SEEKING NURSING DEG$220,000YEZREEL VALLEYYEZREEL VALLEYIS
THE MILKEN INSTITUTE
1250 FOURTH STREETSANTA MONICACA90401N/APCSUPPORTS TO CREATE A STRATEGIC ROADMAP FOR T1D TO INCLUDE SCREENING$150,000
THE MILKEN INSTITUTE
1250 FOURTH STREETSANTA MONICACA90401N/APCCURES FOR LIFE: PATIENT ACCESS TO CELL AND GENE THERAPY$174,998
THE ONE LOVE FOUNDATION IN HONOR OF YEARDLEY LOVE INC
44 PONDFIELD ROAD SUITE 12BRONXVILLENY10708N/APCBUILDING FOR THE FUTURE: SUPPORT FOR DIGITAL PROGRAMS AND OPERATIONS$2,000,000
THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA
OFFICE OF SPONSORED PROGRAMSCHARLOTTESVILLEVA229044195N/APCTYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS$241,490
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE - MAIL CODE 0934LA JOLLACA92093N/APCPERSONALIZING CROHNS DISEASE THERAPEUTICS THROUGH PHASE 0 HUMAN TRIALS$593,024
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCASK - REMOTE SCREENING AND MONITORING$64,636
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCCULTURALLY SENSITIVE GROUP CLINIC MODEL FOR LATINO PATIENTS W/ DIABETES$512,661
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCSEEDS PATHWAY: EMPOWERMENT FOR DIABETES TECHNOLOGY EARLY DEVICE SUCCESS$1,113,823
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCDEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR$313,924
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCSINGLE PERSISTENT ISLET AUTOANTIBODY PHENOTYPE: CUSTOMIZED RISK ANALYSIS$264,224
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCEXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D$228,012
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCCOMPLEMENT SYSTEM IN INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY$224,138
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCCGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION$580,677
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCFAILED GENETIC PROTECTION: T1D IN THE PRESENCE OF DQB1*06:02$268,700
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCASK THE EXPERTS$507,558
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCDEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR$119,036
THE REGENTS OF THE UNIVERSITY OF NEW MEXICO
SPONSORED PROJECTS - PREAWARDALBUQUERQUENM871310001N/AGOVTHE ECHO INSTITUTE: REPLICATION OF THE ECHO MODEL$1,413,438
THE SDEROT DEVELOPMENT FOUNDATION
N/APCESTABLISHING A WARM HOME COMPLEX FOR CHILDREN AT RISK IN SDEROT$1,422,8516 BAR LEV STREETSDEROTIS
THE SHEBA FUND FOR HEALTH SERVICES AND RESEARCH (RA)
N/APCCOMPREHENSIVE INDIVIDUALIZED PROACTIVE THERAPY OF CROHNS DISEASE$452,624TEL-HASHOMERRAMAT GANIS
THE SONIA NABETA FOUNDATION INC
PO BOX 2222NEW YORKNY100082222N/APCPROJECT BODA$314,814
THE TEL AVIV JAFFA ACADEMIC COLLEGE
N/APCSCHOLARSHIP SUPPORT FOR ULTRA-ORTHODOX MEN PURSUING NURSING DEGREES$300,000RABENU YERUHAM ST 2 POB 8401TEL AVIV YAFFOIS
THE UNITED NATIONS INSTITUTE FOR TRAINING AND RESEARCH
N/APCACCELERATING ACCESS: TREATMENT FOR NCDS IN LOW /MIDDLE-INCOME COUNTRIES.$2,000,000UNITED NATIONS INSTITUTE FORTRAINING AND RESEARCHGENEVASZ
THE UNIVERSITY OF ADELAIDE
N/APCENDIA EXPANDED SUPPORT$620,581THE UNIVERSITY OF ADELAIDEADELAIDEAS
THE UNIVERSITY OF ADELAIDE
N/APCENVIRONMENTAL DETERMINANTS OF ISLET AUTOIMMUNITY (ENDIA) STUDY$710,992THE UNIVERSITY OF ADELAIDEADELAIDEAS
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUECHICAGOIL60637N/APCIMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS IN CROHNS$305,349
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUECHICAGOIL60637N/APCA CELL ATLAS OF THE ILEAL COLONIC CROHNS DISEASE$487,806
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUECHICAGOIL60637N/APCIMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS IN CROHNS$411,939
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUECHICAGOIL60637N/APCA CELL ATLAS OF THE ILEAL COLONIC CROHNS DISEASE$487,806
THE UNIVERSITY OF EDINBURGH
N/APCDISCERN ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN T1D$65,459BHF CENTRE FOR CARDIOVASCULARSCIENCESEDINBURGHUK
THE UNIVERSITY OF EDINBURGH
N/APCGCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHNS DISEASE$100,000BHF CENTRE FOR CARDIOVASCULARSCIENCESEDINBURGHUK
THE UNIVERSITY OF EDINBURGH
N/APCMITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION$469,844BHF CENTRE FOR CARDIOVASCULARSCIENCESEDINBURGHUK
THE UNIVERSITY OF EDINBURGH
N/APCGCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHNS DISEASE$400,400CENTRE FOR CARDIOVASCULAR SCIENCESEDINBURGHUK
THE UNIVERSITY OF OXFORD
N/APCTHE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE$244,860UNIVERSITY OFFICES WELLINGTONSQUAREOXFORDUK
THE UNIVERSITY OF OXFORD
N/APCSTUDY OF COVID-19 ANTIBODY RESPONSE UNDER SUSTAINED IMMUNE SUPPRESSION$152,072UNIVERSITY OFFICES WELLINGTONSQUAREOXFORDUK
THE UNIVERSITY OF OXFORD
N/APCPHARMACOLOGICAL MODULATION TO ADDRESS GLUCAGON SECRETION IN T1D$131,216UNIVERSITY OFFICES WELLINGTONSQUAREOXFORDUK
THE UNIVERSITY OF OXFORD
N/APCSTUDY OF COVID-19 ANTIBODY RESPONSE UNDER SUSTAINED IMMUNE SUPPRESSION$627,089UNIVERSITY OFFICES WELLINGTONSQUAREOXFORDUK
THE UNIVERSITY OF QUEENSLAND
N/APCLIPOSOMAL ANTIGEN-SPECIFIC IMMUNOTHERAPY OF RECENT-ONSET T1D$1,231,993CUMBRAE STEWART BUILDING 72BRISBANEAS
THE UNIVERSITY OF WESTERN AUSTRALIA
N/APCCGM ASSESSMENTS OF ENDIA CHILDREN$102,13335 STIRLING HIGHWAYCRAWLEYAS
THE WEIZMANN INSTITUTE OF SCIENCE
N/APCPERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IN CROHNS$100,904234 HERZEL STREHOVOTIS
THE WEIZMANN INSTITUTE OF SCIENCE
N/APCTHE QUANTUM MATERIALS DEVICES FABRICATION LAB$165,000234 HERZEL STREHOVOTIS
TOWNSEND HEALTH SYSTEMS INC
110 NORTH OAKTOWNSENDMT59644N/APCTELE-PHARMACY AT BILLINGS CLINIC BROADWATER$329,602
TOWNSEND HEALTH SYSTEMS INC
110 NORTH OAKTOWNSENDMT59644N/APCEEMERGENCY AT BROADWATER HEALTH CENTER$12,933
TRICKLE UP PROGRAM INC
104 WEST 27TH STREET 12TH FLOORNEW YORKNY10001N/APCGENERAL OPERATING SUPPORT$25,000
TRUSTEES OF INDIANA UNIVERSITY
509 E 3RD STBLOOMINGTONIN474013654N/AGOVCOLLABORATIVE EFFORT TO VALIDATE MICRORNAS AS BIOMARKERS OF T1D$569,823
TRUSTEES OF INDIANA UNIVERSITY
509 E 3RD STBLOOMINGTONIN474013654N/AGOVDEVELOPMENT OF REGULATORY ROADMAP FOR COLONOSCOPY BOWEL PREP FOR CD PTS$290,356
TRUSTEES OF INDIANA UNIVERSITY
509 E 3RD STBLOOMINGTONIN474013654N/AGOVMOLECULAR DESIGN AND TESTING OF GLUCOSE-RESPONSIVE THERAPIES$793,072
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
OFFICE OF RESEARCH SERVICESPHILADELPHIAPA191046205N/APCULTRA PROCESSED DIET, GUT MICROBIOME, AND XENOBIOTIC EXPOSURE IN CD$256,967
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
OFFICE OF RESEARCH SERVICESPHILADELPHIAPA191046205N/APCULTRA PROCESSED DIET, GUT MICROBIOME, AND XENOBIOTIC EXPOSURE IN CD$256,967
UNITED HOSPITAL FUND OF NEW YORK
1411 BROADWAYNEW YORKNY10018N/APCNEW YORK STATE MEDICAL RESPITE PILOT PROGRAM DESIGN$375,000
UNITED HOSPITAL FUND OF NEW YORK
1411 BROADWAYNEW YORKNY10018N/APCNEW YORK STATE MEDICAL RESPITE PILOT PROGRAM DESIGN$300,000
UNITED NATIONS DEVELOPMENT PROGRAMME
1 UNITED NATIONS PLAZANEW YORKNY10017N/APCUNITED NATIONS MULTILATERAL AGENCY$257,967
UNITED OSTOMY ASSOCIATIONS OF AMERICA
PO BOX 525KENNEBUNKME040430525N/APCDEVELOPMENT OF CROHNS DISEASE CONTENT AND AWARENESS FOR THE UOAA$19,104
UNITED OSTOMY ASSOCIATIONS OF AMERICA
PO BOX 525KENNEBUNKME040430525N/APCDEVELOPMENT OF CROHNS DISEASE CONTENT AND AWARENESS FOR THE UOAA$40,350
UNITED STATES FUND FOR UNICEF
125 MAIDEN LANENEW YORKNY10038N/APCACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS$775,779
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
N/AGOVEPITHELIAL BASED DIAGNOSTICS FOR TARGETED THERAPIES OF VEOIBD$173,250HEIDELBERGLAAN 100UTRECHTNL
UNIVERSITE CATHOLIQUE DE LOUVAIN
N/APCSTUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN WITH T1D$144,419PLACE DE LUNIVERSITE 1LOUVAINLANEUVEBE
UNIVERSITE CATHOLIQUE DE LOUVAIN
N/APCDIRECT AND INDIRECT CAUSES FOR THE IMPAIRED GLUCAGON SECRETION IN T1D$246,186PLACE DE LUNIVERSITE 1LOUVAINLANEUVEBE
UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C
1001 MAIN STREETBUFFALONY14203N/APCTELEHEALTH REIMBURSEMENT STUDY FOR UNDERSERVED T1D PEDIATRIC POPULATIONS$627,429
UNIVERSITY COLLEGE LONDON
N/APCSPIT-C: USING SALIVA TO PREDICT CROHNS DISEASE$380,649GOWER STREETLONDONUK
UNIVERSITY OF BIRMINGHAM
N/APCDEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR T1D.$413,518INSTITUTE OF IMMUNOLOGYBIRMINGHAMUK
UNIVERSITY OF BIRMINGHAM
N/APCANTIGEN SPECIFIC IMMUNOTHERAPY IN TYPE 1 DIABETES$102,647INSTITUTE OF IMMUNOLOGYBIRMINGHAMUK
UNIVERSITY OF CALIFORNIA LOS ANGELES
UCLA OFFICE OF CONTRACTS AND GRANTSLOS ANGELESCA900951406N/APCGLUCOSE RESPONSIVE GLUCAGON TO REDUCE HYPOGLYCEMIA IN PEOPLE WITH T1D$601,142
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
3333 CALIFORNIA STREET SUITE 315SAN FRANCISCOCA94143N/APCVALIDATING A CLASS OF DRUGS THAT MAY PROTECT BETA CELLS IN T1D$108,185BOX 0962
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143N/APCISLET AUTOIMMUNITY IN PATIENTS WITH STAT GAIN-OF-FUNCTION MUTATIONS$128,169
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143N/APCID ANALYSIS OF EXTREME FORMS OF T1D, ESTABLISHMENT OF PATIENT REGISTRY$433,333
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143N/APCENGINEERING ISLET ANTIGEN-SPECIFIC TREGS FOR T1D$500,120
UNIVERSITY OF CAMBRIDGE
N/APCCLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D PART 2$247,545THE OLD SCHOOLSCAMBRIDGEUK
UNIVERSITY OF CINCINNATI
PO BOX 210641CINCINNATIOH45221N/AGOVUNDERSTANDING THE EFFECT OF C-PEPTIDE CO-INFUSION WITH INSULIN$363,107
UNIVERSITY OF DUNDEE
N/APCHYPO-RESOLVE - UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA$145,758NETHERGATEDUNDEEUK
UNIVERSITY OF EXETER
N/APCUNDERSTANDING EXTREMELY EARLY-ONSET TYPE 1 DIABETES$615,166NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVT CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER & TECHNOLOGY DEVELOPMENT$248,597
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVCOLLABORATIVE T1D RESEARCH: NETWORK FOR PANCREATIC ORGAN DONORS WITH T1D$1,199,692
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVHUMAN ATLAS NEONATAL DEVELOPMENTAL EARLY LIFE PANCREAS/IMMUNITY CON'T$1,034,449
UNIVERSITY OF GLASGOW COURT
N/APCTHE CLINICAL EFFECTIVENESS OF CD-TREAT IN PATIENTS WITH ACTIVE CROHNS$391,290UNIVERSITY AVENUEGLASGOWUK
UNIVERSITY OF IOWA
DIVISION OF SPONSORED PROGRAMSIOWA CITYIA52442N/AGOVSIMULATION IN MOTION IOWA (SIM-IA)$2,470,869
UNIVERSITY OF IOWA
DIVISION OF SPONSORED PROGRAMSIOWA CITYIA52442N/AGOVRUPRI HEALTH PANEL SUPPORT$174,321
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655N/AGOVDAIN: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS$541,529
UNIVERSITY OF MELBOURNE
N/APCANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR$552,076LEVEL 4 ALAN GILBERT BUILDINGCARLTONAS
UNIVERSITY OF MIAMI
1320 SOUTH DIXIE HIGHWAY SUITE 650CORAL GABLESFL33146N/APCDEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICE$250,000
UNIVERSITY OF MIAMI
1320 SOUTH DIXIE HIGHWAY SUITE 650CORAL GABLESFL33146N/APCA HOLISTIC DIET INTERVENTION FOR PEOPLE WITH CROHNS DISEASE$637,761
UNIVERSITY OF MIAMI
1320 SOUTH DIXIE HIGHWAY SUITE 650CORAL GABLESFL33146N/APCTHE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE$323,935
UNIVERSITY OF NEBRASKA FOUNDATION
1010 LINCOLN MALLLINCOLNNE68501N/APCMOBILE RURAL HEALTHCARE PROVIDER TRAINING$592,963
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/APCMONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS$236,3201350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/APCIDENTIFYING MOLECULAR PROFILES PREDICTIVE OF POST-OPERATIVE CD OUTCOMES$585,7501350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/APCMONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS$93,4221350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/APCANTI-TNF COMBINATION CLINICAL TRIAL IN PEDIATRIC CROHNS DISEASE$42,0221350
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEIN465565708N/APCGLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES$736,645
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEIN465565708N/APCDEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM$581,100
UNIVERSITY OF OULU
N/APCMATERNAL AND PATERNAL T1D - MECHANISMS FOR RECURRENCE RISK IN OFFSPRING$452,607PO BOX 8000OULUFI
UNIVERSITY OF PITTSBURGH
3420 FORBES AVENUEPITTSBURGHPA152603203N/APCRANDOMIZED CONTROLLED TRIAL: ANALOGUE VS HUMAN INSULIN$1,184,954
UNIVERSITY OF TOLEDO
3000 ARLINGTON AVENUETOLEDOOH436142595N/AGOVTYPE 1 DIABETES CAR TREG THERAPEUTIC APPROACH$110,480
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLESALT LAKE CITYUT84112N/APCANTI-PHAGE ANTIBODIES: CROHNS DISEASE DIAGNOSIS AND TREATMENT RESPONSE$291,996
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLESALT LAKE CITYUT84112N/APCANTI-PHAGE ANTIBODIES: CROHNS DISEASE DIAGNOSIS AND TREATMENT RESPONSE$246,267
UNIVERSITY OF VIRGINIA LAW SCHOOL FOUNDATION
580 MASSIE ROADCHARLOTTESVILLEVA22903N/APCGENERAL OPERATING SUPPORT$50,000
UNIVERSITY OF ZURICH
N/AGOVGENERATE BISPECIFIC INTERLEUKIN-2 IMMUNOTHERAPY TO TREAT T1D MELLITUS$118,250DEPARTMENT OF IMMUNOLOGYZURICHSZ
UPPSALA UNIVERSITET
N/AGOVALPHA-CELL SIGNALING FOR GLUCAGON SECRETION$121,182BOX 256UPPSALASW
UPPSALA UNIVERSITY HOSPITAL
N/APCISOLATING ISLETS TO UNDERSTAND ALPHA CELL DYSFUNCTION AND HYPOGLYCEMIA$400,000SJUKHUSVGEN 20UPPSALASW
VAN BUREN COUNTY HOSPITAL
304 FRANKLIN STREETKEOSAUQUAIA52565N/AGOVEEMERGENCY AT VAN BUREN COUNTY HOSPITAL$17,766
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCDEVELOPING AN ISLET MODEL THAT MIMICS T1D$250,000
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCUSE OF MRI OF THE PANCREAS IN T1D$504,261
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCPANCREATLAS DATABASE EXPANSION.$825,315
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES$200,000
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCCOMBINATORIAL SINGLE CELL STRATEGIES FOR CROHNS DISEASE GUT CELL ATLAS$676,092
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCIDENTIFY SMALL MOLECULES ENHANCING GLUCAGON SECRETION UNDER HYPOGLYCEMIA$330,000
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GCA$522,458
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCCOMBINATORIAL SINGLE CELL STRATEGIES FOR CROHNS DISEASE GUT CELL ATLAS$166,933
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCCOMBINATORIAL SINGLE CELL STRATEGIES FOR CROHNS DISEASE GUT CELL ATLAS$509,159
VANDERBILT UNIVERSITY
2201 WEST END AVENASHVILLETN37235N/APCUNDERSTANDING CALCIUM SIGNALING IN ALPHA CELLS AND HOW THEY WORK IN T1D$231,831
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU FEASIBILITY PILOT$591,068
VETERANS MEMORIAL HOSPITAL
40 1ST STREET SEWAUKONIA52172N/AGOVECARE PHARMACY AND EMERGENCY SERVICES AT VETERANS MEMORIAL HOSPITAL$299,175
VILLAGES OF HOPE AFRICA SOCIETY
N/APCZAMBIA DEVELOPMENT: FOOD PRODUCTION, WATER SUPPLY, EDUCATION FACILITIES$622,8182450 MILLTOWER COURTMISSISSAUGACA
VIVLI INC
14 STORY STREET SUITE 406CAMBRIDGEMA02138N/APCPUBLICLY SHARING THE DATA FROM EXERCISE AND T1D STUDIES$147,174
VIVLI INC
14 STORY STREET SUITE 406CAMBRIDGEMA02138N/APCVIVLI TECHNICAL DEBT AMELIORATION$250,000
WASHINGTON UNIVERSITY
660 S EUCLID AVEST LOUISMO63110N/APCVACCINE SAFETY AND EFFICACY$800,222
WASHINGTON UNIVERSITY
660 S EUCLID AVEST LOUISMO63110N/APCMANIPULATING ALPHA CELL SIGNALING TO RESTORE NORMAL GLUCAGON SECRETORY$250,000
WASHINGTON UNIVERSITY
660 S EUCLID AVEST LOUISMO63110N/APCSUPPORT DRUG DISCOVERY/UNDERSTANDING AND PREVENTING HYPOGLYCEMIA IN T1D$300,000
WASHOE BARTON MEDICAL CLINIC
1107 US HIGHWAY 395 NGARDNERVILLENV89410N/APCULTRASOUND EQUIPMENT FOR CARSON VALLEY MEDICAL CENTER$437,369
WASHOE BARTON MEDICAL CLINIC
1107 US HIGHWAY 395 NGARDNERVILLENV89410N/APCRADIOLOGY AND INTERVENTIONAL EQUIPMENT WITH CONSTRUCTION RELATED COSTS.$2,160,914
WATER4 INC
2405 NW 10TH STREETOKLAHOMA CITYOK73107N/APCSCALING THE NUMA MODEL TO DELIVER SAFE, SUSTAINABLE WATER$1,180,873
WATERAID AMERICA INC
233 BROADWAYNEW YORKNY10279N/APCSYSTEM STRENGTHENING FOR SUSTAINABLE WASH SERVICES$900,001
WATERAID AMERICA INC
233 BROADWAYNEW YORKNY10279N/APCCREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA$2,839,148
WHITE PINE COUNTY HOSPITAL DISTRICT
1500 AVENUE HELYNV89301N/AGOVINCREASED ULTRASOUND AVAILABILITY AND ABILITY FOR RURAL NORTHEAST NEVADA$265,831
WHITE PINE COUNTY HOSPITAL DISTRICT
1500 AVENUE HELYNV89301N/AGOVRADIOLOGY EQUIPMENT FOR HOSPITAL$958,500
WILDLIFE CONSERVATION SOCIETY
2300 SOUTHERN BOULEVARDBRONXNY10460N/APCGENERAL OPERATING SUPPORT FOR THE ELEPHANT CONSERVATION PROGRAM$10,000
WNET FOR THE WLIW-21 PUBLIC BROADCASTING
825 EIGHTH AVENUENEW YORKNY100197435N/APCGENERAL OPERATING SUPPORT$5,000
WYOMING DEPARTMENT OF HEALTH
6101 YELLOWSTONE RD SUITE 400CHEYENNEWY82009N/AGOVWYOMING FIRST RESPONDER AED PROJECT$269,693
WYOMING STATE PARKS AND CULTURAL RESOURCES
2301 CENTRAL AVENUECHEYENNEWY82002N/AGOVINTERPRETIVE CENTER AT FORT PHIL KEARNY STATE HISTORIC SITE$885,000
YAD SARAH
N/APCHOME HOSPITAL PROGRAM FOR SOUTHERN ISRAEL$1,376,648124 HERZL BLVDJERUSALEMIS
YALE UNIVERSITY
OFFICE OF SPONSORED PROJECTSNEW HAVENCT065208327N/APCGENERAL OPERATING SUPPORT FOR CLASS OF 1982 40TH REUNION$20,000
YALE UNIVERSITY
OFFICE OF SPONSORED PROJECTSNEW HAVENCT065208327N/APCTHERAPEUTIC TARGETS AT THE HOST MICROBIOTA INTERFACE FOR FIBROSIS$336,846
YALE UNIVERSITY
OFFICE OF SPONSORED PROJECTSNEW HAVENCT065208327N/APCEXPOSOMICS FOR EARLY LIFE CROHNS DISEASE$405,488
YALE UNIVERSITY
OFFICE OF SPONSORED PROJECTSNEW HAVENCT065208327N/APCTHERAPEUTIC TARGETS AT THE HOST MICROBIOTA INTERFACE FOR FIBROSIS$156,907
YEHUDA ABARBANEL GOVERNMENT HOSPITAL
N/AGOVMODERNIZATION OF ABARBANELS INFORMATION TECHNOLOGY AND SECURITY SYSTEMS$1,000,00015 KEREN KAYEMET STBAT YAMIS
YITZHAK SHAMIR MEDICAL CENTER
N/AGOVEXPANSION AND RENOVATION OF SHAMIR MEDICAL CENTER'S CANCER INSTITUTE$729,642BEER YAAKOVTZRIFINIS
YOUNG MEN'S CHRISTIAN ASSOCIATION RETIREMENT FUND
120 BROADWAYNEW YORKNY10271N/ASOIGENERAL OPERATING SUPPORT$5,000
YOUTH DEVELOPMENT ORGANIZATION INC
15 UNION STREET 563LAWRENCEMA01840N/APCEDUCATION AND CHARACTER DEVELOPMENT FOR LOCAL YOUTH$14,516
ZEFAT ACADEMIC COLLEGE
N/APCEQUIPPING ZEFAT ACADEMIC COLLEGE'S INST. FOR ADV. HEALTH TRAINING & ED.$4,114,15211 JERUSALEM STREET POB 160ZEFATIS
ZIV MEDICAL CENTER ZEFAT
N/AGOVPURCHASE OF TWO ECMO MACHINES FOR ZIV MEDICAL CENTER$151,611RAMBAM STZEFATIS
ZIV MEDICAL CENTER ZEFAT
N/AGOVREINFORCE CRUCIAL SITES DURING EMERGENCIES: ORS, BLOOD BANK & PHARMACY$1,503,124RAMBAM STZEFATIS
FieldValueIRS element (for citing)
Total Grant Or Contri Pd Dur Yr$385,014,429TotalGrantOrContriPdDurYrAmt

Grant Or Contri Apprv For Fut GrantOrContriApprvForFutGrp (641 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient RelationshipRecipientRelationshipTxtRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line1RecipientForeignAddress/AddressLine1TxtCityRecipientForeignAddress/CityNmCountryRecipientForeignAddress/CountryCdAddress Line2RecipientUSAddress/AddressLine2TxtAddress Line2RecipientForeignAddress/AddressLine2Txt
4YOUANDME
2901 THIRD AVENUESEATTLEWA98121N/APCWEARABLES TO MEASURE STRESS AND FORECAST CROHNS SYMPTOMS$110,128
A GLIMMER OF HOPE FOUNDATION
3103 BEE CAVES ROADAUSTINTX78746N/APFINTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA$1,854,222
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVEBRONXNY104611975N/APCSUPPLEMENTAL SUPPORT FOR T1DTECHCHW$163,648
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVEBRONXNY104611975N/APCPRECLINICAL WORK TO ADVANCE D-PEPTIDES AS ANTIGEN-SPECIFIC IMMUNOTHERAPY$556,499
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVEBRONXNY104611975N/APCSUPPLEMENTAL SUPPORT FOR T1DTECHCHW$168,556
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVEBRONXNY104611975N/APCSUPPLEMENTAL SUPPORT FOR T1DTECHCHW$173,613
ALIMENTIV INC
N/ANCSTENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM$948,511100 DUNDAS STREETLONDONCA
ALIMENTIV INC
N/ANCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$267,835100 DUNDAS STREETLONDONCA
ALIMENTIV INC
N/ANCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$259,951100 DUNDAS STREETLONDONCA
ALYN HOSPITAL - REHABILITATION CENTER FOR CHILDREN AND YOUTH
N/APCALYN CENTER FOR INNOVATION IN PEDIATRIC REHABILITATION RESEARCH$717,21984 SHMARYAHU LEVIN STJERUSALEMIS
ALYN HOSPITAL - REHABILITATION CENTER FOR CHILDREN AND YOUTH
N/APCALYN CENTER FOR INNOVATION IN PEDIATRIC REHABILITATION RESEARCH$694,03484 SHMARYAHU LEVIN STJERUSALEMIS
AMC MEDICAL RESEARCH BV
N/APCIDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE$50,570MEIBERGDREEF 9AMSTERDAMNL
AMC MEDICAL RESEARCH BV
N/APCIDENTIFICATION OF BIOMARKERS FOR PERIANAL FISTULIZING DISEASE$610,817MEIBERGDREEF 9AMSTERDAMNL
AMERICAN CAMPING ASSOCIATION INC
5000 STATE ROAD 67 NORTHMARTINSVILLEIN46151N/APCACA PROFESSIONAL DEVELOPMENT 2022 - 2024$48,955
AMERICAN CAMPING ASSOCIATION INC
5000 STATE ROAD 67 NORTHMARTINSVILLEIN46151N/APCACA PROFESSIONAL DEVELOPMENT 2022 - 2024$51,040
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCFOCUS ON FELLOWS, DIABETES IS PRIMARY, PROFESSIONAL MEMBERSHIP PROJECTS$300,000
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCADA MENTAL HEALTH EDUCATION PROGRAM 2022 - 2024$337,310
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APC2022-2024 TYPE 1 DIABETES CAMP INITIATIVE$399,368
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APCADA MENTAL HEALTH EDUCATION PROGRAM 2022 - 2024$278,350
AMERICAN DIABETES ASSOCIATION INC
2451 CRYSTAL DRIVE SUITE 900ARLINGTONVA22202N/APC2022-2024 TYPE 1 DIABETES CAMP INITIATIVE$399,368
AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE
4930 DEL RAY AVEBETHESDAMD20814N/APCSPECIALIZED IBD TRAINING FOR ADVANCE PRACTICE PROVIDERS$155,930
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCMISSION: LIFELINE STROKE MT AND POST-ACUTE STROKE CARE QUALITY STANDARDS$1,654,728
AMERICAN HEART ASSOCIATION INC
7272 GREENVILLE AVENUEDALLASTX75231N/APCMISSION: LIFELINE STROKE MT AND POST-ACUTE STROKE CARE QUALITY STANDARDS$690,948
AMERICARES FOUNDATION INC
88 HAMILTON AVESTAMFORDCT06840N/APCMATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS$752,688
AMERICARES FOUNDATION INC
88 HAMILTON AVESTAMFORDCT06840N/APCMATERNAL, NEWBORN, AND CHILD HEALTH INTERVENTIONS$749,599
APHP ST ANTOINE HOSPITAL
N/AGOVFECAL MICROBIOTA TRANSPLANTATION IN CROHNS DISEASE$474,464184 RUE DU FAUBOURG SAINT-ANTOINEPARISFR
APHP ST ANTOINE HOSPITAL
N/AGOVFECAL MICROBIOTA TRANSPLANTATION IN CROHNS DISEASE$474,464184 RUE DU FAUBOURG SAINT-ANTOINEPARISFR
APHP ST ANTOINE HOSPITAL
N/AGOVFECAL MICROBIOTA TRANSPLANTATION IN CROHNS DISEASE$367,129184 RUE DU FAUBOURG SAINT-ANTOINEPARISFR
APHP ST ANTOINE HOSPITAL
N/AGOVFECAL MICROBIOTA TRANSPLANTATION IN CROHNS DISEASE$421,681184 RUE DU FAUBOURG SAINT-ANTOINEPARISFR
ASIAN HEALTH CARE FOUNDATION
N/APCACCESS TO CROHNS DIAGNOSTICS IN INDIA FOR PATIENTS LIVING IN POVERTY$210,5516-3-661 SOMAJIGUDAHYDERABADIN
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606N/ANCEXPANSION OF DANATECH PLATFORM$413,127
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606N/ANCEXPANSION OF DANATECH PLATFORM$831,327
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 SOUTH WACKER DRIVE SUITE 600CHICAGOIL60606N/ANCEXPANSION OF DANATECH PLATFORM$855,546
ASSOCIATION SANTE DIABETE
N/APCDIABETES SUPPORT TO PEOPLE IN BURKINA FASO, MALI AND UNION OF COMOROS$272,36217 AVENUE MALHERBEGRENOBLEFR
ASSOCIATION SANTE DIABETE
N/APCDIABETES SUPPORT TO PEOPLE IN BURKINA FASO, MALI AND UNION OF COMOROS$205,98417 AVENUE MALHERBEGRENOBLEFR
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION
N/APCFECAL MICROBIOTA TRANSPLANTATION IN CROHNS DISEASE: THE MIRO STUDY$587,840LEVEL 2FITZROYAS
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION
N/APCFECAL MICROBIOTA TRANSPLANTATION IN CROHNS DISEASE: THE MIRO STUDY$587,840LEVEL 2FITZROYAS
AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER
1325 S CLIFF AVENUESIOUX FALLSSD57105N/APCAVERA BEHAVIORAL HEALTH CENTER EXPANSION$500,000
AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER
1325 S CLIFF AVENUESIOUX FALLSSD57105N/APCAVERA BEHAVIORAL HEALTH CENTER EXPANSION$1,500,000
AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER
1325 S CLIFF AVENUESIOUX FALLSSD57105N/APCAVERA BEHAVIORAL HEALTH CENTER EXPANSION$1,000,000
AVERA MCKENNAN HOSPITAL AND UNIVERSITY HEALTH CENTER
1325 S CLIFF AVENUESIOUX FALLSSD57105N/APCAVERA BEHAVIORAL HEALTH CENTER EXPANSION$1,500,000
BALLAD RESEARCH INSTITUTE
10865 ROAD TO THE CURESAN DIEGOCA92121N/APCCD127-HIGH T-CELL POPULATIONS AS BIOMARKERS$325,801
BANNER HEALTH
801 EAST WILLIAMS AVEFALLONNV89406N/APCBANNER CHURCHILL COMMUNITY HOSPITAL ULTRASOUND INITIATIVE$139,574
BAYLOR COLLEGE OF MEDICINE
OFFICE OF RESEARCHHOUSTONTX77030N/APCPILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE$500,180
BAYLOR COLLEGE OF MEDICINE
OFFICE OF RESEARCHHOUSTONTX77030N/APCEMR-BASED PREDICTIVE ANALYTICS FOR TARGETED PROACTIVE T1D CARE$532,841
BAYLOR COLLEGE OF MEDICINE
OFFICE OF RESEARCHHOUSTONTX77030N/APCPILOT STUDY TO ADDRESS DIABETES HEALTH-RELATED QUALITY OF LIFE$524,854
BAYLOR COLLEGE OF MEDICINE
OFFICE OF RESEARCHHOUSTONTX77030N/APCEMR-BASED PREDICTIVE ANALYTICS FOR TARGETED & PROACTIVE T1D CARE$547,540
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
1201 NINTH AVENUESEATTLEWA981012795N/APCLINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN IN T1D$661,927
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
1201 NINTH AVENUESEATTLEWA981012795N/APCLINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN IN T1D$567,763
BETH ISRAEL DEACONESS MEDICAL CENTER INC
330 BROOKLINE AVENUEBOSTONMA022155491N/APCPROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD$519,550
BETH ISRAEL DEACONESS MEDICAL CENTER INC
330 BROOKLINE AVENUEBOSTONMA022155491N/APCPROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD$519,548
BETH ISRAEL DEACONESS MEDICAL CENTER INC
330 BROOKLINE AVENUEBOSTONMA022155491N/APCPROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD$538,077
BETH ISRAEL DEACONESS MEDICAL CENTER INC
330 BROOKLINE AVENUEBOSTONMA022155491N/APCPROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD$538,077
BEYOND TYPE 1
1001 LAUREL ST STE BSAN CARLOSCA94070N/APCDIABETIC KETOACIDOSIS (DKA) CAMPAIGN PHASE 3$149,167
BEYOND TYPE 1
1001 LAUREL ST STE BSAN CARLOSCA94070N/APCDIABETIC KETOACIDOSIS (DKA) CAMPAIGN PHASE 3$149,166
BILLINGS CLINIC FOUNDATION
2917 TENTH AVENUE NORTHBILLINGSMT59102N/APCMONTANA PSYCHIATRY RESIDENCY PROGRAM SUSTAINING SUPPORT$1,000,000
BIPARTISAN POLICY CENTER INC
1225 I ST NW 1000WASHINGTONDC20005N/APCSTRENGTHENING HEALTH CARE DELIVERY AND SERVICES IN RURAL AMERICA$625,293
BLUE CIRCLE HEALTH INC
1209 ORANGE STREETWILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$1,740,266
BLUE CIRCLE HEALTH INC
1209 ORANGE STREETWILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$1,740,267
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209WILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$2,500,000ORANGE STREET
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209WILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$3,500,000ORANGE STREET
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209WILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$3,480,533ORANGE STREET
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209WILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$3,480,533ORANGE STREET
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209WILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$4,470,844ORANGE STREET
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209WILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$4,470,844ORANGE STREET
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209WILMINGTONDE19801N/ANCCREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$4,470,843ORANGE STREET
BOULDER CITY HOSPITAL INC
901 ADAMS BLVDBOULDER CITYNV89005N/APCBOULDER CITY HOSPITAL EQUIPMENT REVITALIZATION PROJECT$37,497
BOULDER CITY HOSPITAL INC
901 ADAMS BLVDBOULDER CITYNV89005N/APCBOULDER CITY HOSPITAL EQUIPMENT REVITALIZATION PROJECT$34,997
BRIDGES TO PROSPERITY INC
1031 33RD STREETDENVERCO80205N/APCETHIOPIA ASSESSMENT OF BRIDGE INFRASTRUCTURE$142,110
BRIDGES TO PROSPERITY INC
1031 33RD STREETDENVERCO80205N/APCTRANSFORMATIVE CONNECTIVITY IN RURAL ETHIOPIA$2,812,542
BRIDGES TO PROSPERITY INC
1031 33RD STREETDENVERCO80205N/APCTRANSFORMATIVE CONNECTIVITY IN RURAL ETHIOPIA$2,648,126
BRIDGES TO PROSPERITY INC
1031 33RD STREETDENVERCO80205N/APCZAMBIA ASSESSMENT OF BRIDGE INFRASTRUCTURE$142,110
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCGLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS$1,829,719
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCPEN-PLUS EXPANSION$1,988,392
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCINVESTIGATION OF ANTI-GM-CSF AUAB AS A DISEASE DETERMINANT IN CD$1,326,053
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCGLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS$1,308,107
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCPEN-PLUS EXPANSION$1,914,468
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCINVESTIGATION OF ANTI-GM-CSF AUAB AS A DISEASE DETERMINANT IN CD$562,221
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCGLOBAL PARTNERSHIP TO ACHIEVE UNIVERSAL ACCESS FOR T1D AND NCDS$1,785,375
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCPEN-PLUS EXPANSION$1,914,468
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCINVESTIGATION OF ANTI-GM-CSF AUAB AS A DISEASE DETERMINANT IN CD$499,459
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCPEN-PLUS EXPANSION$3,802,596
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCPEN-PLUS EXPANSION$6,054,477
BRIGHAM AND WOMEN'S HOSPITAL
75 FRANCIS STREETBOSTONMA02115N/APCPASSIVE WIRELESS MONITORING TO PREDICT AND TRACK CROHNS DISEASE$360,771
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
N/AGOVUK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO CD TREATMENTS$561,004HILLS ROADCAMBRIDGEUK
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
N/AGOVUK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO CD TREATMENTS$313,576HILLS ROADCAMBRIDGEUK
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
N/AGOVUK IBD BIORESOURCE: TRANSLATING TODAYS SCIENCE INTO CD TREATMENTS$313,576HILLS ROADCAMBRIDGEUK
CARE-FOR-RARE FOUNDATION
N/APCVEOIBD FROM PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES - MUNICH$655,603DR VON HAUNERSCHES KINDERSPITALMUNICHGMKLINIKUM DER UNIVERSITT MUNCHEN
CARE-FOR-RARE FOUNDATION
N/APCVEOIBD FROM PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES - MUNICH$721,252KINDERSPITAL KLINIKUM DERMUNICHGM
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCRURAL EMERGENCY HEALTH SERVICE AND TRANSPORT FOR SYSTEM DEVELOPMENT$1,344,542
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCMAYI MWANA PROJECT: HELPING ZAMBIAN MOTHERS & NEWBORNS SURVIVE & THRIVE$1,100,098
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCINTEGRATED COMMUNITY WATER, SANITATION AND HYGIENE IMPROVEMENT IN GHANA$1,556,214
CATHOLIC RELIEF SERVICES-USCCB
228 W LEXINGTON STBALTIMOREMD21201N/APCBOUSSOUMA AND ZIGA, BURKINA FASO IMPROVED WASH INFRASTRUCTURE & SERVICES$749,145
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCINTEGRATING GENOMIC AND IMAGING DATA WITH SCRNASEQ TO UNDERSTAND CD$268,151
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCPREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABD SURGERY$204,837
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCINTEGRATING GENOMIC AND IMAGING DATA WITH SCRNASEQ TO UNDERSTAND CD$231,849
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCPREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABD SURGERY$216,002
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCLONG-TERM RESPONSE TO SARS-COV-2 VACCINATION IN A DIVERSE IBD POPULATION$522,999
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCVEOIBD PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES CEDARS-SINAI$115,500
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCPREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABD SURGERY$200,041
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCLONG-TERM RESPONSE TO SARS-COV-2 VACCINATION IN A DIVERSE IBD POPULATION$364,763
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCPREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABD SURGERY$202,791
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCVEOIBD PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES CEDARS-SINAI$115,500
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCPREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABD SURGERY$219,514
CEDARS-SINAI MEDICAL CENTER
8700 BEVERLY BLVDLOS ANGELESCA90048N/APCPREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABD SURGERY$211,815
CENTER FOR EXCELLENCE IN HEALTH CARE JOURNALISM
10 NEFF HALLCOLUMBIAMO65211N/ASOIITRAINING AND DEVELOPMENT OF HEALTH CARE JOURNALISTS AND HEALTH REPORTING$219,995
CENTRAL MONTANA MEDICAL FACILITIES INC
408 WENDELL AVELEWISTOWNMT59457N/APCCANCER CENTER AT CENTRAL MONTANA MEDICAL CENTER$3,469,965
CENTRAL MONTANA MEDICAL FACILITIES INC
408 WENDELL AVELEWISTOWNMT59457N/APCCANCER CENTER AT CENTRAL MONTANA MEDICAL CENTER$690,035
CENTRE HOSPITALIER REGIONAL DE NANCY
N/AGOVPREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS/ COMORBIDITIES IN CD CARE$98,36429 AVENUE MAL DE LATTRE DE TASSIGNYNANCYFR
CENTRE HOSPITALIER REGIONAL DE NANCY
N/AGOVPREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS/ COMORBIDITIES IN CD CARE$89,35229 AVENUE MAL DE LATTRE DE TASSIGNYNANCYFR
CENTRE HOSPITALIER REGIONAL DE NANCY
N/AGOVPREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS/ COMORBIDITIES IN CD CARE$95,27729 AVENUE MAL DE LATTRE DE TASSIGNYNANCYFR
CENTRE HOSPITALIER REGIONAL DE NANCY
N/AGOVPREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS/ COMORBIDITIES IN CD CARE$103,79629 AVENUE MAL DE LATTRE DE TASSIGNYNANCYFR
CENTRE HOSPITALIER REGIONAL DE NANCY
N/AGOVPREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS/ COMORBIDITIES IN CD CARE$153,10229 AVENUE MAL DE LATTRE DE TASSIGNYNANCYFR
CHASE COUNTY COMMUNITY HOSPITAL
600 WEST 12TH STREETIMPERIALNE69033N/AGOVEEMERGENCY AT CHASE COUNTY COMMUNITY HOSPITAL$29,056
CHASE COUNTY COMMUNITY HOSPITAL
600 WEST 12TH STREETIMPERIALNE69033N/AGOVEEMERGENCY AT CHASE COUNTY COMMUNITY HOSPITAL$12,656
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCMOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE$374,591
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCMOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE$374,591
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCDEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM$1,153,809
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCMOLECULAR + SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE$374,591
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCNOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULINS$666,216
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCVEOIBD PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES- BOSTON$1,249,403
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCMOLECULAR SPATIAL SINGLE-CELL REMODELING IN PEDIATRIC CROHNS DISEASE$374,591
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCDEVELOPMENT OF NOVEL GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM$1,173,337
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCVEOIBD PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES- BOSTON$1,226,580
CHILDREN'S HOSPITAL CORPORATION
ATTN RESEARCH FINANCEBOSTONMA022414413N/APCNOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULINS$665,654
CHILDREN'S HOSPITAL LOS ANGELES
SABAN RESEARCH INSTITUTELOS ANGELESCA90027N/APCBEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE$679,025
CHILDREN'S HOSPITAL LOS ANGELES
SABAN RESEARCH INSTITUTELOS ANGELESCA90027N/APCBEYOND COYOT1: EXPANSION OF PATIENT-CENTERED VIRTUAL CARE$684,686
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCPRECISION CROHNS DISEASE MANAGEMENT UTILIZING PREDICTIVE PROTEIN PANELS$235,507
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCBIOMARKERS OF INTESTINAL FIBROSIS IN SMALL BOWEL CROHNS DISEASE$282,554
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCDELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D$1,009,535
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCDEVELOP A PROGNOSTIC AI MODEL FOR FORECASTING CD PATIENT OUTCOMES$1,421,241
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCDEVELOP A PROGNOSTIC AI MODEL FOR FORECASTING CD PATIENT OUTCOMES$1,093,319
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229N/APCDELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D$725,157
CHILDREN'S HOSPITAL OF PHILADELPHIA
2716 SOUTH STREETPHILADELPHIAPA191462305N/APCCROHNS DISEASE EPITHELIAL STEM CELL ATLAS: PEDIATRIC TO ADULT CONTINUUM$272,676
CHILDREN'S HUNGER FUND
13931 BALBOA BLVDSYLMARCA91342N/APCFOOD SUPPORT IN ETHIOPIA AND ZAMBIA$151,800
CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROADKANSAS CITYMO64108N/APCTYPE 1 DIABETES RAPID LEARNING LAB$2,966,873
CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROADKANSAS CITYMO64108N/APCTYPE 1 DIABETES RAPID LEARNING LAB$1,399,624
CITIZENS HOUSING AND PLANNING COUNCIL OF NEW YORK INC
42 BROADWAY STE 2010NEW YORKNY10004N/APCEDUCATION FOR NYC POLICYMAKERS ON HOUSING INITIATIVES TO IMPROVE HEALTH$200,000
CITY PARKS FOUNDATION
830 FIFTH AVENUENEW YORKNY10065N/APCNYC GREEN RELIEF & RECOVERY FUND$300,000
CITY PARKS FOUNDATION
830 FIFTH AVENUENEW YORKNY10065N/APCCATALYST: GROWING INTENSIVE PARK ENGAGEMENT IN VULNERABLE COMMUNITIES$491,131
CLALIT HEALTH SERVICES
N/APCYOSEFTAL HOSPITAL ADDITION$2,058,214101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCYOSEFTAL HOSPITAL ADDITION$3,847,500101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCCOVID-19 VACCINE RESPONSES IN PATIENTS WITH IBD$177,281101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCTHE IBDMED NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL & PREVENTION$242,153101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCCLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM$926,084101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCCLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM$926,084101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCTHE IBDMED NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL & PREVENTION$243,216101 ARLOZOROV STREETTEL AVIVIS
CLALIT HEALTH SERVICES
N/APCTHE IBDMED NUTRITIONAL EDUCATION PROGRAM FOR CD CONTROL PREVENTION$243,216101 ARLOZOROV STREETTEL AVIVIS
CLINTON HEALTH ACCESS INITIATIVE INC
383 DORCHESTER AVENUE SUITE 400BOSTONMA02127N/APCMARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE$1,132,215
CLINTON HEALTH ACCESS INITIATIVE INC
383 DORCHESTER AVENUE SUITE 400BOSTONMA02127N/APCMARKET SHAPING TO IMPROVE ACCESS TO DIABETES CARE$1,372,583
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCNOVEL SPATIALLY RESOLVED GENOMIC PROFILING OF CROHNS DISEASE TISSUE$210,228
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCCOMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE$210,638
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCCOMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE$351,258
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCCOMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE$334,798
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCCOMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE$429,646
COLUMBIA UNIVERSITY
615 WEST 131ST STREETNEW YORKNY100273922N/APCCOMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE$413,263
COMMUNITY MEMORIAL HOSPITAL DISTRICT
2731 HEALTHCARE DRIVESYRACUSENE68446N/AGOVECARE EMERGENCY AT SYRACUSE AREA HEALTH$13,320
CONSORCI INSTITUT D'INVESTIGACIONES BIOMEDICAS AUGUST
N/AGOVEARLY DETECTION OF PERIANAL FISTULIZING DISEASE$261,948ROSSELL 149BARCELONASP
CONSORCI INSTITUT D'INVESTIGACIONES BIOMEDICAS AUGUST
N/AGOVEARLY DETECTION OF PERIANAL FISTULIZING DISEASE$177,122ROSSELL 149BARCELONASP
COUNCIL ON FOUNDATIONS INC
1255 23RD ST NWWASHINGTONDC20037N/APCGENERAL OPERATING SUPPORT$34,000
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD$570,831
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSUPPORT JUNIOR SCIENTISTS TO ESTABLISH CAREERS IN IBD RESEARCH.$1,067,400
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD$570,830
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD$588,266
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSUPPORT JUNIOR SCIENTISTS TO ESTABLISH CAREERS IN IBD RESEARCH.$1,067,400
CROHN'S & COLITIS FOUNDATION INC
733 THIRD AVENUE SUITE 510NEW YORKNY10017N/APCSYSTEMATIZING IMPROVEMENT INTERVENTIONS OF URGENT CARE MANAGEMENT IN CD$588,266
CROHN'S AND COLITIS CANADA
N/APCRCT TO IMPROVE TRANSITION OF PATIENTS W CD FROM PEDIATRIC TO ADULT CARE$255,52160 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCIMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS$275,68860 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCRCT TO IMPROVE TRANSITION OF PATIENTS W CD FROM PEDIATRIC TO ADULT CARE$253,78360 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCIMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS$275,58860 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCRCT TO IMPROVE TRANSITION OF PATIENTS W CD FROM PEDIATRIC TO ADULT CARE$284,64660 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCIMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS$286,83860 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCRCT TO IMPROVE TRANSITION OF PATIENTS W CD FROM PEDIATRIC TO ADULT CARE$297,61260 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS CANADA
N/APCIMPLEMENTATION OF A TELEMEDICINE NETWORK FOR CROHNS DISEASE PATIENTS$374,91260 ST CLAIR AVE EAST SUITE 600TORONTOCA
CROHN'S AND COLITIS UK
N/APC2021 2022 OPERATING SUPPORT FOR CROHNS AND COLITIS UK$75,9001 BISHOPS SQUAREHATFIELDUK
CROHN'S AND COLITIS UK
N/APC2021 2022 OPERATING SUPPORT FOR CROHNS AND COLITIS UK$75,9001 BISHOPS SQUAREHATFIELDUK
CROHN'S AND COLITIS UK
N/APC2021 2022 OPERATING SUPPORT FOR CROHNS AND COLITIS UK$75,9001 BISHOPS SQUAREHATFIELDUK
CROHN'S COLITIS CURE
N/APCDEVELOPMENT OF CCCARE-P, A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE$68,3581 OCONNELL STREETSYDNEYAS
CROHN'S COLITIS CURE
N/APCDEVELOPMENT OF CCCARE-P, A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE$99,8421 OCONNELL STREETSYDNEYAS
CROHN'S COLITIS CURE
N/APCDEVELOPMENT OF CCCARE-P, A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE$90,4671 OCONNELL STREETSYDNEYAS
CROHN'S COLITIS CURE
N/APCDEVELOPMENT OF CCCARE-P, A PEDIATRIC CD EMR TO DRIVE CONSISTENCY IN CARE$66,2671 OCONNELL STREETSYDNEYAS
DARTMOUTH- HITCHCOCK CLINIC
ONE MEDICAL CENTER DRIVELEBANONNH03756N/APCCAPACITY BUILDING FOR VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM$197,461
DE LA SALLE SOLIDARIETAINTERNAZIONALE ONLUS
N/APCETHIOPIAN CATHOLIC UNIVERSITY DIAGNOSTIC LABORATORY$191,462VIA AUREALIA 476ROMEIT
DE LA SALLE SOLIDARIETAINTERNAZIONALE ONLUS
N/APCETHIOPIAN CATHOLIC UNIVERSITY DIAGNOSTIC LABORATORY$94,780VIA AUREALIA 476ROMEIT
DUKE UNIVERSITY
C/O OFFICE OF RESEARCH SUPPORTDURHAMNC277054677N/APCUTILIZATION OF INTERACTION BETWEEN AMINO ACIDS GIP IN PANCREATIC CELLS$275,000
DUNDY COUNTY HOSPITAL
1313 N CHEYENNE STBENKELMANNE69021N/AGOVTELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL$29,310
DUNDY COUNTY HOSPITAL
1313 N CHEYENNE STBENKELMANNE69021N/AGOVTELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL$11,725
DUNDY COUNTY HOSPITAL
1313 N CHEYENNE STBENKELMANNE69021N/AGOVTELE-EMERGENCY SERVICES AT DUNDY COUNTY HOSPITAL$121,593
ENGINEERING MINISTRIES INTERNATIONAL USA
7025 CAMPUS DRIVECOLORADO SPRINGSCO80920N/APCALASKA WASH PROJECT$7,020,410
FLORESTA USA INCORPORATED
4747 MORENA BLVD STE 100SAN DIEGOCA92117N/APCSCALING AT THE WATERSHED LEVEL TO EQUIP RURAL FAMILIES$516,231
FOR INSPIRATION AND RECOGNITION OF SCIENCE TECHNOLOGY
N/APCINSPIRE YOUNG PEOPLE TO BE SCIENCE AND TECHNOLOGY LEADERS$200,000200 BEDFORD STREETMANCHESTERUK
FRANCISCAN CARE SERVICES INC
430 N MONITOR STWEST POINTNE68788N/APCTELE-EMERGENCY SERVICES AT FRANCISCAN HEALTHCARE$42,729
FRANCISCAN CARE SERVICES INC
430 N MONITOR STWEST POINTNE68788N/APCTELE-EMERGENCY SERVICES AT FRANCISCAN HEALTHCARE$17,093
FRIENDS OF THE ISRAEL DEFENSE FORCES
60 EAST 42 STREETNEW YORKNY10165N/APCTHE UNIFORM TO UNIVERSITY SCHOLARSHIP PROGRAM$334,400
FRIENDS OF THE ISRAEL DEFENSE FORCES
60 EAST 42 STREETNEW YORKNY10165N/APCTHE UNIFORM TO UNIVERSITY SCHOLARSHIP PROGRAM$334,400
FUND FOR PUBLIC HEALTH IN NEW YORK INC
22 CORTLANDT STREET SUITE 802NEW YORKNY10007N/APCNYC VACCINE EQUITY PARTNER ENGAGEMENT PROJECT$150,467
GALILEE MEDICAL CENTER
N/AGOVRENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING$2,200,000GALILEE MEDICAL CENTERNAHARIYAIS
GALILEE MEDICAL CENTER
N/AGOVRENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING$2,200,000GALILEE MEDICAL CENTERNAHARIYAIS
GEORGIA TECH RESEARCH CORPORATION
505 10TH STREET NWATLANTAGA303320420N/ASOIII FITRACKING AND INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN CD PATIENTS$480,848
GEORGIA TECH RESEARCH CORPORATION
505 10TH STREET NWATLANTAGA303320420N/ASOIII FITRACKING INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN CD PATIENTS$480,848
GEORGIA TECH RESEARCH CORPORATION
505 10TH STREET NWATLANTAGA303320420N/ASOIII FITRACKING INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN CD PATIENTS$485,617
GEORGIA TECH RESEARCH CORPORATION
505 10TH STREET NWATLANTAGA303320420N/ASOIII FITRACKING & INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN CD PATIENTS$485,616
GIRLS WITH GUTS
6024 RIDGE AVENUEPHILADELPHIAPA19128N/APC2021 2022 OPERATING SUPPORT TO GIRLS WITH GUTS.$11,100
GIRLS WITH GUTS
6024 RIDGE AVENUEPHILADELPHIAPA19128N/APC2021 2022 OPERATING SUPPORT TO GIRLS WITH GUTS.$11,100
GLOBAL SOLIDARITY FUND
425 LEXINGTON AVENEW YORKNY10017N/APCJOB CREATION IN ETHIOPIA$1,508,200
GLOBAL SOLIDARITY FUND
425 LEXINGTON AVENEW YORKNY10017N/APCJOB CREATION IN ETHIOPIA$1,508,200
GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
N/APCGLUCOSE RESPONSIVE GLUCAGON MICRONEEDLE PATCH - HYPOGLYCEMIA PREVENTION$185,46027 KINGS COLLEGE CIRCLETORONTOCA
GRANTMAKERS IN HEALTH
1100 CT AVENUE NWWASHINGTONDC20036N/APCGRANTMAKERS IN HEALTH EFFECTIVE PHILANTHROPY FUND$119,803
GUARDIAN ORG FOUNDATION
900 17TH STREET NW SUITE 250WASHINGTONDC20006N/APCAN INDEPENDENT JOURNALISM SERIES ON NON-COMMUNICABLE DISEASES$625,000
HANNOVERSCHE KINDERHEILANSTALT
N/APCFR1DA IN NORTH GERMANY: PRE-SYMPTOMATIC TYPE 1 DIABETES TESTING IN KIDS$267,694JANUSZ-KORCZAK-ALLEE 12HANNOVERGM
HEBREW UNIVERSITY OF JERUSALEM
N/APCMETHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS$671,024OFFICE OF THE PRESIDENTJERUSALEMIS
HEBREW UNIVERSITY OF JERUSALEM
N/APCMETHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS$362,703OFFICE OF THE PRESIDENTJERUSALEMIS
HELEN KELLER INTERNATIONAL
ONE DAG HAMMARSKJOLD PLAZANEW YORKNY10017N/APCA CONTINUED PATH TO RESILIENCE AND EMPOWERMENT$1,652,490
HELEN KELLER INTERNATIONAL
ONE DAG HAMMARSKJOLD PLAZANEW YORKNY10017N/APCA CONTINUED PATH TO RESILIENCE AND EMPOWERMENT$1,941,293
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCIDENTIFICATION OF INFANTS WITH HIGH RISK OF T1D - PRIMARY PREVENTION$1,431,241HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$668,906HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,277,602HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL$2,350,161HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCCONTINUATION OF THE GPPAD-02-STUDY$2,428,367HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCFR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT$460,108HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,277,602HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCCONTINUATION OF THE GPPAD-02-STUDY$2,451,335HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL$2,622,774HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$847,748HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD DRIED BLOOD SPOT OMICS TO PREDICT HEALTH OUTCOMES IN CHILDREN$80,432HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$847,748HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,454,620HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCCONTINUATION OF THE GPPAD-02-STUDY$2,451,335HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL$2,622,773HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,454,619HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCCONTINUATION OF THE GPPAD-02-STUDY$2,440,023HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL$3,074,101HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$870,315HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD DRIED BLOOD SPOT OMICS TO PREDICT HEALTH OUTCOMES IN CHILDREN$82,445HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$870,314HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,339,873HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCTHE GPPAD-03 STUDY: THE PRIMARY ORAL INSULIN TRIAL$3,074,100HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,339,873HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$830,769HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,482,901HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD COORDINATION CENTER CONTINUATION$830,769HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,482,900HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,410,856HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,410,856HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,301,918HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$1,301,917HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HELMHOLTZ ZENTRUM MUNCHEN (GMBH)
N/APCGPPAD-04 STUDY: SUPPLEMENT W/ B. INFANTIS TO MITIGATE T1D AUTOIMMUNITY$522,291HELMHOLTZ ZENTRUM MUNCHEN GMBHNEUHERBERGGM
HENRY J KAISER FAMILY FOUNDATION
185 BERRY STREET NO 2000SAN FRANCISCOCA94107N/APCKHN RURAL HEALTH DESK$1,239,878
HENRY J KAISER FAMILY FOUNDATION
185 BERRY STREET NO 2000SAN FRANCISCOCA94107N/APCKHN RURAL HEALTH DESK$1,275,901
HERLEV OG GENTOFTE HOSPITAL
N/AGOVTARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D$394,362HERLEV AND GENTOFTE HOSPITALHERLEVDA
HERLEV OG GENTOFTE HOSPITAL
N/AGOVUTILIZATION OF INTERACTION BETWEEN AMINO ACIDS GIP IN PANCREATIC CELLS$275,000HERLEV AND GENTOFTE HOSPITALHERLEVDA
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCMODULATING EARLY LIFE MICROBIOME THROUGH DIETARY INTERVENTION IN CROHNS$409,388
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCNEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE$415,688
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCNEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE$415,688
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCVEOIBD: PRECISION DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES$220,000
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCNEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE$404,688
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCNEXT PHASE OF STEM CELL TRANSPLANT FOR REFRACTORY CROHNS DISEASE$305,349
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1 GUSTAVE L LEVY PLNEW YORK CITYNY10029N/APCVEOIBD: PRECISION DIAGNOSES TO TARGETED THERAPIES: MOUNT SINAI STUDIES$220,000
ICHUD HATZALAH ISRAEL 1221 (RA)
N/APCUNITED HATZALAH HUMANITARIAN MISSION FOR UKRAINE$739,00078 YIRMIYAHU STJERUSALEMIS
IDA COUNTY IOWA COMMUNITY HOSPITAL
701 EAST SECOND STREETIDA GROVEIA51445N/APCECARE PHARMACY AT HORN MEMORIAL HOSPITAL$9,677
IDEOORG
444 SPEAR STREETSAN FRANCISCOCA94105N/APCHUMAN-CENTERED DESIGN STUDY OF T1D IN MEDICALLY UNDERSERVED COMMUNITIES.$227,950
IDEOORG
444 SPEAR STREETSAN FRANCISCOCA94105N/APCHUMAN-CENTERED DESIGN STUDY OF T1D IN MEDICALLY UNDERSERVED COMMUNITIES.$200,000
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$81,8921 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVBIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL$82,3801 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$87,4461 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVBIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL$90,1901 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVBIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL$148,4581 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$92,9991 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$98,5531 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$94,1051 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$99,6591 RUE LOUIS RECHDUDELANGELU
INSTITUT INTEGRATED BIOBANK OF LUXEMBOURG
N/AGOVGPPAD BIOBANK - SINT1A$97,3171 RUE LOUIS RECHDUDELANGELU
INSTITUT NATIONALE DE LA SANTE ET DE LA RECHERCHE MEDICALE
N/AGOVBENIGN ISLET AUTOIMMUNITY TO T1D: CD8+ T-CELL BIOMARKERS OF PROGRESSION$164,33886 RUE REGNAULTPARISFR
INSULIN FOR LIFE USA INC
2555 SW 76TH STREETGAINESVILLEFL32608N/APCINSULIN FOR LIFE USA STRENGTHENING ORGANIZATIONAL CAPACITY$320,933
INSULIN FOR LIFE USA INC
2555 SW 76TH STREETGAINESVILLEFL32608N/APCINSULIN FOR LIFE USA STRENGTHENING ORGANIZATIONAL CAPACITY$341,606
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCPOINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES$172,967HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCTHE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND$779,377HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCTHE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND$718,578HARKORTSTR 1MUNSTERGM
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
N/ANCTHE DEVELOPMENT OF A DISEASE ACTIVITY INDEX FOR INTESTINAL ULTRASOUND$375,221HARKORTSTR 1MUNSTERGM
IOWA DEPARTMENT OF PUBLIC HEALTH
321 EAST 12THDES MOINESIA50319N/AGOVIOWA FIRST RESPONDER AED INITIATIVE$186,944
IOWA DEPARTMENT OF PUBLIC HEALTH
321 EAST 12THDES MOINESIA50319N/AGOVIOWA FIRST RESPONDER AED INITIATIVE$58,968
ISRAEL ANTIQUITIES AUTHORITY
N/AGOVJAY & JEANIE SCHOTTENSTEIN NATIONAL CAMPUS FOR THE ARCHAEOLOGY OF ISRAEL$400,00027 SULTAN SULEIMAN STREETJERUSALEMIS
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEXERCISE IN DIABETES INITIATIVE: LARGE ADULT STUDY$159,838
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCVIRTUAL DIABETES SPECIALTY CLINIC STUDY EVALUATING REMOTE INITIATION CGM$724,198
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY$400,000
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCCGM MONITORING OF MATERNAL DYSGLYCEMIA$425,771
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY$625,000
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEXERCISE IN DIABETES INITIATIVE: PEDIATRIC STUDY$283,542
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W DIABETES RETINOPATHY$286,747
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W DIABETES RETINOPATHY$384,845
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W DIABETES RETINOPATHY$387,943
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W DIABETES RETINOPATHY$331,671
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC
15310 AMBERLY DRIVE SUITE 350TAMPAFL33647N/APCEVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CGM W DIABETES RETINOPATHY$162,082
JDRF AUSTRALIA
N/APCENDIA EARLY TO MID-CAREER SCIENCE ACCELERATOR AWARDS 2021$232,57780-84 CHANDOS STREETSYDNEYAS
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCHELMSLEY AND JDRF CO-FUNDED WORKSHOPS$150,000
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCJDRF GLOBAL DIABETES ACCESS INITIATIVE$999,800
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCHCP T1D EDUCATION PROGRAM (STATE OF AFFAIRS AND PEAK)$99,699
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCJDRF TRAINING PROGRAMS$750,000
JDRF INTERNATIONAL
200 VESEY STREETNEW YORKNY10281N/APCHELMSLEY AND JDRF CO-FUNDED WORKSHOPS$150,000
JERUSALEM COLLEGE OF TECHNOLOGY
N/APCHELMSLEY FACULTY OF LIFE AND HEALTH SCIENCES BUILDING$5,465,00021 HAVAAD HALEUMI STJERUSALEMIS
JOSLIN DIABETES CENTER INC
ONE JOSLIN PLACEBOSTONMA02215N/APCAN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES$941,354
JOSLIN DIABETES CENTER INC
ONE JOSLIN PLACEBOSTONMA02215N/APCAN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES$857,270
JUVENILE DIABETES RESEARCH FOUNDATION CANADA
N/APCJDRF CANADA PSYCHOSOCIAL HEALTH INITIATIVE$36,000235 YORKLAND BLVD SUITE 600TORONTOCA
JUVENILE DIABETES RESEARCH FOUNDATION CANADA
N/APCJDRF CANADA PSYCHOSOCIAL HEALTH INITIATIVE$19,000235 YORKLAND BLVD SUITE 600TORONTOCA
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCAN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT$530,354WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCCOMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD$656,542WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCAN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT$246,663WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCSUPPORT FOR INNODIA HARVEST ACTIVITIES AT ACADEMIC CONSORTIUM MEMBERS.$807,155WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCCOMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD$408,046WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCAN ENTEROCHROMAFFIN CELL AND MACROPHAGE ATLAS OF THE HUMAN GUT$246,662WAAISTRAAT 6 BOX 5105LEUVENBE
KATHOLIEKE UNIVERSITEIT LEUVEN
N/APCCOMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CD$362,770WAAISTRAAT 6 BOX 5105LEUVENBE
KING'S COLLEGE LONDON
N/APCEVALUATE THE BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA$307,779150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCT CELL RECEPTOR SEQUENCING IN T1D - BIOMARKER & TECHNOLOGY DEVELOPMENT$115,097150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III$1,074,992150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCIDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHNS DISEASE$288,101150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III$1,142,151150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCIDENTIFYING THE ROLE OF FOOD ADDITIVE EMULSIFIERS IN CROHNS DISEASE$195,494150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III$1,325,562150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III$1,296,483150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III$369,984150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III$778,535150 STAMFORD STREETLONDONUK
KING'S COLLEGE LONDON
N/APCMULTIPEPT1DE PROOF-OF-CONCEPT STUDY: STAGE III$1,079,926150 STAMFORD STREETLONDONUK
KITTSON MEMORIAL HOSPITAL ASSOCIATION
1010 SOUTH BIRCH AVENUEHALLOCKMN56728N/APCEEMERGENCY AT KITTSON HEALTHCARE$11,729
KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITT
N/AGOVFMT FOR MAINTENANCE OF REMISSION AFTER EEN TREATMENT IN CROHNS DISEASE$600,891FEODOR-LYNEN-STRABE 17MUCHENGM
KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITT
N/AGOVFMT FOR MAINTENANCE OF REMISSION AFTER EEN TREATMENT IN CROHNS DISEASE$644,601FEODOR-LYNEN-STRABE 17MUNCHENGM
KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITT
N/AGOVFMT FOR MAINTENANCE OF REMISSION AFTER EEN TREATMENT IN CROHNS DISEASE$606,581FEODOR-LYNEN-STRABE 17MUNICHGM
KLINIKUM DER UNIVERSITT MUNCHEN
N/AGOVFMT FOR MAINTENANCE OF REMISSION AFTER EEN TREATMENT IN CROHNS DISEASE$659,714FEODOR-LYNEN-STRABE 17MUNCHENGM
KLINIKUM DER UNIVERSITT MUNCHEN
N/AGOVFMT FOR MAINTENANCE OF REMISSION AFTER EEN TREATMENT IN CROHNS DISEASE$649,424FEODOR-LYNEN-STRABE 17MUNCHENGM
LAKES REGIONAL HEALTHCARE
HIGHWAY 71 SOUTHSPIRIT LAKEIA51360N/AGOVECARE PHARMACY AT LAKES REGIONAL HEALTHCARE$10,856
LINCOLN COUNTY HOSPITAL DISTRICT
700 NORTH SPRING STREETCALIENTENV89008N/AGOVGROVER C. DILS MEDICAL CENTER ULTRASOUND PROJECT$36,064
LIVING WATER INTERNATIONAL
4001 GREENBRIAR DRIVESTAFFORDCT77477N/APCINTEGRATED WASH PROGRAM IN CHIPATA DISTRICT, ZAMBIA$1,369,113
LUCAS COUNTY HEALTH CENTER
1200 NORTH 7TH STREETCHARITONIA50049N/APCAVERA ECARE EMERGENCY VIRTUAL HEALTH AT LUCAS COUNTY HEALTH CENTER$45,334
LUCAS COUNTY HEALTH CENTER
1200 NORTH 7TH STREETCHARITONIA50049N/APCAVERA ECARE EMERGENCY VIRTUAL HEALTH AT LUCAS COUNTY HEALTH CENTER$17,970
MACCABI HEALTHCARE SERVICES
N/APCMOBILE MAMMOGRAPHY UNIT$31,50027 HAMERED STTEL AVIVIS
MACCABI HEALTHCARE SERVICES
N/APCMOBILE MAMMOGRAPHY UNIT$31,50027 HAMERED STTEL AVIVIS
MADISON COUNTY MEMORIAL HOSPITAL
300 W HUTCHINGS STREETWINTERSETIA50273N/AGOVIMPLEMENTATION OF EEMERGENCY AT MADISON COUNTY HEALTH CARE SYSTEM$37,965
MADISON COUNTY MEMORIAL HOSPITAL
300 W HUTCHINGS STREETWINTERSETIA50273N/AGOVIMPLEMENTATION OF EEMERGENCY AT MADISON COUNTY HEALTH CARE SYSTEM$15,187
MAINEHEALTH
22 BRAMHALL STREETPORTLANDME04102N/APCTRANSFORMING RURAL DIABETES CARE IN MAINE$848,894
MAINEHEALTH
22 BRAMHALL STREETPORTLANDME04102N/APCTRANSFORMING RURAL DIABETES CARE IN MAINE$596,795
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCDEVELOP A DEVICE TO IMPROVE ROUTINE DISEASE MONITORING FOR CD.$843,986
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCCROHNS DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION$350,278
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCCROHNS DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION$352,645
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCDEVELOP A DEVICE TO IMPROVE ROUTINE DISEASE MONITORING FOR CD.$752,326
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA021142696N/APCCROHNS DISEASE IN SOUTH ASIANS: DEFINING DISEASE BIOLOGY FOR PREVENTION$353,249
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APCOFF-SITE REMOTE CONTROL ROBOTIC PERCUTANEOUS CORONARY INTERVENTIONS$385,906
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APCSTENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM$103,827
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$334,407
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905N/APCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$151,705
MCGILL UNIVERSITY
N/APCTHE HUMAN CELL ATLAS: ETHICS AND DATA GOVERNANCE$189,596JAMES ADMINISTRATION BUILDINGMONTREALCA
MEDSTAR HEALTH INC
3007 TILDEN STREET NWWASHINGTONDC20008N/ASOIII FI2022 SUPPORT FOR THE 'MASTERING CLINICAL CHALLENGES IN IBD' SYMPOSIUM$35,000
MEEKER MEMORIAL HOSPITAL
612 S SIBLEY AVELITCHFIELDMN55355N/AGOVEPHARMACY AT MEEKER MEMORIAL HOSPITAL$12,269
MI STATE UNIVERSITY
HANNAH ADMINISTRATION BUILDINGEAST LANSINGMI488242601N/APCA C-PEPTIDE COMPLEX FOR IMPROVED GLUCOSE METABOLISM IN PEOPLE WITH T1D$382,594
MONROE COUNTY HOSPITAL
6580 165TH STREETALBIAIA52531N/AGOVEPHARMACY AT MONROE COUNTY HOSPITAL & CLINICS$17,577
MONROE COUNTY HOSPITAL
6580 165TH STREETALBIAIA52531N/AGOVEPHARMACY AT MONROE COUNTY HOSPITAL CLINICS$7,031
MONUMENT HEALTH NETWORK INC
2140 JUNCTION AVESTURGISSD57785N/APCEEMERGENCY AT MONUMENT HEALTH STURGIS HOSPITAL$41,418
MONUMENT HEALTH NETWORK INC
2140 JUNCTION AVESTURGISSD57785N/APCEEMERGENCY AT MONUMENT HEALTH STURGIS HOSPITAL$16,568
NATIONAL ACADEMY OF SCIENCES
500 5TH STREET NWWASHINGTONDC20001N/APCSTRENGTHENING MINORITY SERVING INSTITUTIONS$150,000
NATIONAL COMMITTEE FOR QUALITY ASSURANCE
1100 13TH ST NWWASHINGTONDC20005N/APCTRANSFORM HEALTHCARE THROUGH MEASUREMENT, TRANSPARENCY, & ACCOUNTABILITY$836,732
NATIONAL COMMITTEE FOR QUALITY ASSURANCE
1100 13TH ST NWWASHINGTONDC20005N/APCTRANSFORM HEALTHCARE THROUGH MEASUREMENT, TRANSPARENCY, ACCOUNTABILITY$621,487
NATIONAL COMMITTEE FOR QUALITY ASSURANCE
1100 13TH ST NWWASHINGTONDC20005N/APCTRANSFORM HEALTHCARE THROUGH MEASUREMENT, TRANSPARENCY, & ACCOUNTABILITY$753,478
NATIONAL PARK FOUNDATION
1500 K ST NWWASHINGTONDC20005N/APCBADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER$1,500,000
NATIONAL PARK FOUNDATION
1500 K ST NWWASHINGTONDC20005N/APCLITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER$1,400,000
NATIONAL PARK FOUNDATION
1500 K ST NWWASHINGTONDC20005N/APCBERING LAND BRIDGE VISITOR CENTER$2,449,328
NATIONAL PARK FOUNDATION
1500 K ST NWWASHINGTONDC20005N/APCLITTLE BIGHORN BATTLEFIELD NATIONAL MONUMENT VISITOR CENTER$1,750,000
NATIONAL PARK FOUNDATION
1500 K ST NWWASHINGTONDC20005N/APCBADLANDS NATIONAL PARK CEDAR PASS VISITOR CENTER$750,000
NATIONAL PARK FOUNDATION
1500 K ST NWWASHINGTONDC20005N/APCBERING LAND BRIDGE VISITOR CENTER$1,163,270
NEBRASKA DEPARTMENT OF HEALTH & HUMAN SERVICES
301 CENTENNIAL MALL SOUTHLINCOLNNE68508N/AGOVNEBRASKA FIRST RESPONDER AED PROJECT$545,083
NEBRASKA DEPARTMENT OF HEALTH & HUMAN SERVICES
301 CENTENNIAL MALL SOUTHLINCOLNNE68508N/AGOVNEBRASKA FIRST RESPONDER AED PROJECT$309,887
NEVADA COMMUNITY FOUNDATION INC
1980 FESTIVAL PLAZA DRIVELAS VEGASNV89135N/APCRURAL NEVADA ULTRASOUND CARE INITIATIVE$1,035,951
NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES
4150 TECHNOLOGY WAYCARSON CITYNV89706N/AGOVNEVADA VIRTUAL CRISIS CARE$1,333,324
NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES
4150 TECHNOLOGY WAYCARSON CITYNV89706N/AGOVNEVADA VIRTUAL CRISIS CARE$1,230,038
NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES
4150 TECHNOLOGY WAYCARSON CITYNV89706N/AGOVNEVADA VIRTUAL CRISIS CARE$1,239,092
NEW DESTINY HOUSING CORPORATION
12 W 37TH STREET 7TH FLOORNEW YORKNY10018N/APCAFTERCARE INTERVENTION TO IMPROVE HOUSING & HEALTH STABILITY$215,030
NEW VENTURE FUND
1201 CT AVE NW SUITE 300WASHINGTONDC20036N/APCTYPE 1 DIABETES CAMPS PROJECT (2022 - 2024)$1,435,500
NEW VENTURE FUND
1201 CT AVE NW SUITE 300WASHINGTONDC20036N/APCTYPE 1 DIABETES CAMPS PROJECT (2022 - 2024)$1,468,813
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
125 WORTH STREETNEW YORKNY10013N/APCEXPRESSCARE TELE-BEHAVIORAL SERV. & STRATEGIES (NYC HIGH NEEDS PATIENTS)$1,457,500
NEW YORK CITY HEALTH AND HOSPITALS CORPORATION
125 WORTH STREETNEW YORKNY10013N/APCEXPRESSCARE TELE-BEHAVIORAL SERV. & STRATEGIES (NYC HIGH NEEDS PATIENTS)$825,000
NEW YORK UNIVERSITY
665 BROADWAYNEW YORKNY10012N/APCIDENTIFYING ENVIRONMENTAL CONTRIBUTORS TO CROHNS DISEASE$1,046,686
NEW YORK UNIVERSITY
665 BROADWAYNEW YORKNY10012N/APCEVALUATION OF INTERVENTIONS FOR COLLABORATIVE FOR HOMELESS HEALTHCARE$205,596
NEW YORK UNIVERSITY
665 BROADWAYNEW YORKNY10012N/APCANALYSIS OF MEDICAID DATA TO IMPROVE CARE FOR HOMELESS PATIENTS$101,043
NEW YORK UNIVERSITY
665 BROADWAYNEW YORKNY10012N/APCANALYSIS OF MEDICAID DATA TO IMPROVE CARE FOR HOMELESS PATIENTS$100,123
NORTH DAKOTA DEPARTMENT OF HEALTH
600 E BOULEVARD AVENUEBISMARCKND585050200N/AGOVNORTH DAKOTA LAW ENFORCEMENT AED PROJECT$173,689
NORTHERN WESTCHESTER HOSPITAL ASSOCIATION
400 EAST MAIN STREETMOUNT KISCONY10549N/APCMATERNAL CHILD HEALTH UNIT FACILITIES RENOVATION$200,000
OREGON HEALTH & SCIENCE UNIVERSITY
3181 SW SAM JACKSON PARK RDPORTLANDOR972393098N/AGOVTO EXPAND THE NICH PROGRAM IN THE CALIFORNIA BAY AREA$654,234
PALO ALTO VETERANS INSTITUTE FOR RESEARCH
3801 MIRANDA AVENUEPALO ALTOCA943040038N/APCCELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHNS DISEASE$500,825
PALO ALTO VETERANS INSTITUTE FOR RESEARCH
3801 MIRANDA AVENUEPALO ALTOCA943040038N/APCCELL ATLAS OF INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHNS DISEASE$499,175
PANORAMA GLOBAL
2101 FOURTH AVENUE SUITE 2100SEATTLEWA98121N/APCTYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND$999,473
PANORAMA GLOBAL
2101 FOURTH AVENUE SUITE 2100SEATTLEWA98121N/APCTYPE 1 DIABETES GLOBAL ACCESS MICRO-GRANT FUND$1,167,087
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY
1 LETTERMAN DRIVESAN FRANCISCOCA94129N/APCSTUDYING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES.$358,140
PATH
2201 WESTLAKE AVENUESEATTLEWA98121N/APCTHE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE$2,004,478
PATH
2201 WESTLAKE AVENUESEATTLEWA98121N/APCTHE DIABETES CAREPAK PROJECT: ENABLING HIGH-QUALITY DIABETES SELF-CARE$1,838,580
PAWNEE COUNTY MEMORIAL HOSPITAL
600 I STREETPAWNEE CITYNE68420N/AGOVECARE PHARMACY AT PAWNEE COUNTY MEMORIAL HOSPITAL$17,845
PAWNEE COUNTY MEMORIAL HOSPITAL
600 I STREETPAWNEE CITYNE68420N/AGOVECARE PHARMACY AT PAWNEE COUNTY MEMORIAL HOSPITAL$7,139
PHILIP HEALTH SERVICES INC
503 W PINE STREETPHILIPSD57567N/APCIMPLEMENTATION OF AVERA EEMERGENCY AT PHILIP HEALTH SERVICES$12,317
PROJECT NYAME NSA LTD
33 WILLETS LANEMANHASSETNY11030N/APCPROJECT NYAME NSA ZAMBIA EXPANSION$241,600
PROVIDENCE MEDICAL CENTER
1200 PROVIDENCE ROADWAYNENE68787N/APCEPHARMACY AT PROVIDENCE MEDICAL CENTER$8,457
PUBLIC HEALTH SOLUTIONS
40 WORTH STREET 5TH FLOORNEW YORKNY10013N/APCNEW YORK CITY FUND FOR YOUTH AND FAMILY HOMELESSNESS$262,335
PULITZER CENTER ON CRISIS REPORTING
1779 MASSACHUSETTS AVE NWWASHINGTONDC20036N/APCBUILDING RESILIENCE THROUGH JOURNALISM AND EDUCATION$302,170
PULITZER CENTER ON CRISIS REPORTING
1779 MASSACHUSETTS AVE NWWASHINGTONDC20036N/APCBUILDING RESILIENCE THROUGH JOURNALISM AND EDUCATION$310,123
REGENTS OF THE UNIVERSITY OF MI
3003 SOUTH STATE STREETANN ARBORMI48109N/APCUSE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS.$385,780
REGENTS OF THE UNIVERSITY OF MI
3003 SOUTH STATE STREETANN ARBORMI48109N/APCHEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS$454,441
REGENTS OF THE UNIVERSITY OF MI
3003 SOUTH STATE STREETANN ARBORMI48109N/APCUSE NLP FOR EXTRACTION OF CD RELEVANT DATA FROM CLINICAL RECORDS.$369,880
REGENTS OF THE UNIVERSITY OF MI
3003 SOUTH STATE STREETANN ARBORMI48109N/APCHEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS$408,267
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVREDEFINING THE FUTURE OF EMERGENCY MEDICINE$5,026,234
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVPHASE 2: ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR T1D$250,000
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVPRECLINICAL DEVELOPMENT OF A MONOCLONAL ANTIBODY TO SERPINB13$308,267
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVMINNESOTA FIRST RESPONDER AED PROJECT$4,885,390
REGENTS OF THE UNIVERSITY OF MINNESOTA
401 EAST RIVER ROADMINNEAPOLISMN55455N/AGOVMINNESOTA FIRST RESPONDER AED PROJECT$1,296,918
RENOWN HEALTH FOUNDATION
245 E LIBERTY STRENONV89501N/APCSIMULATION LAB AND INNOVATION CENTER$3,099,867
SAFE WATER NETWORK
122 EAST 42ND STREETNEW YORKNY10168N/APCSCALING AFFORDABLE SAFELY MANAGED WATER SUPPLY$1,595,750
SAFE WATER NETWORK
122 EAST 42ND STREETNEW YORKNY10168N/APCSCALING AFFORDABLE SAFELY MANAGED WATER SUPPLY$1,552,050
SAGE BIONETWORKS
2901 THIRD AVESEATTLEWA981213014N/APCEXTENSION OF VEOIBD DATA COORDINATION$73,424
SAGE BIONETWORKS
2901 THIRD AVESEATTLEWA981213014N/APCEXTENSION OF VEOIBD DATA COORDINATION$75,165
SANFORD RESEARCH
2301 E 60TH STREET NSIOUX FALLSD571040569N/APCSANFORD PLEDGE: PHASES 1 AND 2$212,565
SCHWARTZREISMAN SCIENCE EDUCATION CENTER REHOVOT
N/APCTHE HELMSLEY CAMPUS FOR SCIENCE EDUCATION IN NETIVOT$1,982,305HERZL ST 234REHOVOTIS
SEATTLE CHILDREN'S HOSPITAL
PO BOX 5731 M/S S-200SEATTLEWA981455005N/APCDEVELOPMENT OF ANTIGEN-SPECIFIC ETREG THERAPY IN T1D - STAGE 3 STUDIES$1,224,949
SHAARE ZEDEK MEDICAL CENTER
N/APCPREVENTION OF INFLAMMATORY BOWEL DISEASES IN PERSONS AT RISK$355,91612 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APC"TASTY & HEALTHY" DIET: A RANDOMIZED CONTROLLED TRIAL FOR INDUCING AND MAINTAINING REMISSION IN CROHN'S DISEASE.$527,46812 SHMUEL BAIT STREETJERUSALEMIS
SHAARE ZEDEK MEDICAL CENTER
N/APCTHE HELMSLEY CANCER CENTER AT SHAARE ZEDEK MEDICAL CENTER JERUSALEM$5,226,27212 SHMUEL BAIT STREETJERUSALEMIS
SHENANDOAH MEDICAL CENTER
300 PERSHING AVESHENANDOAHIA51601N/APCSHENANDOAH MEDICAL CENTER / AVERA EEMERGENCY IMPLEMENTATION PROJECT$15,320
SIMULATION IN MOTION MONTANA INC
C/O MONTANA MEDICAL ASSOCIATIONHELENAMT59601N/APCCAPACITY BUILDING TOWARD A SUSTAINABLE SIMULATION IN MOTION MONTANA$108,298
SIOUX VALLEY MEMORIAL HOSPITAL ASSOCIATION
300 SIOUX VALLEY DRIVECHEROKEEIA51012N/APCECARE EMERGENCY AT CHEROKEE REGIONAL MEDICAL CENTER$13,877
SNV NETHERLANDS DEVELOPMENT ORGANISATION
N/APCHEALTHY FUTURE FOR ALL IMPROVING WATER, SANITATION, HYGIENE & NUTRITION$1,207,754PARKSTRAAT 83DEN HAAGNL
SNV NETHERLANDS DEVELOPMENT ORGANISATION
N/APCHEALTHY FUTURE FOR ALL IMPROVING WATER, SANITATION, HYGIENE & NUTRITION$962,857PARKSTRAAT 83DEN HAAGNL
SOS CHILDREN'S VILLAGES-USA INC
1620 I STREET NW SUITE 220WASHINGTONDC20006N/APCEDUCARE 4.0: DEBRE TABOR AND GONDAR CITY, ETHIOPIA$1,386,577
SOUTH LINCOLN HOSPITAL DISTRICT
711 ONYX STKEMMERERWY83101N/AGOVTELE-EMERGENCY SERVICE AT SOUTH LINCOLN MEDICAL CENTER$26,976
SOUTH LINCOLN HOSPITAL DISTRICT
711 ONYX STKEMMERERWY83101N/AGOVTELE-EMERGENCY SERVICE AT SOUTH LINCOLN MEDICAL CENTER$10,791
SOUTH LINCOLN HOSPITAL DISTRICT
711 ONYX STKEMMERERWY83101N/AGOVTELE-EMERGENCY SERVICE AT SOUTH LINCOLN MEDICAL CENTER$151,487
SOUTHCENTRAL FOUNDATION
4501 DIPLOMACY DRANCHORAGEAK99508N/APCFWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM$903,283
SOUTHCENTRAL FOUNDATION
4501 DIPLOMACY DRANCHORAGEAK99508N/APCFWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM$818,171
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDIABETESWISE-PRO: INCREASING DIABETES DEVICE UPTAKE IN PEOPLE DIABETES$817,475
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCINVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHNS DISEASE$690,953
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCEXERCISE EDUCATION AT NEW ONSET OF T1D$339,811
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCEXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT$330,000
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCMICROBIOME-BASED THERAPEUTICS FOR CROHNS DISEASE$1,009,155
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCINVESTIGATING THE ROLE OF THE HUMAN EXPOSOME IN CROHNS DISEASE$836,979
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDEVELOPMENT OF A CONTINUOUS MULTIANALYTE SENSOR FOR T1D$1,374,460
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCDEVELOPMENT OF A CONTINUOUS MULTIANALYTE SENSOR FOR T1D$1,374,444
STANFORD UNIVERSITY
443 VIA ORTEGASTANFORDCA94305N/APCEXPANSION & EVALUATION OF ECHO FOR PEOPLE WITH DIABETES ON IIT$1,296,812
STICHTING ACCESS TO MEDICINE FOUNDATION
N/APCEXPANDING ACCESS TO T1D CARE$750,000NARITAWEG 227AMSTERDAMNL
STICHTING ACCESS TO MEDICINE FOUNDATION
N/APCEXPANDING ACCESS TO T1D CARE$875,000NARITAWEG 227AMSTERDAMNL
STICHTING HEALTH ACTION INTERNATIONAL
N/APCADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLLY$1,287,681OVERTOOM 60/IIAMSTERDAMNL
STICHTING HEALTH ACTION INTERNATIONAL
N/APCADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLLY$1,245,075OVERTOOM 60/IIAMSTERDAMNL
STIFTELSEN FORSKNING AVSEENDE INFLAMMATORISKA TARMSJUKDOM
N/APCHELMSLEY IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INV CAREERS IN IBD$132,000DEPT OF GASTROENTEROLOGYOREBROSW
STIFTELSEN UTBILDNING AVSEENDE INFLAMMATORISKA TARMSJUKDOM
N/APCHELMSLEY IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INV CAREERS IN IBD$132,000DEPT OF GASTROENTEROLOGYOREBROSW
STIFTELSENFORSKNING AVSEENDE INFLAMMATORISKA TARMSJUKDOM
N/APCHELMSLEY IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INV CAREERS IN IBD$132,000DEPT OF GASTROENTEROLOGYOREBROSW
SYNERGOS INSTITUTE INC
3 EAST 54TH STREETNEW YORKNY10022N/APCIMPROVING LIVES AND LIVELIHOODS OF SMALLHOLDER FARMERS$1,063,518
T1D EXCHANGE INC
11 AVENUE DE LAFAYETTEBOSTONMA02111N/APCDATA APPROACH TO IMPROVE QUALITY AND OUTCOMES FOR INDIVIDUALS WITH T1D$261,908
TECHNISCHE UNIVERSITT DRESDEN
N/AGOVSUPPORT SCREENING FOR ISLET AUTOANTIBODIES IN CHILDREN.$52,102HELMHOLTZSTR 10DRESDENGM
TECHNISCHE UNIVERSITT DRESDEN
N/AGOVGENOMIC INFLUENCE OF MATERNAL T1D - UNDERSTANDING PROTECTION AGAINST T1D$210,829HELMHOLTZSTR 10DRESDENGM
TECHNISCHE UNIVERSITT DRESDEN
N/AGOVSUPPORT SCREENING FOR ISLET AUTOANTIBODIES IN CHILDREN.$60,079HELMHOLTZSTR 10DRESDENGM
THE ASPEN INSTITUTE INC
2300 N STREETWASHINGTONDC20037N/APCTHE ASPEN INSTITUTE IS AN EDUCATIONAL AND POLICY STUDIES ORGANIZATION$996,251
THE ASPEN INSTITUTE INC
2300 N STREETWASHINGTONDC20037N/APCTHE ASPEN INSTITUTE IS AN EDUCATIONAL AND POLICY STUDIES ORGANIZATION$998,081
THE BARUCH PADEH MEDICAL CENTER PORIYA
N/AGOVTHE HELMSLEY REHABILITATION CENTER OF THE NORTH$4,453,113THE BARUCH PADEH MEDICAL CENTERPORITIBERIASISA
THE BARUCH PADEH MEDICAL CENTER PORIYA
N/AGOVTHE HELMSLEY REHABILITATION CENTER OF THE NORTH$5,431,730THE BARUCH PADEH MEDICAL CENTERPORITIBERIASISA
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCHUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHNS DISEASE$463,751
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCNOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE$1,500,000
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCHUMAN COLON AND SMALL INTESTINE CELL ATLAS IN HEALTH AND CROHNS DISEASE$463,755
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCNOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE$1,500,000
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCNOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE$1,500,000
THE BROAD INSTITUTE INC
415 MAIN STREETCAMBRIDGEMA02142N/APCNOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE$1,500,000
THE CHINESE UNIVERSITY OF HONG KONG
N/APCMATERNAL TRANSFER OF SPECIALIZED CELLS FOR TREATMENT OF BOWEL DISEASE$492,017PI CHIU BUILDINGSHATINHK
THE CHINESE UNIVERSITY OF HONG KONG
N/APCIBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN$430,508PI CHIU BUILDINGSHATINHK
THE CHINESE UNIVERSITY OF HONG KONG
N/APCIBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN$249,337PI CHIU BUILDINGSHATINHK
THE CHINESE UNIVERSITY OF HONG KONG
N/APCIBD GIVES-21: GLOBAL IBD VISUALIZATION OF EPIDEMIOLOGY STUDIES, 21ST CEN$251,789PI CHIU BUILDINGSHATINHK
THE CITY OF HOPE
1500 E DUARTE RDDUARTECA91010N/APCUNDERSTANDING GENETIC PROTECTION FROM T1D.$275,000
THE CITY OF HOPE
1500 E DUARTE RDDUARTECA91010N/APCUNDERSTANDING GENETIC PROTECTION FROM T1D.$275,000
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCCROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS$954,604
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCCROHNS FISTULIZING PROGRAM INVESTIGATOR INITIATED CLINICAL TRIALS$1,335,936
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCSTENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH CONSORTIUM$155,544
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCDEVELOP IUS AND HISTOPATHOLOGY INDICES FOR MONITORING STRICTURING CD$348,000
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$1,355,310
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCDEVELOP IUS AND HISTOPATHOLOGY INDICES FOR MONITORING STRICTURING CD$111,750
THE CLEVELAND CLINIC FOUNDATION
9500 EUCLID AVENUECLEVELANDOH44195N/APCDEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$1,321,210
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCTHE CHANGING EPIDEMIOLOGY OF CROHNS IN THE WESTERN WORLD$186,7772500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCVISUALIZATION OF COVID-19 VACCINE SEROLOGY IN CD$89,0472500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCINTERLEUKIN-4 ACTIVATED MACROPHAGES FOR PERSONALIZED CELL IMMUNOTHERAPY$122,8542500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCDEVELOP PROTEIN PANEL TO IDENTIFY FIBROSTENOTIC CD PATIENTS$419,0102500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCTHE CHANGING EPIDEMIOLOGY OF CROHNS IN THE WESTERN WORLD$191,8832500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCVISUALIZATION OF COVID-19 VACCINE SEROLOGY IN CD$89,0472500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCINTERLEUKIN-4 ACTIVATED MACROPHAGES FOR PERSONALIZED CELL IMMUNOTHERAPY$126,1542500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCTHE CHANGING EPIDEMIOLOGY OF CROHNS IN THE WESTERN WORLD$121,0362500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCVISUALIZATION OF COVID-19 VACCINE SEROLOGY IN CD$89,0472500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCINTERLEUKIN-4 ACTIVATED MACROPHAGES FOR PERSONALIZED CELL IMMUNOTHERAPY$137,1532500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCDEVELOP PROTEIN PANEL TO IDENTIFY FIBROSTENOTIC CD PATIENTS$247,6542500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCINTERLEUKIN-4 ACTIVATED MACROPHAGES FOR PERSONALIZED CELL IMMUNOTHERAPY$127,0772500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCINTERLEUKIN-4 ACTIVATED MACROPHAGES FOR PERSONALIZED CELL IMMUNOTHERAPY$137,4172500 UNIVERSITY DRIVE NWCALGARYCA
THE GOVERNORS OF THE UNIVERSITY OF CALGARY
N/APCINTERLEUKIN-4 ACTIVATED MACROPHAGES FOR PERSONALIZED CELL IMMUNOTHERAPY$119,5542500 UNIVERSITY DRIVE NWCALGARYCA
THE HOSPITAL FOR SICK CHILDREN
N/APCVEOIBD: PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO$548,276555 UNIVERSITY AVETORONTOCA
THE HOSPITAL FOR SICK CHILDREN
N/APCVEOIBD: PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO$555,480555 UNIVERSITY AVETORONTOCA
THE LEGATUM INSTITUTE FOUNDATION
N/ANCPHASE TWO OF THE UNITED STATES PROSPERITY INDEX$50,00011 CHARLES STREETLONDONUK
THE LEGATUM INSTITUTE FOUNDATION
N/ANCPHASE TWO OF THE UNITED STATES PROSPERITY INDEX$50,00011 CHARLES STREETLONDONUK
THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL
N/APCOPP. FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS SEEKING NURSING DEG$220,000YEZREEL VALLEYYEZREEL VALLEYIS
THE MAX STERN ACADEMIC COLLEGE OF EMEK YEZREEL
N/APCOPP. FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS SEEKING NURSING DEG$220,000YEZREEL VALLEYYEZREEL VALLEYIS
THE ONE LOVE FOUNDATION IN HONOR OF YEARDLEY LOVE INC
44 PONDFIELD ROAD SUITE 12BRONXVILLENY10708N/APCBUILDING FOR THE FUTURE: SUPPORT FOR DIGITAL PROGRAMS AND OPERATIONS$1,023,100
THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA
OFFICE OF SPONSORED PROGRAMSCHARLOTTESVILLEVA229044195N/APCTYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS$331,333
THE RECTOR AND VISITORS OF THE UNIVERSITY OF VIRGINIA
OFFICE OF SPONSORED PROGRAMSCHARLOTTESVILLEVA229044195N/APCTYPE 1 DIABETES RISK PREDICTION: INTEGRATION OF PHYSIOLOGY WITH GENETICS$202,177
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE
120 THEORY SUITE 200IRVINECA926971050N/APCDEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D$851,633
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE
120 THEORY SUITE 200IRVINECA926971050N/APCDEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D$837,543
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA AT IRVINE
120 THEORY SUITE 200IRVINECA926971050N/APCDEVELOPMENT OF A MULTI-ANALYTE SENSOR FOR PEOPLE WITH T1D$837,542
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCFEASIBILITY EVAL OF AID IN PRIMARY CARE AND THROUGH TELEHEALTH$705,874
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCCGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION$580,677
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCDEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR$155,376
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCASK THE EXPERTS$543,207
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCSINGLE PERSISTENT ISLET AUTOANTIBODY PHENOTYPE: CUSTOMIZED RISK ANALYSIS$264,341
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCFAILED GENETIC PROTECTION: T1D IN THE PRESENCE OF DQB1*06:02$266,200
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCCGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION$1,111,050
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCCOMPLEMENT SYSTEM IN INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY$223,818
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCEXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D$202,073
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCSEEDS PATHWAY: EMPOWERMENT FOR DIABETES TECHNOLOGY EARLY DEVICE SUCCESS$905,046
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCASK THE EXPERTS$575,810
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCFAILED GENETIC PROTECTION: T1D IN THE PRESENCE OF DQB1*06:02$266,200
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCCGM IN PRIMARY CARE - REFER OR LEARN: IMPLEMENTATION AND EVALUATION$1,008,526
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCEXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D$178,454
THE REGENTS OF THE UNIVERSITY OF COLORADO DENVER
BUILDING 500AURORACO80045N/APCSEEDS PATHWAY: EMPOWERMENT FOR DIABETES TECHNOLOGY EARLY DEVICE SUCCESS$694,245
THE REGENTS OF THE UNIVERSITY OF NEW MEXICO
SPONSORED PROJECTS - PREAWARDALBUQUERQUENM871310001N/AGOVTHE ECHO INSTITUTE: REPLICATION OF THE ECHO MODEL$1,188,238
THE SDEROT DEVELOPMENT FOUNDATION
N/APCSDEROT MEDICAL CENTER$1,558,5736 BAR LEV STREETSDEROTIS
THE SDEROT DEVELOPMENT FOUNDATION
N/APCSDEROT RESILIENCE COMPLEX, RESILIENCE CENTER AND PARENTHOOD HOUSE$184,2866 BAR LEV STREETSDEROTIS
THE SDEROT DEVELOPMENT FOUNDATION
N/APCESTABLISHING A WARM HOME COMPLEX FOR CHILDREN AT RISK IN SDEROT$2,421,2226 BAR LEV STREETSDEROTIS
THE SDEROT DEVELOPMENT FOUNDATION
N/APCSDEROT MEDICAL CENTER$614,3796 BAR LEV STREETSDEROTIS
THE SONIA NABETA FOUNDATION INC
PO BOX 2222NEW YORKNY100082222N/APCPROJECT BODA$412,944
THE TEL AVIV JAFFA ACADEMIC COLLEGE
N/APCSCHOLARSHIP SUPPORT FOR ULTRA-ORTHODOX MEN PURSUING NURSING DEGREES$306,724RABENU YERUHAM ST 2 POB 8401TEL AVIV YAFFOIS
THE TEL AVIV JAFFA ACADEMIC COLLEGE
N/APCSCHOLARSHIP SUPPORT FOR ULTRA-ORTHODOX MEN PURSUING NURSING DEGREES$253,818RABENU YERUHAM ST 2 POB 8401TEL AVIV YAFFOIS
THE UNITED NATIONS INSTITUTE FOR TRAINING AND RESEARCH
N/APCACCELERATING ACCESS: TREATMENT FOR NCDS IN LOW /MIDDLE-INCOME COUNTRIES.$1,000,000UNITARGENEVASZ
THE UNIVERSITY OF ADELAIDE
N/APCENVIRONMENTAL DETERMINANTS OF ISLET AUTOIMMUNITY (ENDIA) STUDY$794,339THE UNIVERSITY OF ADELAIDEADELAIDEAS
THE UNIVERSITY OF ADELAIDE
N/APCENDIA EXPANDED SUPPORT$419,418THE UNIVERSITY OF ADELAIDEADELAIDEAS
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUECHICAGOIL60637N/APCA CELL ATLAS OF THE ILEAL COLONIC CROHNS DISEASE$487,806
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUECHICAGOIL60637N/APCIMMUNO PHARMACOGENOMICS TO PREDICT RESPONSE TO BIOLOGICS IN CROHNS$305,353
THE UNIVERSITY OF EDINBURGH
N/APCMITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION$708,833BHF CENTRE FOR CARDIOVASCULAREDINBURGHUKSCIENCES
THE UNIVERSITY OF EDINBURGH
N/APCDISCERN ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN T1D$230,209BHF CENTRE FOR CARDIOVASCULAREDINBURGHUKSCIENCES
THE UNIVERSITY OF EDINBURGH
N/APCGCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHNS DISEASE$444,247BHF CENTRE FOR CARDIOVASCULAREDINBURGHUKSCIENCES
THE UNIVERSITY OF EDINBURGH
N/APCGCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHNS DISEASE$444,246BHF CENTRE FOR CARDIOVASCULAREDINBURGHUKSCIENCES
THE UNIVERSITY OF EDINBURGH
N/APCDISCERN ALPHA CELL DYSFUNCTION AND CORRECTING GLUCAGON SECRETION IN T1D$109,128BHF CENTRE FOR CARDIOVASCULAREDINBURGHUKSCIENCES
THE UNIVERSITY OF EDINBURGH
N/APCGCA - HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHNS DISEASE$553,832BHF CENTRE FOR CARDIOVASCULAREDINBURGHUKSCIENCES
THE UNIVERSITY OF OXFORD
N/APCPHARMACOLOGICAL MODULATION TO ADDRESS GLUCAGON SECRETION IN T1D$546,306UNIVERSITY OFFICES WELLINGTONOXFORDUKSQUARE
THE UNIVERSITY OF OXFORD
N/APCTHE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE$244,860UNIVERSITY OFFICES WELLINGTONOXFORDUKSQUARE
THE UNIVERSITY OF OXFORD
N/APCTHE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE$244,860UNIVERSITY OFFICES WELLINGTONOXFORDUKSQUARE
THE UNIVERSITY OF QUEENSLAND
N/APCLIPOSOMAL ANTIGEN-SPECIFIC IMMUNOTHERAPY OF RECENT-ONSET T1D$435,713CUMBRAE STEWART BUILDING 72BRISBANEAS
THE UNIVERSITY OF WESTERN AUSTRALIA
N/APCCGM ASSESSMENTS OF ENDIA CHILDREN$166,92335 STIRLING HIGHWAYCRAWLEYAS
THE WEIZMANN INSTITUTE OF SCIENCE
N/APCPERSONALIZED NUTRITIONAL, MICROBIOME AND HOST PATTERNS IN CROHNS$1,720,206234 HERZEL STREHOVOTIS
THE WEIZMANN INSTITUTE OF SCIENCE
N/APCTHE QUANTUM MATERIALS DEVICES FABRICATION LAB$660,000234 HERZEL STREHOVOTIS
THE WEIZMANN INSTITUTE OF SCIENCE
N/APCTHE QUANTUM MATERIALS DEVICES FABRICATION LAB$1,750,000234 HERZEL STREHOVOTIS
TOWNSEND HEALTH SYSTEMS INC
110 NORTH OAKTOWNSENDMT59644N/APCTELE-PHARMACY AT BILLINGS CLINIC BROADWATER$35,128
TOWNSEND HEALTH SYSTEMS INC
110 NORTH OAKTOWNSENDMT59644N/APCTELE-PHARMACY AT BILLINGS CLINIC BROADWATER$15,112
TRUSTEES OF INDIANA UNIVERSITY
509 E 3RD STBLOOMINGTONMI474013654N/AGOVMOLECULAR DESIGN AND TESTING OF GLUCOSE-RESPONSIVE THERAPIES$696,962
TRUSTEES OF INDIANA UNIVERSITY
509 E 3RD STBLOOMINGTONMI474013654N/AGOVCOLLABORATIVE EFFORT TO VALIDATE MICRORNAS AS BIOMARKERS OF T1D$426,380
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
OFFICE OF RESEARCH SERVICESPHILADELPHIAPA191046205N/APCULTRA PROCESSED DIET, GUT MICROBIOME, AND XENOBIOTIC EXPOSURE IN CD$285,463
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
OFFICE OF RESEARCH SERVICESPHILADELPHIAPA191046205N/APCULTRA PROCESSED DIET, GUT MICROBIOME, AND XENOBIOTIC EXPOSURE IN CD$285,463
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
OFFICE OF RESEARCH SERVICESPHILADELPHIAPA191046205N/APCULTRA PROCESSED DIET, GUT MICROBIOME, AND XENOBIOTIC EXPOSURE IN CD$285,079
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
OFFICE OF RESEARCH SERVICESPHILADELPHIAPA191046205N/APCULTRA PROCESSED DIET, GUT MICROBIOME, AND XENOBIOTIC EXPOSURE IN CD$293,370
UNITED NATIONS DEVELOPMENT PROGRAMME
1 UNITED NATIONS PLAZANEW YORKNY10017N/APCUNITED NATIONS MULTILATERAL AGENCY$377,955
UNITED NATIONS DEVELOPMENT PROGRAMME
1 UNITED NATIONS PLAZANEW YORKNY10017N/APCUNITED NATIONS MULTILATERAL AGENCY$339,777
UNITED STATES AFRICAN DEVELOPMENT FOUNDATION
1400 I STREET NWWASHINGTONDC20005N/AGOVLIVELIHOOD IMPROVEMENT PROGRAM$1,779,762
UNITED STATES AFRICAN DEVELOPMENT FOUNDATION
1400 I STREET NWWASHINGTONDC20005N/AGOVLIVELIHOOD IMPROVEMENT PROGRAM$1,283,255
UNITED STATES FUND FOR UNICEF
125 MAIDEN LANENEW YORKNY10038N/APCACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS$784,421
UNITED STATES FUND FOR UNICEF
125 MAIDEN LANENEW YORKNY10038N/APCACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS$869,232
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
N/AGOVEPITHELIAL BASED DIAGNOSTICS FOR TARGETED THERAPIES OF VEOIBD$173,250HEIDELBERGLAAN 100UTRECHTNL
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
N/AGOVEPITHELIAL BASED DIAGNOSTICS FOR TARGETED THERAPIES OF VEOIBD$173,250HEIDELBERGLAAN 100UTRECHTNL
UNIVERSITE CATHOLIQUE DE LOUVAIN
N/APCSTUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN WITH T1D$147,087PLACE DE LUNIVERSITE 1LOUVAINLANEUVEBE
UNIVERSITE CATHOLIQUE DE LOUVAIN
N/APCSTUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN WITH T1D$62,567PLACE DE LUNIVERSITE 1LOUVAINLANEUVEBE
UNIVERSITE LIBRE DE BRUXELLES
N/AGOVDEVELOP TOOLS FOR QUANTIFICATION OF HUMAN BETA CELL MASS.$213,582AVENUE FRANKLIN ROOSEVELT 50BRUSSELSBE
UNIVERSITE LIBRE DE BRUXELLES
N/AGOVDEVELOP TOOLS FOR QUANTIFICATION OF HUMAN BETA CELL MASS.$213,602AVENUE FRANKLIN ROOSEVELT 50BRUSSELSBE
UNIVERSITE LIBRE DE BRUXELLES
N/AGOVDEVELOP TOOLS FOR QUANTIFICATION OF HUMAN BETA CELL MASS.$295,566AVENUE FRANKLIN ROOSEVELT 50BRUSSELSBE
UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C
1001 MAIN STREETBUFFALONY14203N/APCTELEHEALTH REIMBURSEMENT STUDY FOR UNDERSERVED T1D PEDIATRIC POPULATIONS$576,839
UNIVERSITY AT BUFFALO PEDIATRIC ASSOCIATES P C
1001 MAIN STREETBUFFALONY14203N/APCTELEHEALTH REIMBURSEMENT STUDY FOR UNDERSERVED T1D PEDIATRIC POPULATIONS$233,094
UNIVERSITY OF BIRMINGHAM
N/APCDEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR T1D.$322,720INSTITUTE OF IMMUNOLOGYBIRMINGHAMUK
UNIVERSITY OF CALIFORNIA LOS ANGELES
UCLA OFFICE OF CONTRACTS AND GRANTSLOS ANGELESCA900951406N/APCGLUCOSE RESPONSIVE GLUCAGON TO REDUCE HYPOGLYCEMIA IN PEOPLE WITH T1D$568,851
UNIVERSITY OF CALIFORNIA LOS ANGELES
UCLA OFFICE OF CONTRACTS AND GRANTSLOS ANGELESCA900951406N/APCGLUCOSE RESPONSIVE GLUCAGON TO REDUCE HYPOGLYCEMIA IN PEOPLE WITH T1D$568,027
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143N/APCENGINEERING ISLET ANTIGEN-SPECIFIC TREGS FOR T1D$537,711
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
490 ILLINOIS STREET FOURTH FLOORSAN FRANCISCOCA94143N/APCID ANALYSIS OF EXTREME FORMS OF T1D, ESTABLISHMENT OF PATIENT REGISTRY$433,333
UNIVERSITY OF CAMBRIDGE
N/APCCLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D PART 2$496,568THE OLD SCHOOLSCAMBRIDGEUK
UNIVERSITY OF CAMBRIDGE
N/APCCLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D PART 2$500,000THE OLD SCHOOLSCAMBRIDGEUK
UNIVERSITY OF CAMBRIDGE
N/APCCLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH T1D PART 2$353,223THE OLD SCHOOLSCAMBRIDGEUK
UNIVERSITY OF DUNDEE
N/APCHYPO-RESOLVE - UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA$133,804NETHERGATEDUNDEEUK
UNIVERSITY OF EXETER
N/APCSTIMULATED GLUCAGON LEVELS BIOMARKER OF HYPOGLYCEMIA RISK IN T1D$323,139NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF EXETER
N/APCSTIMULATED GLUCAGON LEVELS BIOMARKER OF HYPOGLYCEMIA RISK IN T1D$268,565NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF EXETER
N/APCUNDERSTANDING EXTREMELY EARLY-ONSET TYPE 1 DIABETES$566,086NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF EXETER
N/APCUNDERSTANDING EXTREMELY EARLY-ONSET TYPE 1 DIABETES$451,469NORTHCOTE HOUSE THE QUEENS DRIVEEXETERUK
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVHUMAN ATLAS NEONATAL DEVELOPMENTAL EARLY LIFE PANCREAS/IMMUNITY CON'T$1,043,638
UNIVERSITY OF FLORIDA
219 GRINTER HALLGAINESVILLEFL326115500N/AGOVCOLLABORATIVE T1D RESEARCH: NETWORK FOR PANCREATIC ORGAN DONORS WITH T1D$1,199,692
UNIVERSITY OF IOWA
DIVISION OF SPONSORED PROGRAMSIOWA CITYIA52442N/AGOVSIMULATION IN MOTION IOWA (SIM-IA)$999,877
UNIVERSITY OF IOWA
DIVISION OF SPONSORED PROGRAMSIOWA CITYIA52442N/AGOVSIMULATION IN MOTION IOWA (SIM-IA)$748,244
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655N/AGOVDAIN: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS$311,133
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655N/AGOVDAIN: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS$311,131
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655N/AGOVDAIN: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS$286,613
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655N/AGOVDAIN: A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS$286,614
UNIVERSITY OF MELBOURNE
N/APCANIMAL AND CLINICAL EVALUATION OF A NOVEL CONTINUOUS KETONE SENSOR$703,827LEVEL 4 ALAN GILBERT BUILDINGVICTORIAAS
UNIVERSITY OF MIAMI
1320 SOUTH DIXIE HIGHWAY SUITE 650CORAL GABLESFL33146N/APCTHE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE$326,055
UNIVERSITY OF MIAMI
1320 SOUTH DIXIE HIGHWAY SUITE 650CORAL GABLESFL33146N/APCTHE GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE$328,238
UNIVERSITY OF NEBRASKA FOUNDATION
1010 LINCOLN MALLLINCOLNNE68501N/APCMOBILE RURAL HEALTHCARE PROVIDER TRAINING$582,072
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/APCMONITORING COVID-19 VACCINE EFFECTIVENESS IN IBD PATIENTS$966,8651350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/APCIDENTIFYING MOLECULAR PROFILES PREDICTIVE OF POST-OPERATIVE CD OUTCOMES$585,7501350
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
104 AIRPORT DRIVE SUITE 2200 CBCHAPEL HILLNC275991350N/APCIDENTIFYING MOLECULAR PROFILES PREDICTIVE OF POST-OPERATIVE CD OUTCOMES$581,6251350
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEIN465565708N/APCDEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM$593,043
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEIN465565708N/APCGLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES$503,082
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEIN465565708N/APCDEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM$652,642
UNIVERSITY OF NOTRE DAME DU LAC
940 GRACE HALLNOTRE DAMEIN465565708N/APCGLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES$542,672
UNIVERSITY OF OULU
N/APCMATERNAL AND PATERNAL T1D - MECHANISMS FOR RECURRENCE RISK IN OFFSPRING$284,289PO BOX 8000OULUFI
UNIVERSITY OF OULU
N/APCMATERNAL AND PATERNAL T1D - MECHANISMS FOR RECURRENCE RISK IN OFFSPRING$263,104PO BOX 8000OULUFI
UNIVERSITY OF PITTSBURGH
3420 FORBES AVENUEPITTSBURGHPA15260N/APCRANDOMIZED CONTROLLED TRIAL: ANALOGUE VS HUMAN INSULIN$1,338,570
UNIVERSITY OF PITTSBURGH
3420 FORBES AVENUEPITTSBURGHPA15260N/APCRANDOMIZED CONTROLLED TRIAL: ANALOGUE VS HUMAN INSULIN$998,931
UNIVERSITY OF TOLEDO
3000 ARLINGTON AVENUETOLEDOOH436142595N/AGOVTYPE 1 DIABETES CAR TREG THERAPEUTIC APPROACH$110,480
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLESALT LAKE CITYUT84112N/APCANTI-PHAGE ANTIBODIES: CROHNS DISEASE DIAGNOSIS AND TREATMENT RESPONSE$203,988
UNIVERSITY OF ZURICH
N/AGOVGENERATE BISPECIFIC INTERLEUKIN-2 IMMUNOTHERAPY TO TREAT T1D MELLITUS$126,830DEPARTMENT OF IMMUNOLOGY UNIVERSITYZURICHSZOF ZURICH AND UNIVERSITY HOSPITAL Z
UPPSALA UNIVERSITET
N/AGOVALPHA-CELL SIGNALING FOR GLUCAGON SECRETION$305,920BOX 256UPPSALASW
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCCOMBINATORIAL SINGLE CELL STRATEGIES FOR CROHNS DISEASE GUT CELL ATLAS$656,092
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GCA$244,200
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCCOMBINATORIAL SINGLE CELL STRATEGIES FOR CROHNS DISEASE GUT CELL ATLAS$146,933
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCIDENTIFY SMALL MOLECULES ENHANCING GLUCAGON SECRETION UNDER HYPOGLYCEMIA$330,000
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES$200,000
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GCA$244,200
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCUSE OF MRI OF THE PANCREAS IN T1D$373,041
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCPANCREATLAS DATABASE EXPANSION.$659,685
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GCA$248,256
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES$200,000
VANDERBILT UNIVERSITY MEDICAL CENTER
OFFICE OF SPONSORED PROGRAMSNASHVILLETN37203N/APCADMINISTRATIVE CORE AND COLLABORATIVE DATA REPOSITORY FOR THE GCA$248,256
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU FEASIBILITY PILOT$146,667
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU FEASIBILITY PILOT$591,068
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU FEASIBILITY PILOT$146,667
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU FEASIBILITY PILOT$700,486
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU FEASIBILITY PILOT$146,666
VAYU HEALTH
19 ALISO WAYPORTOLA VALLEYCA94028N/APCVAYU FEASIBILITY PILOT$233,495
VETERANS MEMORIAL HOSPITAL
40 1ST STREET SEWAUKONIA52172N/AGOVECARE PHARMACY AND EMERGENCY SERVICES AT VETERANS MEMORIAL HOSPITAL$74,191
VETERANS MEMORIAL HOSPITAL
40 1ST STREET SEWAUKONIA52172N/AGOVECARE PHARMACY AND EMERGENCY SERVICES AT VETERANS MEMORIAL HOSPITAL$30,504
VILLAGES OF HOPE AFRICA SOCIETY
N/APCZAMBIA DEVELOPMENT: FOOD PRODUCTION, WATER SUPPLY, EDUCATION FACILITIES$502,0102450 MILLTOWER COURTMISSISSAUGACA
VIVLI INC
14 STORY STREET SUITE 406CAMBRIDGEMA02138N/APCPUBLICLY SHARING THE DATA FROM EXERCISE AND T1D STUDIES$72,174
VIVLI INC
14 STORY STREET SUITE 406CAMBRIDGEMA02138N/APCPUBLICLY SHARING THE DATA FROM EXERCISE AND T1D STUDIES$72,174
WASHINGTON UNIVERSITY
660 S EUCLID AVEST LOUISMO63110N/APCVACCINE SAFETY AND EFFICACY$656,480
WASHOE BARTON MEDICAL CLINIC
1107 US HIGHWAY 395 NGARDNERVILLENV89410N/APCRADIOLOGY AND INTERVENTIONAL EQUIPMENT WITH CONSTRUCTION RELATED COSTS.$1,465,248
WATER4 INC
2405 NW 10TH STREETOKLAHOMA CITYOK73107N/APCSCALING THE NUMA MODEL TO DELIVER SAFE, SUSTAINABLE WATER$1,439,503
WATER4 INC
2405 NW 10TH STREETOKLAHOMA CITYOK73107N/APCSCALING THE NUMA MODEL TO DELIVER SAFE, SUSTAINABLE WATER$1,673,164
WATERAID AMERICA INC
233 BROADWAYNEW YORKNY10279N/APCCREATING A NEW REALITY FOR WASH IN HEALTHCARE FACILITIES IN ZAMBIA$2,166,773
WYOMING DEPARTMENT OF HEALTH
6101 YELLOWSTONE RD SUITE 400CHEYENNEWY82009N/AGOVWYOMING FIRST RESPONDER AED PROJECT$183,693
WYOMING STATE PARKS AND CULTURAL RESOURCES
2301 CENTRAL AVENUECHEYENNEWY82002N/AGOVINTERPRETIVE CENTER AT FORT PHIL KEARNY STATE HISTORIC SITE$30,000
YALE UNIVERSITY
OFFICE OF SPONSORED PROJECTSNEW HAVENCT065208327N/APCEXPOSOMICS FOR EARLY LIFE CROHNS DISEASE$443,827
YALE UNIVERSITY
OFFICE OF SPONSORED PROJECTSNEW HAVENCT065208327N/APCEXPOSOMICS FOR EARLY LIFE CROHNS DISEASE$298,606
YEHUDA ABARBANEL GOVERNMENT HOSPITAL
N/AGOVMODERNIZATION OF ABARBANELS INFORMATION TECHNOLOGY AND SECURITY SYSTEMS$454,96015 KEREN KAYEMET STBAT YAMIS
YITZHAK SHAMIR MEDICAL CENTER
N/AGOVEXPANSION AND RENOVATION OF SHAMIR MEDICAL CENTER'S CANCER INSTITUTE$6,082,143BEER YAAKOVTZRIFINIS
YITZHAK SHAMIR MEDICAL CENTER
N/AGOVEXPANSION AND RENOVATION OF SHAMIR MEDICAL CENTER'S CANCER INSTITUTE$1,978,286BEER YAAKOVTZRIFINIS
YOUTH DEVELOPMENT ORGANIZATION INC
15 UNION STREET 563LAWRENCEMA01840N/APCCAPACITY BUILDING PROJECT SUPPORT 2022$200,000
YOUTH DEVELOPMENT ORGANIZATION INC
15 UNION STREET 563LAWRENCEMA01840N/APCCAPACITY BUILDING PROJECT SUPPORT 2022$200,000
FieldValueIRS element (for citing)
Total Grant Or Contri Apprv Fut$462,030,416TotalGrantOrContriApprvFutAmt

Analysis Income Producing Acty AnalysisIncomeProducingActyGrp

Int On Sav And Temp Cash Invst IntOnSavAndTempCashInvstGrp

FieldValueIRS element (for citing)
Exclusion14ExclusionCd
Exclusion$17,175ExclusionAmt

Dividends And Interest From Sec Dtl DividendsAndInterestFromSecDtl

FieldValueIRS element (for citing)
Business901101BusinessCd
Unrelated Business Taxbl Incm$13,523,625UnrelatedBusinessTaxblIncmAmt
Exclusion14ExclusionCd
Exclusion$23,107,617ExclusionAmt

Other Investment Income OtherInvestmentIncomeGrp

FieldValueIRS element (for citing)
Exclusion14ExclusionCd
Exclusion$40,305,895ExclusionAmt

Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp

FieldValueIRS element (for citing)
Business901101BusinessCd
Unrelated Business Taxbl Incm$7,559,982UnrelatedBusinessTaxblIncmAmt
Exclusion18ExclusionCd
Exclusion$754,085,920ExclusionAmt

Other Revenue Described OtherRevenueDescribedGrp (3 entries)

DescDescExclusionExclusionCdExclusionExclusionAmtBusinessBusinessCdUnrelated Business Taxbl IncmUnrelatedBusinessTaxblIncmAmt
GRANT RECOVERIES01$892,513
OTHER TAXABLE INCOME01$414
UBI ORDINARY INCOME THROUGH K-1S - NOT ON BOOKS14-$4,651,930901101$4,651,930

Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp

FieldValueIRS element (for citing)
Unrelated Business Taxbl Incm$25,735,537UnrelatedBusinessTaxblIncmAmt
Exclusion$813,757,604ExclusionAmt
Related Or Exempt Function Incm$0RelatedOrExemptFunctionIncmAmt
FieldValueIRS element (for citing)
Total Income Producing Acty$839,493,141TotalIncomeProducingActyAmt

Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp

FieldValueIRS element (for citing)
Trnsfr Of Cash To Nonchrtbl EOYes (1)TrnsfrOfCashToNonchrtblEOInd
Trnsfr Other Asset Nonchrtbl EO0TrnsfrOtherAssetNonchrtblEOInd
Sales Or Exchanges Of Assets0SalesOrExchangesOfAssetsInd
Purchase Of Assets Nonchrtbl EO0PurchaseOfAssetsNonchrtblEOInd
Rental Of Facilities Oth Assets0RentalOfFacilitiesOthAssetsInd
Reimbursement Arrangements0ReimbursementArrangementsInd
Loans Or Loan Guarantees0LoansOrLoanGuaranteesInd
Performance Of Services Etc0PerformanceOfServicesEtcInd
Sharing Of Facilities Etc0SharingOfFacilitiesEtcInd

Transfer Schedule Detail TransferScheduleDetail (2 entries)

Line NumberLineNumberTxtInvolvedInvolvedAmtTransfers Trans And Shr ArrngmTransfersTransAndShrArrngmDesc
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
1a(1)$616,544GRANT IN SUPPORT OF AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS
INSTITUTIONAL LIMITED PARTNER ASSOCIATION
1a(1)$4,000MEMBERSHIP FEE
FieldValueIRS element (for citing)
Relationships Nonchrtbl EO0RelationshipsNonchrtblEOInd

Accounting Fees Schedule AccountingFeesSchedule

Accounting Fees Detail AccountingFeesDetail (4 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
DEMASCO, SENA & JAHELKA LLP (BOOKKEEPING)$30,862$4,721$24,654
PKF O'CONNOR DAVIES, LLP (AUDIT & TAX)$494,690$283,800$168,025
PRICEWATERHOUSECOOPERS ADVISORY LTD. (GRANTS ADMINISTRATION)$92,823$0$87,761
UKG INC. (DBA ULTIMATE SOFTWARE GROUP)$99$0$99

All Oth Prog Rltd Investments Sch AllOthProgRltdInvestmentsSch

All Other Program Related Invst AllOtherProgramRelatedInvstGrp

FieldValueIRS element (for citing)
DescBIORASIS, INC. - EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARDDesc
Amt$410,000Amt

Expenditure Responsibility Stmt ExpenditureResponsibilityStmt

Expenditure Responsibility ExpenditureResponsibilityGrp (27 entries)

Address Line1USAddress/AddressLine1TxtAddress Line2USAddress/AddressLine2TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdGrantGrantDtGrantGrantAmtPurpose Of GrantPurposeOfGrantTxtExpended By GranteeExpendedByGranteeAmtAny Diversion By GranteeAnyDiversionByGranteeTxtDates Of Reports By GranteeDatesOfReportsByGranteeTxtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmProvince Or StateForeignAddress/ProvinceOrStateNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCd
A GLIMMER OF HOPE FOUNDATION
3600 N CAPITAL OF TEXAS HWY BLDG BSUITE 330AUSTINTX787462019-09-09$7,923,870INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA$4,400,291NONE1/2020, 7/2020, 1/2021, 3/2021, 7/2021, 1/2022, 7/2022
A GLIMMER OF HOPE FOUNDATION
3600 N CAPITAL OF TEXAS HWY BLDG BSUITE 330AUSTINTX787462018-02-20$5,000,000INTEGRATED COMMUNITY DEVELOPMENT IN AMHARA, ETHIOPIA$5,000,000NONE1/2019, 1/2020, 2/2021, 1/2022
AKSTON BIOSCIENCES CORPORATION
100 CUMMINGS CENTER SUITE 454CBEVERLYMA019152017-03-01$6,194,000PRECLINICAL TRIAL OF INSULIN-FUSION TO END AUTOIMMUNITY & IMPROVE T1D$5,586,294NONE10/2018, 1/2019, 4/2019, 8/2019, 10/2019, 3/2020, 10/2020, 2/2021, 6/2022
ALIMENTIV INC (FKA ROBARTS)
2022-02-10$894,043DEVELOP AN INTESTINAL MUCOSAL AND IMAGING BIOMARKER FOR STRICTURING CD$0NONEPENDING100 DUNDAS STREETLONDONONCAN6A5B6
ALIMENTIV INC (FKA ROBARTS)
2018-11-20$3,390,428STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM$1,983,840NONEPRIOR + 12/2019, 1/2020, 6/2020, 12/2020, 1/2021, 6/2021, 12/2021, 6/2022100 DUNDAS STREETLONDONONCAN6A5B6
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 S WACKER DRIVE SUITE 600CHICAGOIL606062021-11-20$2,500,000EXPANSION OF THE DANATECH PLATFORM$195,070NONE1/2022, 5/2022
ASSOCIATION OF DIABETES CARE & EDUCATION SPECIALISTS
125 S WACKER DRIVE SUITE 600CHICAGOIL606062018-07-11$2,679,637AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS$2,639,117NONE2/2019, 8/2019, 1/2020, 8/2020, 1/2021, 6/2021, 1/2022
ASITY MADAGASCAR
2017-03-01$284,790IMPLEMENT SUSTAINABLE MANAGEMENT STRATEGIES FOR WETLAND CONSERVATION$284,790NONE2/2018, 2/2019, 5/2020, 9/2021LOT IAB 39 TER C ANALAMHINTSYANTANANARIVOMA101
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD
2020-07-23$2,309,216FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY$742,482NONE2/2021, 8/2021, 2/2022, 7/2022, 8/2022LEVEL 2 55 VICTORIA PARADEFITZROYAS3065
AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD
2017-02-15$3,719,569THE ENIGMA STUDIES - EASTERN INFLAMMATORY BOWEL DISEASE GUT MICROBIOTA$3,719,569NONEPRIOR + 11/2019, 1/2020, 4/2020, 10/2020, 11/2020, 3/2021, 9/2021, 3/2022LEVEL 2 55 VICTORIA PARADEFITZROYAS3065
BIORASIS INC
1392 STORRS RD U4213 ATL ROOM 106STORRSCT062692018-02-06$3,016,000EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD IN CARE FOR T1D$1,648,500NONEPRIOR + 9/2019, 2/2020, 5/2020, 8/2020, 11/2020, 2/2021, 7/2021, 5/2022
BLUE CIRCLE HEALTH INC
THE CORPORATION TRUST CENTER 1209ORANGE STREETWILMINGTONDE198012021-12-21$45,430,130CREATION OF BLUE CIRCLE HEALTH FOR UNDERSERVED COMMUNITIES WITH T1D$15,476,957NONE2/2022, 7/2022
CAPILLARY BIOMEDICAL INC
2 WRIGLEYIRVINECA926172020-09-02$1,500,000ADVANCED EXTENDED INFUSION SET TO IMPROVE CARE IN T1D$1,428,325NONE10/2020, 3/2021, 4/2021, 10/2021, 1/2022, 5/2022, 6/2022
DIABETOMICS INC
2345 NE OVERLOOK DRIVE SUITE 140HILLSBOROOR970062018-01-11$4,031,900POINT-OF-CARE RAPID TESTS FOR TID SCREENING AND INTERVENTION$3,031,900NONEPRIOR +1/2020, 5/2020, 10/2020, 4/2021, 10/2021, 12/2021, 2/2022, 4/2022
DREAMED DIABETES LTD
2016-02-01$3,585,828MD-LOGIC PUMP GUIDE4U - ADVISORY SYSTEM TO IMPROVE CARE OF T1D$3,546,253NONE10/2016, 1/2017, 7/2017, 9/2017, 2/2018, 6/2018, 9/2018, 12/20195 MOTA GUR STPETAH TIKVAIS4952701
FEROX THERAPEUTICS
111 TOWN SQUARE PLACE SUITE 1203PMB 1034JERSEY CITYNJ073102018-11-20$872,300INSULIN INDUCED HYPOGLYCEMIA PREVENTION PROGRAM$872,300NONE7/2019, 10/2019, 1/2020, 4/2020, 7/2020, 12/2020, 1/2021, 4/2021, 7/2021
GRAND CANYON UNIVERSITY
3300 WEST CAMELBACK ROADPHOENIXAZ850172019-06-26$2,274,027DEVELOPMENT OF A CONTINUOUS INSULIN-GLUCOSE SENSOR$1,410,426NONE6/2020, 7/2020, 7/2021, 4/2022
INTERNATIONAL BOWEL ULTRASOUND GROUP EV
2020-10-21$172,967POINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES$0NONEPENDINGHARKORTSTR 1MUNSTERGM
JDRF INTERNATIONAL
200 VESEY STREET 28TH FLOORNEW YORKNY102812012-05-21$8,200,000ORTHOGONALLY REDUNDANT GLUCOSE SENSOR TO IMPROVE CARE OF T1D$8,200,000NONE7/2015, 5/2016, 7/2016, 6/2017, 6/2019, 11/2019, 5/2020, 8/2020
NURU INTERNATIONAL
2020 PENNSYLVANIA AVE NWWASHINGTONDC200062013-11-25$4,680,506CREATING A SELF-SUSTAINING, SCALING, AGRICULTURE-BASED DEVELOPMENT MODEL$4,680,506NONEPRIOR + 12/2015, 1/2017, 2/2018, 1/2019, 1/2020, 6/2020, 1/2022
PACIFIC DIABETES TECHNOLOGIES
12154 SW GARDEN PLACEPORTLANDOR972232014-09-08$2,867,072DUAL USE CATHETER FOR INSULIN DELIVERY & SENSING TO IMPROVE CARE OF T1D$2,867,072NONE1/2015, 5/2015, 12/2015, 2/2016, 7/2016, 2/2017, 12/2017, 6/2018
PERCUSENSE INC
25134 RYE CANYON LOOPVALENCIACA913552020-09-02$2,500,000DEVELOPMENT OF CONTINUOUS GLUCOSE AND KETONE METER FOR TREATMENT IN T1D$641,203NONE7/2021, 8/2021, 5/2022
SOUTH DAKOTA BROADCASTERS ASSOCIATION
106 WEST CAPITOL AVEPIERRESD575012020-12-03$1,110,000COVID-19 PUBLIC AWARENESS AND BEHAVIOR$1,100,000NONE5/2021, 1/2022
THETIS PHARMACEUTICALS LLC
54 DANBURY ROAD SUITE 285RIDGEFIELDNJ068772022-02-24$4,166,030DEVELOPMENT OF A NOVEL RESOLVIN E1 THERAPY FOR TREATMENT OF CROHNS DISEASE$117,079NONE5/2022, 8/2022
THE LEGATUM INSTITUTE FOUNDATION
2021-09-21$150,000PHASE TWO OF US PROSPERITY INDEX: EXPANDING COUNTY-LEVEL INDEX TO INCLUDE WYOMING AND DEEPENING IMPACT$4,050NONE1/202211 CHARLES STREETLONDONUKW1J 5DW
THE LEGATUM INSTITUTE FOUNDATION
2017-12-04$1,013,551UNITED STATES PROSPERITY INDEX$1,013,551NONEPRIOR +7/2019, 8/2019, 1/2020, 7/2020, 12/2020, 1/2021, 11/2021, 1/202211 CHARLES STREETLONDONUKW1J 5DW
ZUCARA THERAPEUTICS
2018-02-06$3,900,000PRECLINICAL DEVELOPMENT OF ZT-01 TO PREVENT HYPOGLYCEMIA IN T1D$3,900,000NONEPRIOR + 7/2020, 2/2021, 4/2021, 7/2021, 10/2021, 2/2022, 4/2022, 7/20221300-661 UNIVERSITY AVENUETORONTOONCAM5G 0B7

General Explanation Attachment GeneralExplanationAttachment

General Explanation GeneralExplanationGrp (3 entries)

IdentifierIdentifierTxtForm And Line ReferenceFormAndLineReferenceDescMedium ExplanationMediumExplanationTxt
CONTROLLED ENTITIESFORM 990-PF, PART VI-A, LINE 11:THE FOLLOWING CONTROLLED ENTITIES ARE NOT EXCESS BUSINESS HOLDINGS:ACADIAN FRONTIER MARKETS EQUITY FUND260 FRANKLIN STREETBOSTON, MA 02110EIN# 20-5852756CHATHAM CO-INVEST26 MAIN STREET, SUITE 204CHATHAM, NJ 07928EIN# 85-0651355ESTATE OF LEONA M. HELMSLEY230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 20-7535047HELMSLEY ENTERPRISES, INC.230 PARK AVENUE, SUITE 659NEW YORK, NY 10169EIN# 13-2665914LACM GLOBAL EQUITY FUND, LP11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025EIN# 45-3646231 LACM WORLD SMALL CAP EQUITY FUND, L.P.11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025EIN# 83-2888004MARATHON-LONDON GLOBAL SELECTORION HOUSE, 5 UPPER ST. MARTIN'S LANELONDON, UK WC2H 9EAEIN# 61-1915057MHR LONGEVITY PARTNERS1345 AVENUE OF THE AMERICAS 42ND FLOORNEW YORK, NY 10105EIN# 98-1471155NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER, L.P.2929 ARCH STREET 17TH FLOORPHILADELPHIA, PA 19104EIN# 98-1142649PITANGO SPVBEIT ACKERSHTEIN - BLDG. B, 11 HAMENOFIM ST. 11TH FL.HERZLIYA, ISRAELEIN# 98-1492234
FORM 990-PF, PART VII, LINE 1:STEPHANIE A. CUSKLEY WAS CHIEF EXECUTIVE OFFICER FROM 4/1/21-10/31/21.SARAH E. PAUL WAS GENERAL COUNSEL 4/1/21-10/31/21 AND FROM 11/1/21-3/31/22 CEO AND GENERAL COUNSEL.
FORM 990-PF, PART VII, LINE 1 AND 2, COLUMN (C), COMPENSATION:ALL REPORTED COMPENSATION AMOUNTS INCLUDE "SALARY, FEES, BONUSES AND SEVERANCE PAYMENTS RECEIVED BY EACH PERSON LISTED," AS WELL AS CURRENT YEAR PAYMENTS OF AMOUNTS REPORTED OR REPORTABLE AS DEFERRED COMPENSATION IN CURRENT OR PRIOR YEARS.

Investments Corp Stock Schedule InvestmentsCorpStockSchedule

Investments Corporate Stock InvestmentsCorporateStockGrp (134 entries)

StockStockNmEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
ALPHABET INC, 2,862 SHRS$7,993,537$7,993,537
AMAZON.COM INC, 1,739 SHRS$5,669,053$5,669,053
AMERICAN TOWER CORP, 15,113 SHRS$3,796,688$3,796,688
ANSYS INC, 16,010 SHRS$5,085,577$5,085,577
BIO-TECHNE CORP, 12,546 SHRS$5,432,920$5,432,920
BLACKLINE INC, 33,880 SHRS$2,480,694$2,480,694
AZENTA INC, 10,673 SHRS$884,578$884,578
CBRE GROUP INC, 55,720 SHRS$5,099,494$5,099,494
CABLE ONE INC, 2,855 SHRS$4,180,405$4,180,405
CARMAX INC, 33,809 SHRS$3,261,892$3,261,892
COSTAR GROUP INC, 42,938 SHRS$2,860,100$2,860,100
CROWDSTRIKE HOLDINGS INC, 9,928 SHRS$2,254,450$2,254,450
DANAHER CORP, 22,680 SHRS$6,652,724$6,652,724
DOLLAR GENERAL CORP, 16,258 SHRS$3,619,519$3,619,519
ECOLAB INC, 20,601 SHRS$3,637,313$3,637,313
FASTENAL CO, 59,691 SHRS$3,545,645$3,545,645
GUIDEWIRE SOFTWARE INC, 23,015 SHRS$2,177,679$2,177,679
HEICO CORP, 45,587 SHRS$5,781,799$5,781,799
IDEXX LABORATORIES INC, 4,096 SHRS$2,240,758$2,240,758
ILLUMINA INC, 16,733 SHRS$5,846,510$5,846,510
INTUITIVE SURGICAL INC, 21,969 SHRS$6,627,608$6,627,608
MARKEL CORP, 3,399 SHRS$5,014,341$5,014,341
MASTERCARD INC, 19,236 SHRS$6,874,562$6,874,562
MOODY'S CORP, 6,951 SHRS$2,345,337$2,345,337
OKTA INC, 7,695 SHRS$1,161,637$1,161,637
QUALCOMM INC, 32,515 SHRS$4,968,942$4,968,942
S&P GLOBAL INC, 14,521 SHRS$5,956,224$5,956,224
SBA COMMUNICATIONS CORP, 9,184 SHRS$3,160,214$3,160,214
SHOPIFY INC, 1,604 SHRS$1,084,240$1,084,240
SPROUT SOCIAL INC, 8,650 SHRS$693,038$693,038
TELEFLEX INC, 11,542 SHRS$4,095,448$4,095,448
THERMO FISHER SCIENTIFIC INC, 11,560 SHRS$6,827,914$6,827,914
TRANSDIGM GROUP INC, 8,842 SHRS$5,760,917$5,760,917
TWILIO INC, 6,204 SHRS$1,022,481$1,022,481
VEEVA SYSTEMS INC, 12,632 SHRS$2,683,795$2,683,795
VERISK ANALYTICS INC, 18,395 SHRS$3,948,119$3,948,119
VISA INC, 39,464 SHRS$8,751,931$8,751,931
VULCAN MATERIALS CO, 20,911 SHRS$3,841,351$3,841,351
WASTE CONNECTIONS INC, 39,215 SHRS$5,478,336$5,478,336
WILLSCOT MOBILE MINI HOLDINGS, 43,251 SHRS$1,692,412$1,692,412
WORKIVA INC, 11,503 SHRS$1,357,354$1,357,354
ATLASSIAN CORP PLC, 3,724 SHRS$1,094,223$1,094,223
ALPHABET INC, 2,653 SHRS$7,378,922$7,378,922
AVERY DENNISON CORP, 5,781 SHRS$1,005,721$1,005,721
BERKSHIRE HATHAWAY INC, 30,799 SHRS$10,869,275$10,869,275
BOOKING HOLDINGS INC, 2,792 SHRS$6,556,872$6,556,872
CDW CORP/DE, 8,780 SHRS$1,570,654$1,570,654
CARLISLE COS INC, 12,678 SHRS$3,117,774$3,117,774
CARMAX INC, 33,476 SHRS$3,229,764$3,229,764
COMCAST CORP, 116,977 SHRS$5,476,863$5,476,863
DOLLAR GENERAL CORP, 37,840 SHRS$8,424,319$8,424,319
DOLLAR TREE INC, 44,089 SHRS$7,060,853$7,060,853
DOVER CORP, 27,994 SHRS$4,392,259$4,392,259
META PLATFORMS INC, 14,120 SHRS$3,139,723$3,139,723
FRESENIUS MEDICAL CARE AG & CO, 129,576 SHRS$4,364,120$4,364,120
JPMORGAN CHASE & CO, 37,415 SHRS$5,100,413$5,100,413
KONINKLIJKE PHILIPS NV, 145,657 SHRS$4,446,908$4,446,908
MASCO CORP, 150,820 SHRS$7,691,820$7,691,820
MICRON TECHNOLOGY INC, 84,147 SHRS$6,554,210$6,554,210
NORTHERN TRUST CORP, 45,944 SHRS$5,350,179$5,350,179
OMNICOM GROUP INC, 62,210 SHRS$5,280,385$5,280,385
PPG INDUSTRIES INC, 31,507 SHRS$4,129,622$4,129,622
PACCAR INC, 63,404 SHRS$5,583,990$5,583,990
PROGRESSIVE CORP/THE, 46,833 SHRS$5,338,494$5,338,494
QUEST DIAGNOSTICS INC, 33,976 SHRS$4,649,955$4,649,955
SAP SE, 31,806 SHRS$3,529,194$3,529,194
SCHLUMBERGER LTD, 100,410 SHRS$4,147,937$4,147,937
CHARLES SCHWAB CORP/THE, 81,139 SHRS$6,840,829$6,840,829
SMITH & NEPHEW PLC, 149,359 SHRS$4,764,552$4,764,552
SONY GROUP CORP, 66,468 SHRS$6,826,928$6,826,928
TJX COS INC/THE, 54,941 SHRS$3,328,326$3,328,326
UNILEVER PLC, 118,915 SHRS$5,418,957$5,418,957
UNITEDHEALTH GROUP INC, 12,444 SHRS$6,346,067$6,346,067
ARCH CAPITAL GROUP LTD, 81,943 SHRS$3,967,680$3,967,680
EATON CORP PLC, 21,836 SHRS$3,313,831$3,313,831
CHUBB LTD, 16,804 SHRS$3,594,376$3,594,376
UNILEVER PLC, 112,629 SHRS$5,131,091$5,131,091
NINTENDO CO LTD, 15,800 SHRS$8,027,897$8,027,897
TGS ASA, 64,852 SHRS$976,043$976,043
GLAXOSMITHKLINE PLC, 349,926 SHRS$7,589,146$7,589,146
RECKITT BENCKISER GROUP PLC, 105,210 SHRS$8,078,763$8,078,763
INFORMA PLC, 650,658 SHRS$5,155,554$5,155,554
NOVARTIS AG, 124,594 SHRS$11,000,557$11,000,557
NESTLE SA, 66,975 SHRS$8,748,052$8,748,052
CIE FINANCIERE RICHEMONT SA, 64,029 SHRS$8,210,184$8,210,184
ALCON INC, 40,429 SHRS$3,237,835$3,237,835
ALPHABET INC, 2,923 SHRS$8,129,886$8,129,886
BOOKING HOLDINGS INC, 2,867 SHRS$6,733,006$6,733,006
BRISTOL-MYERS SQUIBB CO, 175,887 SHRS$12,845,028$12,845,028
CORTEVA INC, 134,177 SHRS$7,712,494$7,712,494
EBAY INC, 136,662 SHRS$7,825,266$7,825,266
ELECTRONIC ARTS INC, 58,456 SHRS$7,395,269$7,395,269
FOX CORP, 243,582 SHRS$9,609,310$9,609,310
INTERCONTINENTAL EXCHANGE INC, 63,295 SHRS$8,362,535$8,362,535
JOHNSON & JOHNSON, 39,431 SHRS$6,988,356$6,988,356
MICROSOFT CORP, 20,632 SHRS$6,361,052$6,361,052
NEWS CORP, 369,723 SHRS$8,189,364$8,189,364
NEWS CORP, 163,588 SHRS$3,684,002$3,684,002
ORACLE CORP, 83,656 SHRS$6,920,861$6,920,861
S&P GLOBAL INC, 14,641 SHRS$6,005,445$6,005,445
SALESFORCE INC, 20,882 SHRS$4,433,666$4,433,666
TRANSUNION, 46,201 SHRS$4,774,411$4,774,411
WESTERN UNION CO/THE, 220,210 SHRS$4,126,735$4,126,735
ZILLOW GROUP INC, 21,460 SHRS$1,035,016$1,035,016
ZILLOW GROUP INC, 120,087 SHRS$5,919,088$5,919,088
AON PLC, 27,075 SHRS$8,816,432$8,816,432
ACCENTURE PLC, 56 SHRS$18,885$18,885
ACCENTURE PLC, 11,632 SHRS$3,922,659$3,922,659
CHINA RENAISSANCE HOLDINGS LTD, 127,556 SHRS$157,768$157,768
MEITUAN, 183,364 SHRS$3,643,210$3,643,210
JW CAYMAN THERAPEUTICS CO LTD, 7,143 SHRS$7,406$7,406
BRII BIOSCIENCES LTD, 80,115 SHRS$113,553$113,553
AFFIRM HOLDINGS INC, 90,830 SHRS$4,203,612$4,203,612
AIRBNB INC, 12,774 SHRS$2,194,062$2,194,062
BERKELEY LIGHTS INC, 2,018 SHRS$14,348$14,348
BILL.COM HOLDINGS INC, 6,110 SHRS$1,385,687$1,385,687
CROWDSTRIKE HOLDINGS INC, 5,806 SHRS$1,318,426$1,318,426
DADA NEXUS LTD, 16,164 SHRS$147,577$147,577
DIGITALOCEAN HOLDINGS INC, 79,471 SHRS$4,597,397$4,597,397
DOORDASH INC, 22,663 SHRS$2,655,877$2,655,877
META PLATFORMS INC, 10,000 SHRS$2,223,600$2,223,600
FUTU HOLDINGS LTD, 5,962 SHRS$194,123$194,123
GUARDANT HEALTH INC, 4,000 SHRS$264,960$264,960
LYFT INC, 17,155 SHRS$658,752$658,752
OSCAR HEALTH INC, 22,936 SHRS$228,672$228,672
PINDUODUO INC, 146,148 SHRS$5,861,996$5,861,996
ROBLOX CORP, 72,000 SHRS$3,329,280$3,329,280
SENTINELONE INC, 23,937 SHRS$927,319$927,319
SNOWFLAKE INC, 11,358 SHRS$2,602,459$2,602,459
SUMO LOGIC INC, 55,907 SHRS$652,435$652,435
TWILIO INC, 10,000 SHRS$1,648,100$1,648,100
UIPATH INC, 133,883 SHRS$2,890,534$2,890,534
UNITY SOFTWARE INC, 30,651 SHRS$3,040,886$3,040,886
ZOOM VIDEO COMMUNICATIONS INC, 11,000 SHRS$1,289,530$1,289,530

Investments Other Schedule2 InvestmentsOtherSchedule2

Investments Other InvestmentsOtherGrp (177 entries)

Category Or ItemCategoryOrItemTxtListed At Cost Or FMVListedAtCostOrFMVCdBook ValueBookValueAmtEOYFMVEOYFMVAmt
JPM US LARGE CAPFMV$125,183,266$125,183,266
SPDR TRUST SERIES IFMV$124,358,622$124,358,622
JPM CORE BONDFMV$1,255,541,161$1,255,541,161
JPM SHORT DURATION BONDFMV$326,609,332$326,609,332
CHATHAMFMV$108,419,200$108,419,200
CHATHAM CO INVESTFMV$70,062,390$70,062,390
CHATHAM OFFSHOREFMV$107,383,116$107,383,116
BRILLIANT PARTNERSFMV$75,250,122$75,250,122
CAMBERFMV$140,373,678$140,373,678
ORBIMED GENESIS FUNDFMV$17,968,765$17,968,765
JERICHOFMV$187,120,249$187,120,249
SEQUOIA CAP GLOBALFMV$218,057,635$218,057,635
ACADIAN FRONTIERFMV$104,404,213$104,404,213
HIGHCLERE INTL SCFMV$151,927,907$151,927,907
HIGHCLERE INTL SMIDFMV$82,124,194$82,124,194
LA CAPITAL GLOBALFMV$111,532,600$111,532,600
LACM WORLD SMALL CAPFMV$110,390,023$110,390,023
MARATHON GLOBALFMV$105,854,074$105,854,074
SILCHESTER INTLFMV$141,761,870$141,761,870
BLACKROCK US DEBTFMV$231,439,336$231,439,336
ACCEL GROWTH FUND IVFMV$30,645,594$30,645,594
ACCEL GROWTH IIFMV$14,875,787$14,875,787
ACCEL GROWTH IIIFMV$19,128,215$19,128,215
ACCEL GROWTH VFMV$38,337,112$38,337,112
ACCEL GROWTH VIFMV$11,625,605$11,625,605
ACCEL INDIA VFMV$15,744,558$15,744,558
ACCEL INDIA VIFMV$8,221,624$8,221,624
ACCEL INDIA VIIFMV$640,000$640,000
ACCEL LEADERS FUNDFMV$12,870,376$12,870,376
ACCEL LEADERS IIFMV$11,190,585$11,190,585
ACCEL LEADERS IIIFMV$25,535,297$25,535,297
ACCEL XIFMV$7,610,255$7,610,255
ACCEL XIIFMV$28,131,818$28,131,818
ACCEL XIIIFMV$19,705,081$19,705,081
ACCEL XIVFMV$11,574,672$11,574,672
ACCEL XVFMV$3,872,286$3,872,286
AH BIO FUND IFMV$9,110,573$9,110,573
AH BIO FUND IIFMV$19,043,732$19,043,732
AH BIO IIIFMV$14,243,936$14,243,936
AH BIO IVFMV$1,046,617$1,046,617
AH CNK IVFMV$2,000,000$2,000,000
AH CNK SEED IFMV$1,250,000$1,250,000
AH FUND VIIFMV$11,938,432$11,938,432
AH FUND VIIIFMV$1,326,986$1,326,986
AH IIIFMV$63,683,169$63,683,169
AH III PARALLELFMV$12,003,088$12,003,088
AH IVFMV$50,068,896$50,068,896
AH IV PARALLELFMV$21,653,467$21,653,467
AH LSV FUND IIFMV$21,569,100$21,569,100
AH LSV FUND IIIFMV$5,641,070$5,641,070
AH LSV IFMV$22,356,136$22,356,136
AH VFMV$55,628,188$55,628,188
AH V PARALLELFMV$31,505,964$31,505,964
AH VIFMV$29,989,545$29,989,545
ANGELENO INV IIIFMV$16,814,435$16,814,435
ARBORETUM IIIFMV$6,292,132$6,292,132
ARBORETUM IVFMV$38,759,884$38,759,884
ARBORETUM VFMV$15,421,213$15,421,213
BAYVIEWFMV$61,702,904$61,702,904
COLLER VIFMV$7,988,854$7,988,854
COLLER VIIFMV$41,152,855$41,152,855
COLLER VIIIFMV$20,280,774$20,280,774
CRESTVIEW ELOFMV$7,213,977$7,213,977
CRESTVIEW IIIFMV$44,406,113$44,406,113
CRESTVIEW IVFMV$21,758,970$21,758,970
EIG ENERGY FUND XVIFMV$50,259,711$50,259,711
EIG ENERGY XVFMV$8,117,949$8,117,949
EIG ENERGY XVIIFMV$11,222,263$11,222,263
EMERGENCE IIIFMV$87,147,420$87,147,420
EMERGENCE IVFMV$49,692,754$49,692,754
EMERGENCE OPP IFMV$5,987,177$5,987,177
EMERGENCE VFMV$35,174,100$35,174,100
EMERGENCE VIFMV$2,347,654$2,347,654
EPIRIS IIFMV$20,029,076$20,029,076
FORTISSIMOFMV$24,365,576$24,365,576
FORTISSIMO VFMV$16,714,172$16,714,172
FRAZIER GTH BUYOUT XFMV$4,187,317$4,187,317
FRAZIER IXFMV$8,040,922$8,040,922
FRAZIER PUBLIC FUNDFMV$10,041,196$10,041,196
FRAZIER SUNMD CO INVFMV$6,000,000$6,000,000
FRAZIER XFMV$9,849,046$9,849,046
GAVEA IVFMV$1,423,455$1,423,455
GAVEA VFMV$8,901,233$8,901,233
GAVEA V PLUSFMV$2,202,473$2,202,473
GENERL ATLANTIC 2013FMV$96,361,826$96,361,826
GENERL ATLANTIC 2018FMV$108,629,521$108,629,521
GSO CAP SOLUTION IIIFMV$3,348,966$3,348,966
GSO CAPITAL SOLS IIFMV$3,475,632$3,475,632
GSO CAPITAL SOLUTIONFMV$417,946$417,946
HARBOUR ENERGYFMV$244,087,504$244,087,504
HIG BAYSIDE IIIFMV$3,904,650$3,904,650
HIG BIOVENTURE IIFMV$18,420,605$18,420,605
HIG BRAZILFMV$3,808,092$3,808,092
HIG BRAZIL LATAM BFMV$20,121,078$20,121,078
HIG BRAZIL LATAM CFMV$20,121,078$20,121,078
HIG CAPITAL VFMV$17,693,596$17,693,596
HIG GROWTH B&E F IIFMV$30,934,699$30,934,699
HIG GROWTH IIIFMV$3,936,960$3,936,960
HIG MID MARKET IIFMV$21,131,884$21,131,884
HIG MID MARKET IIIFMV$5,892,715$5,892,715
IDG BREYERFMV$3,622,962$3,622,962
IDG CHINA CAP IIIFMV$33,453,637$33,453,637
IDG CHINA VTR IVFMV$40,828,775$40,828,775
IDG CHINA VTR VFMV$45,266,218$45,266,218
IDG-ACCEL CHINA CAPFMV$19,941,265$19,941,265
IDG-ACCEL CHINA GWTHFMV$17,001,054$17,001,054
IRON POINT IVFMV$19,326,121$19,326,121
JPM PEG SECONDRY IIIFMV$7,398,507$7,398,507
MHR AXIOMFMV$130,163,165$130,163,165
MHR INST PARTNERS IVFMV$53,702,525$53,702,525
NEWMARKET IIFCFMV$28,151,533$28,151,533
ORBIMED ASIA IIIFMV$46,543,663$46,543,663
ORBIMED ASIA IVFMV$14,622,698$14,622,698
ORBIMED ISRAELFMV$8,495,791$8,495,791
ORBIMED ISRAEL IIFMV$19,994,911$19,994,911
ORBIMED PI VIFMV$13,579,228$13,579,228
ORBIMED PI VIIFMV$25,075,044$25,075,044
ORBIMED PI VIIIFMV$13,269,232$13,269,232
ORBIMED ROYALTY IIFMV$2,700,553$2,700,553
PEP IV COREFMV$24,547$24,547
PEP IV SUPPLFMV$6,620$6,620
PEP VIFMV$10,582,867$10,582,867
PITANGO GROWTHFMV$58,909,417$58,909,417
PITANGO GROWTH IIFMV$16,020,456$16,020,456
PITANGO HEALTHTECH IFMV$8,483,389$8,483,389
PITANGO SPVFMV$22,465,094$22,465,094
PITANGO VI, LPFMV$32,581,826$32,581,826
PITANGO VTR VIIFMV$39,038,518$39,038,518
PITANGO VTR VIIIFMV$9,600,875$9,600,875
RIDGEWOOD IIIFMV$47,262,943$47,262,943
RIDGEWOOD IVFMV$20,839,295$20,839,295
S CAPITALFMV$28,861,155$28,861,155
S CAPITAL IIFMV$8,110,693$8,110,693
SEQUOIA CAPITAL FUNDFMV$14,513,399$14,513,399
SEQUOIA CH GWTH VIFMV$17,764,152$17,764,152
SEQUOIA CH VTR VIIIFMV$4,007,521$4,007,521
SEQUOIA CHINA GR IIIFMV$64,873,538$64,873,538
SEQUOIA CHINA GR IVFMV$22,456,554$22,456,554
SEQUOIA CHINA GRTH VFMV$31,877,099$31,877,099
SEQUOIA CHINA VE VIIFMV$6,961,358$6,961,358
SEQUOIA CHINA VTR IVFMV$12,117,192$12,117,192
SEQUOIA CHINA VTR VFMV$9,516,172$9,516,172
SEQUOIA CHINA VTR VIFMV$8,435,406$8,435,406
SEQUOIA GBL GRTH IIIFMV$126,509,054$126,509,054
SEQUOIA GG 3 CH ANXFMV$8,055,631$8,055,631
SEQUOIA GLB GROWTHFMV$58,737,501$58,737,501
SEQUOIA GLB GRWTH IIFMV$46,203,352$46,203,352
SEQUOIA IND GWTH IIIFMV$10,112,804$10,112,804
SEQUOIA IND VTR VIIFMV$2,976,104$2,976,104
SEQUOIA INDIA VFMV$16,011,246$16,011,246
SEQUOIA INDIA VIFMV$12,021,946$12,021,946
SEQUOIA ISRAEL VFMV$8,061,256$8,061,256
SEQUOIA SCOUT IIIFMV$2,319,529$2,319,529
SEQUOIA SCOUT IVFMV$383,454$383,454
SEQUOIA US GROWTH VFMV$3,644,549$3,644,549
SEQUOIA US GRTH VIIIFMV$14,487,067$14,487,067
SEQUOIA US GRWTH VIIFMV$17,899,869$17,899,869
SEQUOIA US GWTH IXFMV$8,210,652$8,210,652
SEQUOIA US GWTH VIFMV$13,536,477$13,536,477
SEQUOIA US VENT XVIFMV$7,127,542$7,127,542
SEQUOIA US VTR XIVFMV$33,485,268$33,485,268
SEQUOIA US VTR XVFMV$8,007,347$8,007,347
SEQUOIA US VTR XVIIFMV$2,734,071$2,734,071
SQUOIA GG 3 US IN AXFMV$12,398,506$12,398,506
STARWOOD XFMV$27,691,411$27,691,411
STARWOOD XIFMV$46,862,402$46,862,402
STARWOOD XIIFMV$6,883,036$6,883,036
TAURUS RESOURCES IIFMV$32,766,833$32,766,833
WTI VLL IXFMV$16,144,368$16,144,368
WTI VLL VIIFMV$11,404,600$11,404,600
WTI VLL VIIIFMV$21,471,065$21,471,065
WTI VLL XFMV$1,869,752$1,869,752
YORK CO INVEST 1FMV$1,745,106$1,745,106
YORK DISTRESSED IIIFMV$50,404,072$50,404,072
YORK DISTRESSED IVFMV$24,545,279$24,545,279
YORK EUROPEANFMV$2,094,171$2,094,171
YORK EUROPEAN IIFMV$35,947,200$35,947,200

Land Etc Schedule2 LandEtcSchedule2

Land Etc LandEtcGrp (3 entries)

Category Or ItemCategoryOrItemTxtCost Or Other BasisCostOrOtherBasisAmtAccumulated DepreciationAccumulatedDepreciationAmtBook ValueBookValueAmtEOYFMVEOYFMVAmt
FURNITURE, FIXTURES AND EQUIPMENT$2,533,661$1,473,077$1,060,584$1,060,584
LEASEHOLD IMPROVEMENTS$6,857,003$865,085$5,991,918$5,991,918
WORK IN PROGRESS$246,869$0$246,869$246,869

Legal Fees Schedule LegalFeesSchedule

Legal Fees LegalFeesGrp (6 entries)

CategoryCategoryTxtLegal FeesLegalFeesAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
HAROLD A MERIAM III (INVESTMENT RELATED)$34,176$34,176$0
LOEB & LOEB LLP (GENERAL AND ADMINISTRATIVE)$114,796$0$105,257
ROPES & GRAY LLP (INVESTMENT RELATED)$206,358$206,358$0
PATTERSON BELKNAP WEBB & TYLER LLP (GENERAL & ADMINISTRATIVE)$62,644$0$35,011
PROSKAUER ROSE LLP (GENERAL & ADMINISTRATIVE)$13,675$0$13,675
OTHER LEGAL FEES$15,220$0$17,165

Other Assets Schedule OtherAssetsSchedule

Other Assets Schedule OtherAssetsScheduleGrp (6 entries)

DescDescBOY Book ValueBOYBookValueAmtEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
ACCRUED INCOME RECEIVABLE$1,758,404$1,399,923$1,399,923
DUE FROM BROKER$10,708,909$107,058,082$107,058,082
RETIREMENT PLAN ASSET$1,725,098$1,898,891$1,898,891
ADVANCES AND OTHER RECEIVABLES$13$22,058$22,058
PREPAID FEDERAL EXCISE TAX$9,454,455$2,228,391$2,228,391
PROGRAM RELATED INVESTMENTS$16,614,400$20,909,674$20,909,674

Other Decreases Schedule OtherDecreasesSchedule

Other Decreases Detail OtherDecreasesDetail

FieldValueIRS element (for citing)
DescUNREALIZED LOSS ON INVESTMENTSDesc
Amt$468,837,509Amt

Other Expenses Schedule OtherExpensesSchedule

Other Expenses Schedule OtherExpensesScheduleGrp (8 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
AMERICAN DEPOSITARY RECEIPT FEE$16,890$16,890$0
CONSULTING REIMBURSEMENTS$19,042$0$19,391
CUSTODY, BANK, & PERFORMANCE REPORTING FEES$830,104$829,889$215
FILING FEES AND PENALTIES$51,276$0$1,625
INFORMATION TECHNOLOGY/COMPUTERS$1,554,580$241,219$1,289,674
INSURANCE$336,673$39,538$319,924
OFFICE EXPENSES$791,818$300,793$470,551
PORTFOLIO DEDUCTIONS$19,483,419$51,341,400$0

Other Income Schedule2 OtherIncomeSchedule2

Other Income Detail OtherIncomeDetail (6 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtNet Investment IncomeNetInvestmentIncomeAmtAdjusted Net IncomeAdjustedNetIncomeAmt
FX TRANSACTION NET GAIN$1,538,224$1,521,732$1,538,224
CLASS ACTION PROCEEDS, NET$26,593$26,593$26,593
OTHER PARTNERSHIP INCOME$38,741,078$44,425,949$38,741,078
SECTION 951(A) INCOME INCLUSION$233,106,429
GRANT RECOVERIES$892,513$892,513
OTHER TAXABLE INCOME$414$414$414

Other Increases Schedule OtherIncreasesSchedule

Other Increases Detail OtherIncreasesDetail

FieldValueIRS element (for citing)
DescDEFERRED FEDERAL EXCISE TAX BENEFITDesc
Amt$6,516,842Amt

Other Liabilities Schedule OtherLiabilitiesSchedule

Other Liabilities Detail OtherLiabilitiesDetail (6 entries)

DescDescBOY Book ValueBOYBookValueAmtEOY Book ValueEOYBookValueAmt
DEFERRED FEDERAL EXCISE TAX$43,954,729$37,437,887
RETIREMENT PLAN LIABILITY$2,389,093$2,509,260
ACCRUED VACATION$934,558$1,452,558
DEFERRED RENT EXPENSE$586,204$560,586
REFUNDABLE DEPOSITS$317$319
GRANT REFUNDS PENDING MODIFICATION$1,103,455$1,005,850

Other Professional Fees Schedule OtherProfessionalFeesSchedule

Other Professional Fees Detail OtherProfessionalFeesDetail (24 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
COLLER VI (INVESTMENT MANAGEMENT)$826,179$826,179$0
COLLER VII (INVESTMENT MANAGEMENT)$514,686$514,686$0
COLLER VIII (INVESTMENT MANAGEMENT)$260,342$260,342$0
DF DENT & COMPANY, INC. (INVESTMENT MANAGEMENT)$896,140$896,140$0
EDWARD GILLEN (PROGRAM CONSULTING)$125,020$0$125,020
FIDUCIARY MANAGEMENT, INC. (INVESTMENT MANAGEMENT)$772,776$772,776$0
GAVEA INVESTMENT FUND V B L.P.$538,219$538,219$0
GENESIS ANALYTICS (PROGRAM CONSULTING)$135,605$0$85,605
GLOBAL HEALTH STRATEGIES (PROGRAM CONSULTING)$423,023$0$512,839
GLOBAL STRATEGY GROUP LLC (PUBLIC RELATIONS)$324,670$0$327,170
IFP GLOBAL EQUITY LP (INVESTMENT MANAGEMENT)$1,516,006$1,516,006$0
OTHER CONSULTING FEES - GENERAL MANAGEMENT$60,982$4,086$47,321
OTHER CONSULTING FEES - GRANTS MANAGEMENT$111,105$0$107,745
OTHER CONSULTING FEES - HUMAN RESOURCES$12,330$4,000$8,330
OTHER CONSULTING FEES - INFORMATION TECHNOLOGY$44,545$0$38,985
OTHER INVESTMENT MANAGEMENT & CONSULTING FEES$42,937$42,937$0
OTHER PROGRAM RELATED CONSULTING FEES$508,285$0$513,251
OTHER PUBLIC RELATIONS CONSULTING FEES$115,331$0$130,835
OTHER RECRUITMENT FEES$50,838$0$73,947
PRECISION ADVISORS, LLC DBA PRECISION FOR VALUE, LLC (PROGRAM CONSULTING)$178,684$0$188,381
SCOTT KAHN (PROGRAM CONSULTING)$194,890$0$207,265
SOLUTION SIMPLE (INFORMATION TECHNOLOGY)$246,425$29,416$210,297
T. ROWE PRICE ASSOCIATES INC. (INVESTMENT MANAGEMENT)$694,426$694,426$0
WILSHIRE ASSOCIATES INCORPORATED (INVESTMENT ADVISORY)$438,320$438,320$0

Taxes Schedule TaxesSchedule

Taxes Detail TaxesDetail (3 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
STATE UNRELATED BUSINESS INCOME TAX$1,777,255$0$0
FOREIGN TAXES WITHHELD$530,184$3,095,765$0
FEDERAL EXCISE TAX$13,726,064$0$0

Transfers Frm Controlled Entities TransfersFrmControlledEntities

Transfers From Controlled Ent TransfersFromControlledEntGrp (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINDescDescAmtAmtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCdAddress Line2USAddress/AddressLine2Txt
ACADIAN FRONTIER MARKETS EQUITY FUND
260 FRANKLIN STREETBOSTONMA02110205852756DISTRIBUTION FROM PARTNERSHIP$1,204,747
CHATHAM CO-INVEST
26 MAIN STREET SUITE 204CHATHAMNJ07928850651355DISTRIBUTION FROM PARTNERSHIP$0
LACM GLOBAL EQUITY FUND LP
11150 SANTA MONICA BLVD STE 200LOS ANGELESCA90025453646231DISTRIBUTION FROM PARTNERSHIP$0
LACM WORLD SMALL CAP EQUITY FUND LP
11150 SANTA MONICA BLVD STE 200LOS ANGELESCA90025832888004DISTRIBUTION FROM PARTNERSHIP$0
MARATHON-LONDON GLOBAL SELECT INVESTMENT TRUST
611915057DISTRIBUTION FROM PARTNERSHIP$0ORION HOUSE 5 UPPER ST MARTINS LANELONDONUKWC2H 9EA
MHR LONGEVITY PARTNERS
1345 AVENUE OF THE AMERICAS 42NDNEW YORKNY10105981471155DISTRIBUTION FROM PARTNERSHIP$55,474,168FLOOR
NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANY FEEDER LP
2929 ARCH STREET 17TH FLOORPHILADELPHIAPA19104981142649DISTRIBUTION$0
FieldValueIRS element (for citing)
Total$315,126,035TotalAmt

Transfers To Controlled Entities TransfersToControlledEntities

Transfers To Controlled Ent TransfersToControlledEntGrp (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINDescDescAmtAmtAddress Line2USAddress/AddressLine2TxtAddress Line1ForeignAddress/AddressLine1TxtAddress Line2ForeignAddress/AddressLine2TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCd
ACADIAN FRONTIER MARKETS EQUITY FUND
260 FRANKLIN STREETBOSTONMA02110205852756MANAGEMENT FEE$1,204,747
MHR LONGEVITY PARTNERS
1345 AVENUE OF THE AMERICAS 42NDNEW YORKNY10105981471155CONTRIBUTION OF CAPITAL$55,474,168FLOOR
PITANGO SPV
981492234CONTRIBUTION OF CAPITAL$1,065,000BEIT ACKERSHTEIN - BLDG B 11HAMENOFIM ST 11TH FLHERZLIYAIS
FieldValueIRS element (for citing)
Total$57,743,915TotalAmt